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Zusammenfassung 
Ziele dieser Untersuchungen waren zum einen die Suche nach neuen Inhibitoren der Coenzym-
B12 abhängigen Glutamat-Mutase und zum anderen der Mechanismus des ersten Schritts der 
Katalyse, die Homolyse der Kobalt-Kohlenstoff-Bindung. Das Enzym Glutamat-Mutase aus dem 
Glutamat-fermentierenden Clostridium cochlearium ist aus zwei getrennt isolierbaren 
Untereinheiten, S und E2 aufgebaut, die in sich in Gegenwart Coenzym-B12 zu dem enzymatisch 
aktiven Holoenzym E2S2-B12 vereinigen, das die reversible Isomerisierung von (S)-Glutamat zu 
(2S,3S)-3-Methylaspartat katalysiert. Diese Reaktion wurde mit der Deaminierung von 
Methylasparat zu dem bei 240 nm absorbierenden Mesaconat gekoppelt, um einen UV-
spektrophotometrischen Test für die Glutamat-Mutase zu erhalten. Als potentielle Inhibitoren 
wurden Verbindungen ausgewählt, die sp
2
-Zentren und strukturelle Ähnlichkeiten zu den im 
Mechanismus postulierten Radikalen aufwiesen. Als Analoga zum 4-Glutamylreadikal wurden 
(E)- und (Z)-Glutaconat verwandt, während als Analoga zum 3-Methylenaspartat-Radikal 
Itaconat, Buta-1,3-dien-2,3-dicarboxylat, Mesaconat, Fumarat und Maleat eingesetzt wurden. Da 
alle diese ungesättigten Dicarbonsäuren das Hilfsenzym Methylaspartase inhibierten, wurde 
Glutamat-Mutase mit je einem der potentiellen Inaktivatoren inkubiert und nach Abtrennung der 
niedermolekularen Verbindungen mittels Gelfiltration, die Restaktivität bestimmt. Dabei zeigte 
sich, dass unerwarteter Weise nur Mesaconat, Fumarat und Maleat das Enzym inaktivierten. Um 
zu prüfen, ob die anderen Verbindungen das Enzym reversibel inhibierten, wurde ein neuer Test 
mit (2S,3S)-3-Methylaspartat, Pyruvat und NAD
+
 als Substrate ausgearbeitet. Mit Hilfe der 
Enzyme Glutamat-Pyruvat-Aminotransferase und (R)-2-Hydroxyglutarat-Dehydrogenase konnte 
die Bildung von Glutamat bei 340 nm gemessen werden. Dabei zeigte es sich, dass 2.5 mM 
Itaconat oder 8 mM (E)-Glutaconat die Glutamat-Mutase in Gegenwart von 200 mM (2S,3S)-3-
Methylaspartat zu 50% inhibierten. Zur Überprüfung der Zuverlässigkeit des neuen Tests wurden 
die kinetischen Konstanten für (2S,3S)-3-Methylaspartat bestimmt: Km= 7 ± 0.07 mM, kcat= 0.54 
± 0.6 s
-1
and kcatKm
-1
= 77 s
-1
M
-1
. Daraus berechnet sich mit den bekannten Konstanten für 
Glutamat und der Briggs-Haldane Gleichung die Gleichgewichtskonstante Keq = [Glutamat] × 
[Methylaspartat]
-1
 = 16, die mit dem Literaturwert von 12 gut übereinstimmt.  
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Ob 2-Fluoroglutarat, das Marta Drozdowska und Bernard T. Golding (Newcastle) synthetisiert 
worden war, als Substrat oder Inhibitor agiert, wurde sowohl mit dem Methylaspartase Test als 
auch mittels 
19
F-NMR und LC-MS bestimmt. Die Ergebnisse zeigten, dass 2-Fluoroglutarat zwar 
das Enzym inhibierte aber auch langsam zu einer anderen Verbindung mit gleicher Masse, sehr 
wahrscheinlich 3-Fluormethylaspartat, umgesetzt wurde. Die weitere Deaminierung zu 
Fluormethylfumarat konnte nicht beobachtet werden. 
Die Bildung, Stabilisierung und Wanderung des primären organischen 5'-
Desoxyadenosylradikals zum Substrat wurde kinetisch mit Hilfe folgender Coenzym B12 
Derivative untersucht: 2',5'-Didesoxyadenosylcobalamin, 3',5'-Didesoxyadenosylcobalamin und 
Peptidoadenylcobalamin, die von Felix Zelder (Zürich) synthetisiert worden waren; in letzterer 
Verbindung ist die Ribose des 5'-Desoxyadenosylliganden durch Peptid mit der geleichen Länge 
ersetzt. Mit diesen modifizierten Kofaktoren konnte zwar der E2S2-B12 Komplex rekonstituiert 
werden, aber nur das 3',5'-Derivat zeigte Aktivität: Km = 0.56 ± 0.02 μM, kcat = 0.089 ± 0.01 s
1
. 
Beim Vergleich mit den Werten für Coenzym B12, Km = 0.52 ± 0.06 μM, kcat = 1.24 ± 0.36 s
1
, 
fällt auf, dass die Bindungseigenschaften fast gleich sind, während der Verlust des 3'-O kcat/Km 
15-fach erniedrigte. Diese Ergebnisse unterstützen Daten der Röntgenkristallographie und 
quantenmechanische Rechnungen. Beide Methoden zeigten, dass 2'-OH und 3'-OH 
Wasserstoffbrücken mit Glutamat E330 und C19-H des Corrinrings bilden. Während eine 
konstante Brücke zwischen 3'-OH und Glutamat E330 besteht, erleichtern Brückenbildungen 
zwischen 2'-OH mit Glu330 und 3'-O mit C19-H die Homolyse der Kobalt-Kohlenstoff-Bindung. 
Diese neuen Interaktionen geleiten das 5'-Desoxyadenosylradikal zum Substrat, dass in einer 
Entfernung von 6 Å in der sogenannten “arginine claw” gebunden ist. Die kinetischen Daten 
ergaben mit weniger als 7 kJ, eine wesentlich niedrigere Interaktion als der berechnete Wert von 
30 kJ/mol. Sie passen daher viel besser zu der von Peter Friedrich in unserem Labor bestimmten 
äußerst niedrigen C19-H Azidität.  
Kinetische Messungen mit einem Coenzym B12 Derivat, in dem die untere Ribonukleotidschleife 
durch ein gleichlanges Peptid ersetzt ist, ergab wieder einen ähnlichen Km = 0.35 ± 0.05 µM aber 
einen 10-fach niedrigeren kcat = 0.12 ± 0.01 s
-1
 im Vergleich zu den Werten von Coenzym B12. 
Offensichtlich bindet das Derivat wie das natürliche Coenzym ähnlich fest ans Enzym, aber in 
einer leicht veränderten Konformation, die die Homolyse erschwert. 
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Das mutL Gen von Clostridium tetanomorphum liegt zwischen den strukturellen Genen der 
Glutamat-Mutase, mutE and mutS. Wir spekulieren, dass MutL als ATP-abhängiges Chaperon 
Co(II)alamin aus inaktiven Glutamat-Mutase-Komplexen entfernt. Die dabei freigesetzten 
Komponenten MutE und MutS vereinigen sich mit Coenzym B12 wieder zum aktiven Enzym. 
Um diese Hypothese zu überprüfen, wurde mutL in pASG-IBA3 und pASG-IBA5 
Expressionsvektoren über den pre-entry vector IBA-20 kloniert. Die Expression in E. coli 
Rossetta führte zu guten Ausbeuten. 
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Summary 
Aims of this study were the search for inhibitors of the coenzyme B12-dependent glutamate 
mutase and for insight into the first step of its catalytic mechanism, the homolytic cleavage of the 
cobalt-carbon bond. Glutamate mutase is composed of two separately isolated protein 
components S and E2, which in the presence of coenzyme B12 assemble to the active holo-
glutamate mutase E2S2-B12 that catalyzes the reversible conversion of (S)-glutamate to (2S,3S)-3-
methylaspartate. This reaction has been coupled with methylaspartase, which deaminates 
(2S,3S)-3-methylaspartate to mesaconate absorbing at 240 nm, to allow activity assays for 
glutamate mutase by UV-spectrophotometry. As potential inhibitors, compounds with sp
2
-
centers and structural analogies to the intermediate radicals in the proposed mechanism were 
selected. Analogues to the 4-glutamyl radical were (E)- and (Z)-glutaconates, whereas analogues 
to the (2S,3S)-3-methyleneaspartate radical included itaconate, buta-1,3-diene-2,3-dicarboxylate, 
fumarate, maleate and mesaconate. Because all these compounds inhibited the auxiliary enzyme 
methylaspartase, glutamate mutase was incubated with these compounds for a certain time, 
followed by gelfitration on Sephadex G25. The residual activity of the inactivator-free enzyme 
was then determined by the coupled assay described above, whereby unexpectedly fumarate, 
maleate and mesaconate caused inactivation of the mutase. To check whether the other 
compounds acted as reversible inhibitors, a new assay with (2S,3S)-3-methylaspartate and 
pyruvate as substrates involving glutamate-pyruvate aminotransferase and the NADH-dependent 
(R)-2-hydroxyglutarate dehydrogenase was developed. Application of this assay showed that 2.5 
mM itaconate and 8 mM (E)-glutaconate inhibited glutamate mutase in the presence of 200 mM 
(2S,3S)-3-methylaspartate by 50%. Furthermore, the kinetic constants of (2S,3S)-3-
methylaspartate in the reaction of glutamate mutase were determined as Km= 7 ± 0.07 mM, kcat= 
0.54 ± 0.06 s
-1
and kcatKm
-1
= 77 s
-1
M
-1
. Together with the kinetic constants of (S)-glutamate 
determined with the methylaspartase assay (Km = 2.25 ± 0.03 mM, kcat = 2.85 ± 0.5 s
-1
 and 
kcatKm
-1
 = 1.3 × 10
-3
 s
-1
M
-1
), an equilibrium constant of Keq = [glutamate] × [methylaspartate]
-1
 = 
16 was calculated by the Briggs-Haldane equation close to that described in the literature (Keq = 
12).  
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Whether 2-fluoroglutarate acted as substrate or inhibitor was analyzed by the coupled assay as 
well as by 
19
F NMR and LC-MS. The results showed that 2-fluoroglutarate inhibited the enzyme 
but was slowly converted to most likely 3-fluoromethylaspartate, which was not deaminated by 
methylaspartase. 
The formation, stabilization and movement of the primary organic 5'-deoxyadenosylradical to 
the substrate was kinetically investigated by the coenzyme B12 derivatives 2',5'-
dideoxyadenosylcobalamin, 3',5'-dideoxyadenosylcobalamin and peptidoadenylcobalamin. In the 
latter compound the ribose of the 5'-deoxyadenosyl ligand was replaced by a peptide of the same 
length. These modified cofactors accomplished the reconstitution of holo-glutamate mutase but 
only the 3',5'-dideoxy derivative gave measurable activity: Km = 0.56 ± 0.02 μM, kcat = 0.089 ± 
0.01 s
1
. When compared with the values for coenzyme B12, Km = 0.52 ± 0.06 μM, kcat = 1.24 ± 
0.36 s
1
, the almost equal Km suggested similar binding properties to the enzyme, whereas the 
loss of the 3'-oxygen caused a 15-times reduced kcat/Km. These results support data from X-ray 
crystallography as well as from quantum mechanical calculations, which revealed hydrogen-
bond interactions of the 2'- and 3'-oxygens with the conserved glutamate residue 330 of 
component E of glutamate mutase and C19-H of the corrin ring of the coenzyme. The calculations 
established a constant interaction of 3'-OH with Glu330, whereas the homolytic cleavage of the 
cobalt-carbon bond was promoted by the emerging hydrogen bonds of 2'-OH with Glu330 and 
3'-O with C19-H of the corrin ring. This new interactions guide the 5'-deoxyadenosylradical to the 
substrate bound in the “arginine claw” 6.6 Å apart from the cobalt. The kinetic data, however, 
revealed an interaction between C19-H and 3'-O of less than 7 kJmol
-1
, much lower than the 
calculated value of 30 kJ/mol, which is in complete agreement with measurements of the low 
C19-H acidity.  
Kinetic investigations with a derivative of coenzyme B12, in which the ribonucleotide loop 
connecting the lower ligand of the cobalt atom, 5,6-dimethylbenzimidazole, to the corrin ring 
was replaced by a peptide, again revealed a similar Km = 0.35 ± 0.05 µM but a 10-fold lower kcat 
= 0.12 ± 0.01 s
-1
. Apparently, this derivative binds to the enzyme in a similar tight manner as 
coenzyme B12, but in a slightly different conformation that impedes homolytic cleavage of Co-C 
bond.  
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The mutL gene from Clostridium tetanomorphum is located between the structural genes of 
glutamate mutase. We speculate that MutL acts as chaperone, which removes cob(II)alamin from 
inactive glutamate mutase complexes in an ATP dependent manner. The liberated components 
E2 and S recombine with coenzyme B12 to form a new active enzyme. To check this hypothesis, 
mutL was successful cloned on pASG-IBA3 and pASG-IBA 5 expression vectors via the pre-
entry vector IBA-20. The MutL chaperone was produced in E. coli Rossetta in good yields
1 
 
1. Introduction 
 
1.1 The anti-pernicious anemia discovery of vitamin B12 
The corrinoid cobalt complex vitamin B12 was discovered from diet in relation to the treatment 
of pernicious anemia (PA) after almost a century of the search for the cause and cure of 
pernicious anemia (PA) from the mid of the 19
th
 century. An earliest literature on the PA as 
authored by a Scottish physician J S Combe appears in the 1824 Transactions of Medico- 
Chirurgical Society in Edinburgh.
1
 Twenty five years later the foremost clinical descriptions for 
the disease were presented by an English physician, Thomas Addison at the meeting of the South 
London Medical Society in1849.
2
 Addison’s accounts defined the pallor, weakness and a 
progressive decline in health which culminated to death as the diagnostic symptoms for the 
idiopathic anemic syndrome which was later named after him.
2,3 
However, the cause for the disease remained uncertain throughout during the 19
th
century with 
emerged cases which were clinically diagnosed concurrent with neurological symptoms as first 
reported in the late 1860s by a German physician Anton Biermer.
4
 Despite with insufficient 
details, further descriptions for associating PA with spinal cord lesions followed in 1887 and 
1900 by Lichtheim and Russell respectively.
5
 A breakthrough for understanding PA association 
with the neurological disorders came in 1922 when Arthur Hurst at Guy’s Hospital in London 
revealed the same underlying pathological cause for the two diseases.
6
 Hurst’s finding also 
established the relation between the two diseases with the loss of hydrochloric acid in gastric 
juice as earlier demonstrated by Cahn and Mering in 1886.
7
    
Despite the recognitions on the influence of diet in the recovery of PA patients by the disease 
earlier investigators; Habershon (1863), Biermer (1872) and Pepper (1875), 
8,9
greater emphasis 
on investigations for the identification of nutritional components related to anti-PA began five 
decades later. It was from the early 1920s studies of food efficacy in restoring haemoglobin level 
of experimental anemic dogs: George Whipple reported liver was the most effective.
10
 
Expanding the work of Whipple and other medical records, George Minot and William Murphy 
successfully treated 45 PA patients with enormous liver diet in 1926.
11
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The publication of the therapy by Minot and Murphy prompted investigations for searching the 
liver component which is responsible for the recovery of the PA patients. Further studies on 
factors contributing to the therapy by William Castle in 1926 revealed the recovery of only PA 
patients fed with both liver and gastric juices taken from stomachs of health individuals. Non-
response of patients fed with only one factor, either liver or gastric juice as control experiments, 
led to Castle’s descriptions on the requirement of the interactions between the liver and stomach 
respectively extrinsic and intrinsic factors for the health status.
12
 Endeavors to identify the liver 
factor by various laboratories was accomplished in 1948 when Folkers at Merck research 
laboratories in New Jersey successful isolated small quantities of red crystalline compound from 
relative large amount of liver.
13
 Microgram quantities of the crystalline compound which was 
branded as vitamin B12 elicited rapid haemotological restorations in PA patients.        
                    
1.2 Vitamin B12 structure  
Preliminary chemical analysis for the determination of the isolated liver crystalline vitamin 
composition disclosed its cyano and cobalt contents. In the same year of isolation, E.L. Smith at 
Glaxo research laboratories in Greenford reported about 11.7 to13.9% of nitrogen content in the 
crystalline.
14
 Despite the several efforts for structure elucidation by various laboratories, it was 
not until 1954 when Doroth Hodgkin and her group in Oxford solved the complete structure of 
the liver isolated vitamin B12 by using x-ray crystallography.
15, 16
  
The x-ray crystal structure revealed an octahedral complex of nearly planner porphyrin 
resembling a macro corrinoid core constructed from 3,4-diyhdro-2H-pyrrole subunits which 
provide nitrogen atoms for the completion of complex four equatorial coordinates to the central 
cobalt atom. The complex α- coordinate (lower face) is completed by a dimethylbenzyl 
imidazole which is covalent bonded to D-ribonucleotide. The latter structure is linked back to the 
corrinoid system by a phosphodiester bond and has been useful in defining the vitamin B12 
derivatives cobalamins as those corrinoid complexes of cobalt with α-dimethylbenzyl imidazole-
D-ribonucleotide coordinate that distinguishes them from pseudocobalamins. The structure of the 
β-coordinate (upper face) specifies the cobalamin among the existing four forms.  
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As revealed in the preliminary chemical analysis and later x-ray crystallography, the liver 
crystalline vitamin was isolated with a cyano-group completing the upper coordinate for which it 
has also being known as cyanocobalamin (1). Generally referred as vitamin B12, cyanocobalamin 
(1) is widely used as a food additive through which consumers of processed food are supplied 
with the vitamin. However, cynocobalamin (1) does not exist in any biological system and the 
original liver isolate was an artifact due to the used purification protocol which involved 
treatment with potassium cyanide.
17
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Figure 1: Structures of vitamin B12 derivatives 
Other cobalamins are; hydroxocobalamin (2), known as from the β-hydroxyl ligand and the 
biological active forms; methylcobalamin (3) and adenosylcobalamin (4) with respective methyl 
and adenosyl groups completing the β-coordinate. Adenosylcobalamin (4), which is also known 
as the coenzyme B12, as well as the methylcobalamin (3), are cofactors for several known 
reactions of archaea, bacteria and higher animals. Most of the industrial used bacteria for 
commercial production of vitamin B12 biosynthesize hydroxycobalamin (2), which is converted 
to cyanocobalamin (1) during the purification stage that employs an activated charcoal.  
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Also industrial important are mixed culture fermentation that give a mixture of 
hydroxycobalamin (2), methylcobalamin (3), and adenosylcobalamin (4) which are converted to 
cyanocobalamin (1) by heating with potassium cyanide and sodium nitrite.  
Determinations on the magnetic properties of cobalamins revealed the octahedrals 
diamagnetisms in all four forms of cobalamins. These diamagnetisms have been demonstrated by 
the existence of Co(III) state with (d
6
) configuration.
 
The alterations between the 2 electrons 
filled dz orbital Co(III) with the Co(II) which is filled with 1 electron  in the dz orbital, as well as 
the Co(I) which contains 2 electrons in the dz orbital during the respective coenzyme B12  and 
methylcobalamin co-enzymatic catalysis cause changes in both the UV/Vis absorptions and the 
magnetic properties of cobalamin. These redox states changes have been followed 
spectrophotometrically in both the coenzyme B12 and methylcobalamin dependent reactions.
18, 19
 
The Co(II) state cause paramagnetisms and absorption peak at 470 nm, whereas Co(I) retains 
diamagnetism with maximum absorption peak close to 400 nm,
 
hence provided insights on the 
two cofactors mode of actions.  
  
1.3 Vitamin B12 transport and delivery 
 
1.3.1 The gastrointestinal pathway for vitamin B12 
In contrast to those archaea and bacteria species, which are able to synthesize cobalamins, higher 
animals depend on vitamin B12 supplied with diet. Although the amount of the vitamin B12 
differs with food type, most contain enough quantinty to meet the minimum requirement for the 
health status. An individual is required to ingest 1-2 µg of the vitamin per day.
20
 The main 
vitamin B12 source for humans include liver, meat, fish, eggs and milk. In access to balance diet, 
an adult ingests between 5 to 30 µg of vitamin B12 daily, from which about 2 to 3 mg is retained 
by the body store of cobalamin with permanent reserve of about 1 mg in the liver.
21
   
Three soluble carrier proteins; haptocorrin (HP), intrisic factor (IF) and transcobalamin (TC) are 
involved in the uptake of vitamin B12 along the gastrointestinal track and circulation to its two 
intracellular destinations; cytosolic methionine synthase and mitochondrial methylmalonyl -CoA 
mutase, where it plays a role as coenzyme.
22-25
 Cobalamins bound to diet proteins are usually 
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released during food preparation or due to acidic conditions of gastrointestinal tract and actions 
of peptic enzymes after which they bind to haptocorrins (HP) present in saliva during ingestion. 
Secreted by saliva glands and gastric mucosa, haptocorrins (HP) bind cobalamins with high 
affinity in low pH and therefore protect them from the acidic environment as well as intestinal 
bacteria while transported along the track. The decreased cobalamins affinities to haptocorrins 
due to the increased pH in duodenum together with the digestion of carrier proteins by the action 
of pancreatic enzymes liberate cobalamins which are then taken by intrinsic factors in 
intestines.
26
 Intrinsic factors are secreted with gastric juices in stomach but bind cobalamins at 
the alkaline pH in intestines where they assist their transportation across intestinal enterocyte to 
circulation by cubilin mediated IF-B12 endocytosis.
27,28
 It takes up to 4 hours after ingestion for 
cobalamins to enter the circulation where they bind transcobalamins (TC) present in blood 
plasma. Up to 1.4 µg per day of vitamin B12 from enterohepatic circulation is excreted via bile 
salts through which it lost from being taken intracellular.
21
 With such a discharge amount, the 
several years of optimal B12 level after an individual absorption has been impaired is accounted 
by the fact that the enterohepatic circulation is coupled with total body reserve of B12. The 
plasma TC-B12 complexes are subsequently taken intracellular by membrane receptors mediated 
endocytosis where cobalamins are freed from TC and exposed for enzymatic transformations to 
coenzyme forms after the carrier protein digestion by lysozymes.
28
  
The delivery of vitamin B12 from diet to cells consequently requires an intact and functioning 
gastro-intestinal track. Impairment of any organ involved during its uptake pathway will 
eventually lead to the vitamin B12 deficiency diseases due to the decrease of intracellular level of 
cobalamins as it has been mostly attributed by failure of the vitamin absorption. The current 
comprehended mechanism for the vitamin uptake along the tract explains the clinical association 
of PA and neurological symptoms which have been diagnosed concurrent since the mid-19th 
century era of controversial relation between these two diseases. Mysterious during those times, 
the cobalamin carrier protein intrinsic factor (IF) was the focus of those earlier landmark 
descriptions for the relation between the two diseases. Among several, the foremost were; the 
same underlying pathological cause for PA and its associated neurological lesions which also 
relates the diseases with the gastric juice by Arthur Hurst in 1920
6
 and the existence of intrinsic 
factor in the stomach that both with the liver factor are necessary for the health status of PA 
patients by William Castle in 1926.
12 
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1.3.2 Application of B12 uptake for delivery of therapeutic agents  
The mechanism by which B12 is shielded from various unfavorable conditions as well as 
intestinal fauna while transported to cells along the gastrointestinal track promises the provision 
of a reliable mean for delivery of molecules into cells. Potentials for protection against 
enzymatic degradation and efficiencies in absorption from intestines while coupled with B12 have 
brought particular interest to parenteral administred peptides and protein drugs. Developments to 
exploit the B12 diet uptake pathway for oral delivery of therapeutic agents have therefore gained 
extraordinary attention over the last five decades.
 
However, the effective delivery through the 
pathway is relying on the ability of those therapeutic agents to travel with the vitamin without 
interfering with its uptake mechanism while remain unaltered. Vital to success has therefore been 
the coupling of B12 with an agent in a manner such that neither is impeded by the other.
21
 
Restoration of carrier proteins specificities and affinities to the modified vitamin (i.e drug linked 
B12) with achieved agents desired effects at the target require conjugation on functional groups 
which are not involved in either molecule mechanism.  
Several endeavors by various laboratories to combine these acquaintances toward delivery of 
drugs and radiopharmaceuticals have been reported. Attempted exploitation of the uptake 
mechanism to deliver peptide and protein drugs employed various length of spacer linkers which 
achieved tuning to ideal recognition and affinity of modified B12 to carrier proteins as well as 
absorption from intestines. B12 offers three sites for conjugation with this class of drugs; ɛ-
propionamide, α-5'-hydroxy and α-phosphate (Figure 2a).21, 29 Among the described successful 
deliveries since 1990s include that of a 34 kDa erythropoietin (EPO), which stimulate erythroid 
progenitors maturation to erythrocytes for increasing erythrocytes count in patients receiving 
kidney treatment by dialysis. The oral delivery of granulocyte-colony-stimulating factor (G-CSF) 
(19.6 kDa) by B12 for increasing the production of leucocytes during chemotherapy treatment of 
cancer was also reported.
30,31
 Other published results from this area include the delivery of 1.2 
kDa luteinizing-hormone-releasing hormone (LHRH) and 1.6 kDa LHRH antagonists 
(ANTIDE).
32
 LHRH and LHRH ANTIDE proteins have been used for management of disorders 
which arises in due to the impairment of gonadotropin level. The coupling of insulin (5.7 kDa) 
with B12 and its subsequent delivery to circulation via the oral route has also been reported 
(Figure 2b).
 33
 Delivering insulin into the circulation is necessary for maintaining optimal level of 
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sugar in blood of diabetic patients. Synthesis for delivery of EPO, G-CSF and ANTIDE 
employed linkers which conjugated the proteins from ɛ-propionamide on the B12 while insulin 
was linked from either ɛ-propionamide or α-5'-hydroxy with maximal affinities to IF as well as 
absorption to circulation from intestines. 
                                                                  
 
   
(a)                                                                                  (b) 
Figure 2 (a) Cobalamins functional groups (in circle) for conjugations to peptides/protein drugs with 
optimal affinities of the modified vitamin to the transporting proteins HP, IF and TC. (b) Top: vitamin B12 
conjugated to insulin by linker which connects the vitamin ribose hydroxyl group with lysine 29 residue 
of insulin B strand. Bottom: The modified vitamin B12 i.e B12-insulin conjugate bound to transcobalamin
21
                                            
 
Other studies for exploring the applications of B12 uptake have been those aimed to deliver metal 
agents for both diseases diagnosis and treatment. There have been many reports from this line of 
research including the synthesis and hypoglycemic properties of vanadium-B12 bioconjugates
34
 
(figure 3) and those for developing B12-conjugated radiolabelled agents for tissue imaging and 
cytotoxicity.
35, 36
 Among several reported successful delivery of imaging agents has been the 
results of the studies based on the fact that rapid proliferating cells up-regulate transcobalamin II 
receptors during DNA replication in preparations for cells division. This hypothesis led to the 
work which achieved the delivery of radiolabelled diethylenetriaminepentaacetate (DTPA) 
cobalamin derivatives for imaging malignant and non-malignant transcobalamin II expressing 
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tissues.
37 
Pilot experiments with animals have lead to recommendations for further development 
towards the in vivo application of DTPA cobalamin derivative in imaging transcobalamin II 
expressing tissues. Hypothetical relation to the transcobalamin II target of DTPA is that for 
studies which aimed towards the development of B12 mediated endocytosis of theraupatic agents 
in choriocarcinoma placental BeWo cell lines. These cells express cubilin receptors for 
anchoring IF-B12 complex. Cubilins were targeted for selectively delivery of B12 conjugated 
rhenium complex bioprobe in experiments which reported uptake and cytotoxicity effects of the 
complex as well as its interaction with nuclear DNA.
38
 This study has demonstrated the potential 
of cubilin mediated endocytosis in delivering B12 conjugated agents which can be used in both 
diagnosis and treatment of cancer. 
 
 
 
Figure 3:  Structures of hypoglycemic mono- (1) and bis- (2) ligated vanadium-B12 conjugates
34 
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1.4 B12 dependent enzymatic reactions 
The B12 dependent enzymes are found in archaea, bacteria and higher animal domains where 
they are involved in the catalysis of various reactions for several biosynthesis and energy 
conservation metabolisms. The classification of these enzymes into three major groups; 1) 
methylcobalamin, 2) coenzyme B12 and 3) cob(I)alamin dependent enzymes has based on the 
participating cobalamin cofactor during their respective reactions.
39
 While the methylcobalamin 
dependent enzymes catalyze the addition of methyl group to substrate and therefore conversion 
to the methylated product, the coenzyme B12 dependent group comprises enzymes which 
catalyze the skeletal rearrangement of substrates to their structure isomers products. The 
described environmental useful cob(I)alamin mediated abiotic and enzymatic dehalogenations 
have form a third type of B12 dependent reactions.  
 
1.4.1 The cob(I)alamin dehaloganations 
The cob(I)alamin mediated dehalogenations have been generally postulated to proceed via the 
SN2 substitution reaction of cob(I)alamin with alkyl halides which form an alkylcobalamin as an 
intermediate of the catalytic cycle. Conversely, the well studied abiotic reductive dehalogenation 
of polychlorinated ethenes revealed cob(I)alamin initiates the reaction by releasing an electron 
which is transferred to the halogenated ethene. This one electron reduction lead to a free 
polychlorinated ethene radical that proceed by disintegration to halogenide ion and 
dehalogenated product related radical which is further reduced to dehalogenated product.
40, 41
 
Reduction rates for these cob(I)alamin mediated dehaloganations highly depend on the number 
of halogen substituents on the organohalide as verified by the 82,000-times lower rate of 
vinylchloride dehalogenation in comparison to that of CCl4.
40, 42
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Figure 4: The proposed mechanism for the abiotic cob(I)alamin mediated reductive dechlorination of 
tetrachloroethene
40 
The mechanism for dehalogenation of polychlorinated ethenes by reductive dehalogenases from 
Dehalobacter restrictus, Dehalospirillum multivorans and Desulfitobacterium strain PCE-S has 
also been proposed to be initiated by cob(I)alamin. In these enzymatic dehalogenations, which 
are believed to be in compliance with the largely accepted tentative mechanism, the cob(I)alamin 
is alkylated by chlorinated ethene in the SN2 substitution which is followed by heterolytic 
cleavage of the alkylated cobalamin Co-C bond into cob(III)alamin and chlorinated ethene with 
the loss of chloride ion.
43, 44 
Electrons generated from oxidations of Fe-S clusters reduce the 
former to cob(I)alamin via cob(II)alamin to complete the redox cobalamin reductive 
dehaloganation cycle.  
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Figure 5: Proposed mechanism for the dehalogenases catalyzed reductive dechlorination of 
tetrachloroethene via the addition of cob(I)alamin at C1 which is followed by the loss of Cl

 at C2 
40
  
 
Since chlorinated hydrocarbons also occur naturally,
45
 this redox cobalamin mechanism for their 
reductive dehalogenations has been considered to evolve specifically for the bacterial adaptation 
on these xenobiotics well before their industrial use. Recent era of industrial pollutions by these 
organochlorines have lead to the exploration of the mechanism for possible application in 
bioremediations of polychloroethenes polluted environments.          
 
1.4.2 Methylcobalamin dependent enzymatic reactions 
The three types of methylcobalamin dependent enzymes; methionine synthase, CoM 
methyltransferase and corrinoid Fe/S proteins are known to catalyze the transfer of a methyl 
group from pterin compounds to nucleophilic substrates, usually thiolated compounds with 
potential to accept methyl carbocation (Table 1).
46
 The mechanism for methylations by these 
enzymes proceeds via the heterolytic cleavage of the methylcobalamin Co-C β-coordinate 
resulting into the super nucleophile cob(I)alamin and methyl carbocation. The latter is 
subsequently accepted by a thiol group of the substrate to give the methylated product. The 
catalytic cycle achieves the regeneration of methylcobalamin through the donation of the methyl 
12 
 
group by activated pterins, N
5
-methyltetrahydrofolate or N
5
-methyltetrahydromethanopterin to 
cob(I)alamin.  
 
 
Methyltransferases 
 
Cobalamin dependent methyltransferases reactions 
 
Methyl donors 
 
Methionine synthase 
 
Homocysteine + CH3-H4folate → Methionine + H4folate 
 
N
5
-methyltetrahydrofolate 
 
CoM methyltransferase 
 
CH3-H4MPT + HSCoM → H4MPT + CH3-SCoM 
 
CH3-OH + HSCoM → CH3-SCoM + H2O  
 
N
5
-methyltetrahydromethanopterin 
 
Methanol 
 
Corrinoid Fe/S proteins 
 
(i) CH3-H4folate + Corrinoid/FeS protein → H4folate + CH3-
corrinoid Fe/S protein 
 
(ii) CH3-corrinoid Fe/S protein + CO dehydrogenase → Corrinoid 
Fe/S protein + CH3- CO dehydrogenase 
 
N
5
-methyltetrahydrofolate 
 
 
 
Table 1:  Cobalamin dependent methyltransferases catalysed transfer of methyl group from pterins or 
methanol (methyl donors) to nucleophilic substrates (usually thiolated compounds) which are transformed 
to methylated products 
 
The de novo biosynthesis of pterins is restricted to certain plants and bacteria. Similar to 
cobalamins, in mammals pterins are supplied via diet and recycled by various folate dependent 
metabolic pathways like those for thymidylate biosynthesis (figure 12). Main diet source of 
folate include leaf vegetables, egg yolks, sunflower seeds, legumes e.g beans and peas, as well as 
baker’s yeast. Liver provides a secondary source of folate to human since it contains derivatives 
of folate metabolites. In some contries fortifications of grains with vitamin B9 have been useful 
in supplementing diet with folate.     
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Figure 6: Structures of pterins methyl donors in methylcobalamin dependent methyltransferase reactions: 
tetrahydrofolate (1a), N
5
-methyltetrahydrofolate (1b), tetrahydromethanopterin (2a) and N
5
-
methyltetrahydromethanopterin (2b)  
 
The well-studied bacterial (136 kDa) and mammalian (141-155 kDa) methionine synthase 
systems catalyse the addition of a methyl group donated by N
5
- methyltetrahydrofolate (5) to 
homocysteine (6) which is converted to methionine (7).
46, 47, 48
 While in bacteria this methylation 
forms the last step of the de novo bio-synthesis of methionine, in mammals it is also significant 
in recycling of homocysteine via methionine. Being a proteineous amino acid, the methionine is 
either incorporated in protein during the translation of the mRNA codons to peptide amino acid 
sequence, or converted to S-adenosylmethionine (SAM) (8) during its ATP dependent reaction 
with an adenosine which is catalyzed by S-adenosylmethionine synthase. The positive charged 
sulfur atom in SAM promotes the leaving of methyl group as carbocation, hence makes SAM to 
be a potent methylating agent for various biological nucleophiles. During these SAM dependent 
specific methyltransferase catalyzed reactions, SAM is converted to adenosylhomocysteine (9) 
along with the formation of the methylated products. The hydrolysis of adenosylhomocysteine 
(9) achieves an adenine and homocysteine (6) which keeps recycling by accepting methyl 
carbocation donated by N
5
- methyltetrahydrofolate (5) via cob(I)alamin. The deficiency of 
cobalamin leads to decline of tetrahydrofolate level in cells with increased concentrations of N
5
-
methyltetrahydrofolate and homocysteine.
 
The medical consecuences resulted from this decrease 
of the cellular level of tetrahydrofolate is discussed in the section for the medical aspects of B12 
in metabolisms (1.5.1).   
14 
 
The deviations from the primary catalytic cycle resulted from the cob(I)alamin oxidative 
deactivation or the photolysis of methylcobalamin which form cob(II)alamin are enzymatically 
re-directed to the catalytic active cob(I)alamin in a single electron reduction process. The 
electron used in this reductive activation is derived from NADPH and transferred to cobalamin 
via flavodoxin.
49
 Regeneration of methylcobalamin cofactor is subsequent achieved from the 
irreversible methylation of cob(I)alamin by SAM.
50
  Since the cob(I)alamin inactivating oxidant 
is molecular oxygen, the methionine synthase system for reductive activation has not been 
required during the enzyme anaerobic turnover. 
49, 51, 52
  
  
Figure 7: The catalytic cycle of the folate and cobalamin dependent methylation reaction which is catalyzed by 
methionine synthase. The deviation from the primary turnover due to the oxidative deactivation to cob(II)alamin is 
enzymatically re-directed to the primary cycle in the one electron reduction to cob(I)alamin by flavin which is 
followed by the irreversible methylation to methycobalamin by SAM.  
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The methionine synthase system efficient enhances the heterolytic cleavage of the 
methlycobalamin β coordinate by 105 folds.46,53 During the catalytic cycle, the formation of 
cob(I)alamin from the cofactor bond cleavage as well as cob(II)alamin which resulted from the 
oxidative deactivation of cob(I)alamin have been demonstrated by UV/Vis spectroscopy.
18,19
 
Further characterization on the methionine synthase catalytic cycle by EPR spectroscopy also 
established the formation of cob(II)alamin which disappear following the reductive methylation 
in consistence to the results of the UV/Vis spectroscopy.
18,47
 While in action the holomethionine 
synthase has been composed of two alternating methylating coenzymes; the N
5
-
methyltetrahydrofolate and methylcobalamin which are constant recycled after their 
demethylations. Other catalytic significant prosthetic groups are also existing in the methionine 
synthase as well as the coenzyme M and corrinoid Fe/S methyltransferases. Studies for 
methionine synthase by proteolytic approach established the four domains modular constitutional 
of the apo-enzyme with defined catalytic functions of its residues.
54, 55, 56
 Tryptic digestion of the 
bacterial methionine synthase lead to the enzyme domains fragmentation which allowed 
experimental verifications of the different catalytic roles by various enzyme regions.
57, 58
 The 61 
kDa amino terminal fragment was revealed to contain cysteines bound Zn
2+
. Purified 
recombinant protein comprising residue 2-353 of methionine synthase was able to catalyze the 
transfer of methyl group from free methylcobalamin to homocysteine but not from N
5
-
methyltetrahydrofolate to free cob(I)alamin. In another studies, a portion containing residue 2-
649 of the truncated enzyme was demonstrated with ability to catalyzed the transfer of methyl 
group from N
5
-methyltetrahydrofolate to free cob(I)alamin and further methylation of 
homocysteine by free methylcobalamin. The Cys310Ala and Cys311Ala mutations of residue 2-
649 portion retained only the ability of this fragment to transfer the methyl group from the N
5
-
methyltetrahydrofolate to the free cob(I)alamin. The fragment ability to catalyze the transfer of 
the methyl group from the free methylcobalamin to homocysteine was complete lost in due these 
mutations. These results indicate the homocysteine is bound within residue 2-353 portion of the 
enzyme whereas the residues 354-649 binds the N
5
-methyltetrahydrofolate.
55
 The cysteines 
bound Zn
2+
 in the region 2-353 is postulated to acts as a lewis acid by which the homocysteine is 
activated to accept the methyl carbocation in the course of Zn
2+
 coordination to the thiol group 
from the homocysteine.
 59
 Moreover, the methionine synthase mechanistic fascinating has been 
the supernucleophile cob(I)alamin is unreactive toward N
5
-methyltetrahydrofolate in the absence 
16 
 
of an enzyme because of the unactivated N
5 
methyl group on the folate which is in contrast to the 
non-enzymatic SN2 methylation of cob(I)alamin by SAM. This folate inertness demonstrates the 
uniqueness of methionine synthase catalysis that involves the enzymatic activation of N
5
-
methyltetrahydrofolate which is necessary for methyl donation in the mechanism with no 
similarity in conventional chemistry. The activation is predicted to be accomplished within the 
proximity of the identified folate binding region. Based on the structure of the methyl donor 
tertiary amine on the N
5
-methyltetrahydrofolate, four mechanisms have been proposed for the 
activations of the N
5
-methyltetrahydrofolate.
18, 19
 Proposed two electrons oxidation on either of 
the two carbons α to the methyl donor tertiary amine lead to the formation of the quinoid 5-
methyldihydrofolate (8a) and 5-methyl-7, 8-dihydrofolate (8b) intermediates with activated N
5 
methyl group due to the quaternization of the folate N
5
. The amine one electron oxidation will 
form the hypothetical potential methyl donor amine radical (8c). Also proposed mechanism for 
the N
5
-methyltetrahydrofolate activation is the quarternization of the folate tertiary amine 
nitrogen by protonation (8d).
18
 These proposed activations by oxidations and protonation have 
exuhasted the theoretical mechanistic possibilities for the activation of the methyl donor tertiary 
amine group on the N
5
-methyltetrahydrofolate.   
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Figure 8: Structures of the proposed activated states of N
5
-methyltetrahyofolate.
18
 The structure of the R 
group is shown in figure 6 
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However, the non-existance of any group which can be reduced by the hydride within the 
holomethionine synthase system has waived the possibilities for the activations by the two 
electrons oxidations of either of the two carbons α to the tertiary amine of the N5-
methyltetrahydrofolate. Furthermore, neither the successful characterization of amine radical 
cation nor the loss of tritium from the C-6 tritium labeled N
5
-methyltetrahydrofolate when in the 
solution has been established. 
60
 The N
5
-methyltetrahydrofolate susceptibility for protonation
61
 
has suggested the activation by protonation via the intermediate (8d). However, the activation by 
protonation of N
5
 cannot be concluded since atoms which accept protons on the N
5
-
methyltetrahydrofolate are yet to be identified.    
  
The cobalamin binding motif, His759-Asp-Ser triad is located within residues 650 to 896 which 
form a 27 kDa fragment following the partial proteolysis.
58
 This 650-896 region was established 
to be responsible for binding the cobalamin by the x-ray crystallography.
62 
The methionine 
synthase without this cobalamin binding domain catalyses the transfer of methyl group from the 
N
5
-methyltetrahydrofolate to homocysteine via the free cob(I)alamin.
55
 Crystal structure of this 
cobalamin binding region revealed that methylcobalamin is bound to methionine synthase 
through cobalt coordination to imidazole from the enzyme his-759 which replaces the 
dimethylbenzimidazole. This B12 “base off, his on” binding mode has also been reported in other 
B12 partner proteins with conserved triad motif (His-Asp-Ser) for cobalamin binding. Replaced 
dimethylbenzimidazole in the “base off, his on” binding mode is usually found deposited in 
protein hydrophobic patches. Residues 897-1227 forms the 38 kDa c-terminal fragment of the 
methionine synthase which binds SAM.
55
 This fragment interacts with the methionine synthase 
reductase (MSR) which depends on NADPH and diflavin oxidoreductase to accomplish the 
reductive activation of the cob(II)alamin that arises following the deviation from the catalysis 
primary turnover resulted from oxidative deactivation of cob(I)alamin or the photolysis of 
methylcobalamin.
56
 Muting of this fragment was characterized with a comparable rate of methyl 
group transfer from the N
5
-methyltetrahydrofolate to homocysteine with that of complete 
enzyme, but with decreasing activity after about 2000 turnovers which could not be rescued by 
SAM. 
58
 The decreasing of the holoenzyme activity due to the absence of this domain has also 
been associated with the build up of the cob(II)alamin which provided further evidence for the 
reductive activation of methionine synthase by this domain. 
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1.4.3 Coenzyme B12 dependent enzymatic reactions 
Coenzyme B12 dependent enzymes accomplish the catalysis of an unusual vicinal exchange 
between a hydrogen atom and a functional group on the substrate molecule resulting into skeletal 
rearrangement to a product which is a structure isomer of the reaction substrate. There are more 
than ten so far described coenzyme B12 dependent enzymes, which are classified into two major 
groups; mutases and eliminases. The rearrangement reactions catalyzed by these enzymes are 
represented by the below general equation (figure 9), where the migrating group X is usually an 
electron withdrawing functional group.  
 
X H H X
SH PH  
 
Figure 9: Schematic presentation for the coenzyme B12 dependent vicinal groups exchange resulting into 
the rearrangement of substrate (SH) to form product (PH) 
                
Based on their substrate migrating groups; mutases have been further classified into carbon 
skeleton and amino mutases with respective migrating skeletal carbon structures and amino 
group of substrates (table 2). While all mutases have the conserved His-Asp-Ser triad motif for 
“base off, his on” binding of the coenzyme B12 like in methylcobalamin dependent 
methyltransferases, in eliminases the coenzyme is bound to a partner enzyme by hydrogen 
bonding between its various functional groups and active sites protein residues.
63
 Since in the 
latter mode of binding the cobalamin α Co-N coordinate remain intact when the cofactor is 
bound to protein as shown only in the described eliminases, hence it has been known as “his-off, 
base on”. It is therefore important to note that; the “his-off base on”  binding of coenzyme B12 to 
eliminases represent a third type of mode for cobalamins binding to their partner proteins after 
“base off his-on” as well as that for  binding HP, IF and TC carrier proteins.  
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Enzyme 
 
Rearrangment reaction 
 
Group X 
 
Glutamate mutase 
O2C CO2
NH3
H3C
CO2
NH3
CO2
 -CH(NH2)CO2H 
 
2-Methyleneglutarate mutase 
O2C CO2
CO2
CO2
 -C(=CH2)CO2H 
 
Methylmalonyl-CoA mutase 
O2C SCoA
H3C
SCoA
O
O
CO2
 -COSCoA 
 
Isobutyryl-CoA mutase SCoA
SCoA
O
HH3C
O
 -COSCoA 
 
D-α-Lysine-5,6-aminomutase 
CO2
NH2
NH2
CO2
NH2
H2N
 -NH2 
 
1,2-Diol dehydratase HO
OH
H3C H
O
+ HOH
 -OH 
 
Glycerol dehydratase 
HO OH
HO O
OH H
+ HOH
 -OH 
 
Ethanolamine amino lyase 
H2N
OH
H3C H
O
+   NH2/H2
 -NH2 
 
Ribonucleotide reductase 
O
B
OHOH
RO
O
B
OH
RO
 None 
 
Table 2: Selected rearrangement reactions catalyzed by coenzyme B12 dependent enzymes. The migrating carbon 
skeleton groups in carbon skeleton mutases are shown in blue and in amino mutase the migrating amine is in red. In 
the eliminases the migrating groups which are irreversible eliminated are shown in green. 
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Unlike the methylcobalamin dependent methylations by methyltransferases, the coenzyme B12 
dependent reactions involve the homolytic cleavage of the cofactor Co-C bond that switches to 
the radical mechanism which accomplishes the rearrangement of substrates to products. The 
reported 130 kJmol
-1
 bond strength of the coenzyme B12 β coordinate 
64
 has been predicted to be 
not exceedingly weak to an extent which will allow the facile homolysis to occur.  The addition 
of extra energy towards the homolysis of Co-C bond during the catalysis by the coenzyme B12 
dependent enzymes has consequently been considered compusary. This extra energy has long 
been suggested to be derived from the conformational changes by both the coenzyme B12 and 
partner protein which are induced by binding of the substrate to holoenzyme. Although the 
mechanism by which these enzymes accomplish the bond homolysis is yet to be uncovered, the 
extent of assistance derived from the conformational changes is estimated to 1 x 10
11
. 
65, 66
 
Coenzyme B12 dependent reactions are therefore initiated by substrates binding to holoenzymes 
which triggers the homolysis of the cofactor Co-C β coordinate resulting into the primary organic 
radical; 5'-deoxyadenosyl and the paramagnetic species; cob(II)alamin (figure 10).  
 
 
 
 
 
 
 
 
Figure 10: Homolytic cleavage of the coenzyme B12 Co-C β coordinate resulting into 5'-deoxyadenosyl 
radical and the paramagnetic species; cob(II)alamin. 
 
The 5'-deoxyadenosyl radical stereo-selectively abstracts hydrogen atoms vinyl to the migrating 
electron withdrawing functional groups on substrates molecules to give an adenosine and the 
substrates derived radicals which rearrange to products related radicals.  Hydrogen from the 
methyl group of the 5'-deoxyadenosine is finally claimed back by the product related radical to 
form the reaction product with regeneration of the coenzyme. The minimal mechanistic scheme 
for coenzyme B12 dependent rearrangements shows the hydrogen atom and its vicinal electron 
withdrawing functional group migrations and subsequent exchange of positions which lead to 
Co
H2C
HH
H
HO
OH
H
NH2
N
N
N
NO
Co
O N
N
N
N
NH2
H
OH
HO
H
HH
H2C
IIIII
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products of these reactions. The hydrogen atom migrates inter-molecularly via 5'-deoxyadenosyl 
radical while that of an electron withdrawing group is happening intra-molecularly.
67, 68
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: The minimal mechanistic scheme for coenzyme B12 dependent reactions showing the 
rearrangement of the substrate to form the reaction product via the intermediates substrate derived and 
product related radicals
68
   
  
As shown in the minimal mechanistic scheme, the vicinal interchange is reversible in all 
coenzyme B12 dependent reactions. In eliminases catalyzed reactions the irreversible loss of the 
migrating groups occur after the vicinal exchange which leads to their elimination as water or 
ammonia as implied by the class name. 
 
1.5  The diversity of B12 in metabolism 
Exceptions to the methylation of homocysteine (6) to methionine (7) by the methylcobalamin 
dependent methionine synthase and the coenzyme B12 dependent rearrangement of 
methylmalonyl -CoA to succinyl -CoA by methylmalonyl -CoA mutase which are also found in 
mammals,
69
 all other discovered B12 dependent reactions are confined to archaea and bacteria.  
Nature solution to the protection of the highly reactive intermediate radicals from reacting with 
dioxygen in coenzyme B12 dependent reactions is restriction of most of these enzymes to strictly 
Ad
H
H
Co
Ad
H
H Co(II)
HY
ba
XH
HY
ba
X
Substrate
Substrate derived radical
H
Ad
H
H
HY
ba
X
HY
ba
HX
Product
Product related radical
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anaerobic organisms where they catalyze intermediate rearrangement reactions for various 
energy conservation and biosynthesis metabolisms. Besides the fermentations and biosynthesis 
pathways with intermediate coenzyme B12 dependent rearrangements, other described 
metabolisms with intermediate B12 dependent reactions are those in human beings through which 
the deficiency of the vitamin consequent lead to PA and neurological disorders. Methylmalonyl-
CoA mutase in mitochondria protects the radicals from oxygen by a protein-sealed active site.  
Recent reports on coenzyme B12 dependent rearrangements in bacteria new discovered pathway 
for acetyl CoA assimilation
70, 71
 and the speculation on the intermediate mutase reaction in the 
tentative pathway for the anaerobic respiration of n-hexane
72
 have expanded the diversity of B12 
in metabolism. The highlight of co-enzymatic role by B12 has therefore spans in wide variety of 
metabolic pathways from those of medical usefulness with which the vitamin was discovered in 
relation to human diseases to pathways for biosynthesis, carbon assimilation and anaerobic 
energy conservations in archaea and bacteria.             
 
1.5.1 Medical aspects of B12 in metabolism 
The methionine synthase catalyzed transfer of methyl group from N
5
-methyltetrahydrofolate (5) 
to homocysteine (6) via cob(I)alamin lead to the formation of methionine (7) along with 
demethylated product; the tetrahydrofolate (10). By the action of serine-hydroxymethyl 
transferase, the letter is converted to 5,10-methylenetetrahydrofolate (11) which serves to donate 
the methyl group during the thymidylate synthase catalyzed methylation of dUMP (12) to form 
dTMP (13) for use as a precursor in DNA synthesis. In this methylation, 5,10-
methylenetetrahydrofolate(11) is converted to 7,8-dihydrofolate(14) which together with non 
demethylated molecules of 5,10-methylenetetrahydrofolate(11) are respective reduced to 
tetrahydrofolate(10) and N
5
-methyltetrahydrofolate(5), hence completing the metabolic cycle. 
This human metabolic pathway is fundamental to DNA replication as it maintains a constant 
supply of dTMP which is achieved via the folate-B12 dependent methyl transfer reaction of 
methionine synthase.
20
 Since the pterin donor of methyl group is N
5
-methyltetrahydrofolate, the 
mammalian methionine synthase has also been known as N
5
-methyltetrahydrofolate 
homocysteine methyltransferase. 
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Figure 12: Interacting B12-folate metabolic pathway which provides precusor for synthesis of DNA 
 
Deficiencies of vitamin B12 or folate conspicuously lead to the accumulation of N
5
-
methyltetrahydrofolate resulted from the failure of its cobalamin and folate dependent 
conversion to tetrahydrofolate. These deficiencies, so as any other impairment of the interacting 
B12-folate metabolism lead to the unavailability of the methyl donor; 5, 10 –
methylenetetrahydrofolate (11) during the thymidylate synthase catalyzed methylation for 
synthesis of DNA precusors. Because the mitotic division of a cell relies on the doubling of 
24 
 
DNA content in the nucleus of the cell, the end result of the deficiencies of these vitamins is the 
inability of cells to multiply. Rapid proliferating cells like erythrocytes in the bone marrow and 
cells of organs like tongue and small intestines are severely affected, hence the development to 
PA as well as other clinical symptoms for B12 deficiency in association to these organs.  
However, the remarkable development to PA and other clinical symptoms of B12 deficiency 
without extended to the neurological disorders resulted from the lack of folate alone
73
 indicates 
the PA associated neurological diseases are not related to the B12-folate shared metabolic 
pathway. Metabolism with another coenzyme form of B12 was then sensible implicated to the PA 
associated neurological diseases. The mammalian conventional oxidation of branched chain 
amino acids to pyruvate via a metabolic pathway which exploits coenzyme B12 for the 
intermediate reaction catalyzed by methylmalonyl -CoA mutase convicts B12 in the course of 
development to neurological diseases. Odd chain fatty acids and cholestols share the same 
oxidation pathway with branched chain amino acids with which B12 deficiency leads to failure in 
methylmalonyl -CoA mutase catalyzed rearrangement of methylmalonyl -CoA to succinyl -CoA 
resulting into the medical condition known as methylmalonic aciduria.
74
 Although, yet the 
mechanism to the neurological disorder is controversial, the accumulated methylmalonate 
resulted from the B12 deficiency has been linked with the formation of the alkyl chains with 
methyl groups which cause nerve damage.  
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Figure 13: The mammalian oxidation of propionate to pyruvate with intermediate coenzyme B12 
dependent rearrangement of (R)-3-methylmalonyl -CoA to succinyl -CoA by methylmalonyl -CoA 
mutase 
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The present time medical triumph from the discovery of B12 in relation to PA together with the 
comprehension of the B12-folate shared pathway for DNA synthesis is the prescriptions of 
cyanocobalamin or hydroxocobalamin for the treatment of pernicious anaemia. These 
cobalamins are also prescribed for the treatment of the demyelinating diseases of the spinal cord 
which are caused by methylmalonic aciduria. The two B12 metabolic pathways in human have 
therefore mark a clear cut between PA and its associated nerve diseases which have become 
apparent as a result of these conceptions on the medical aspects of B12 in metabolism.   
 
1.5.2 Energy conservations in anaerobic food chains 
Owing to the putrefactive processes by aerobic organisms, niches of oxygen deficiency have 
been created to inhabit life
75
 with metabolisms which have successful lead the food chain to 
ecological consequent transformations into a simplest hydrocarbon; the methane and CO2.
76, 77
   
In these anoxic habitants the hydrolysis of carbohydrates and proteins to energy rich sugar 
monomers and amino acids by the actions of exogenous enzymes is succeeded by non-oxygenic 
respirations. Chemotrophic anaerobes treasure metabolisms which have purposely evolved with 
potential to achieve oxidations of varieties of compounds in devoid of oxygen. Among described 
anaerobic respirations are the fermentations of several compounds including proteinogenic 
amino acids,
78-81
 as well as various oxidation pathways with terminal inorganic electron 
acceptors.
82,83
  These metabolisms derive entire energy from the products of exogenous 
hydrolysis and other energy rich compounds for sustaining the life of anaerobes in their anoxic 
habitants like soil, sewage sludge, marine and fresh water sediments as well as in the 
gastrointestinal tract of animals. The significant role by B12 in the anaerobic life is revealed from 
the described coenzyme B12 dependent enzymatic reactions which serve as intermediate steps to 
several energy conservations pathways. The major role of these pathways has been to provide 
energy for sustaining the anaerobic life.     
             
1.5.2.1 Amino acids fermentations 
Proteinogenic amino acids form a major source of energy to anaerobic life that is conserved in 
various archaeal and bacterial fermentation pathways. The fermentative degradations of amino 
acids are accomplished in redox reactions
75, 84, 85
 which involve either a pair of amino acids as 
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described in Stickland metabolism or between an amino acid with non-nitrogenous compounds 
formed as intermediates during fermentation. Unlike the aerobic respirations, oxyganations are 
not found in fermentations. However, other non-oxygen requiring oxidation reactions of 
fermentations such as oxidative deaminations, transaminations and keto acid oxidations are 
similar to those found in aerobic respiration.
 
Fermentation processes differ from aerobic 
respiration by their reduction reactions which have to depend on electron acceptors generated 
during the organism metabolisms.
79 
Anaerobes metabolic reactions usually lead to substrates 
conversions into both electrons acceptors oxidants as well as reductant metabolites which 
accomplish the electron transferring processes for fermentations energy productions. Used 
electron acceptors in amino acid fermentations include amino acids themselves, unsaturated α- 
and β-acids and their coenzyme A thioesters as well as protons.79  
Fermentative bacteria are the metabolic most diversified in the anaerobic food chain in view of 
the fact that; each amino acid among the twenty proteinogenic amino acids can be fermented 
with others being fermented in more than one pathway. 
78, 79, 81, 86
 Also several other pathways 
for fermentations of non-amino acids compounds have been reported. An exceptional substrate 
for fermentation has been glutamate which can be fermented via five different pathways.
 86
  
Nature’s solution to the metabolic chemical challenging removal of -NH2 group from glutamate 
in the two methylaspartate pathways for this amino acid fermentation by clostridia is the 
rearrangement to (2S,3S)-3-methylaspartate by coenzyme B12 dependent glutamate mutase. The 
enzyme base abstraction of a proton on carbon 3 of (2S,3S)-3-methylaspartate during the 
pathway’s subsequent reaction of methylaspartase readily eliminates the -NH2 group as ammonia 
leaving mesaconate as an intermediate of the pathway (figure 14).  Further transformations by 
the hydration and cleavage reactions lead to the formation of acetate and pyruvate. 
87
 The latter is 
either converted to acetyl-CoA with subsequent catabolic transformations to butyrate or 
carboxylated to oxaloacetate before further conversions to propionate.
86
 In the metabolic route 
via acetyl-CoA, 0.6 ATP (63.5 kJmol
-1
) per glutamate is conserved via substrate level 
phosphorylation
84, 88 
 while the conservation of the additional 42.5 kJmol
-1
 is achieved via 
electrochemical H
+
 or Na
+ 
gradients generated via electron bifurcation and the membrane-bound 
ferredoxin-NAD
+
 reductase. 
89
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5 Glutamate
- 
+ 6 H2O + 2H
+
 → 5 NH4
+
 + 5 CO2 + 6 Acetate + 2 Butyrate + H2 
Δ G°' = -63.5 kJmol
-1 
Glutamate : 106 kJmol
-1
 ATP 
 
In the alternate metabolic branch, 3 glutamates give rise to 3 acetates and 3 pyruvates. Two 
pyruvates are oxidized to 2 acetyl-CoA from which 2 acetates and 2 ATPs are formed. The third 
pyruvate is reduced via oxaloacetate, succinate and methylmalonyl-CoA to propionate.  The 
coenzyme B12 dependent rearrangement by methylmalonyl CoA mutase is an intermediate in the 
pathway. 2 ATPs are conserved via acetyl-CoA and further energy is conserved via proton/Na
+
 
translocating ferredoxin oxidation and fumarate respiration.
86, 90 
 
3 Glutamate
-
 + 4 H2O → 3 NH4
+
 + 2 CO2 + 5 Acetate
-
 + Propionate
- 
Δ G°' = -69.0 kJmol
-1
 glutamate; ≥ 62 kJmol-1 ATP 
 
Other described routes for the fermentation of glutamate are the (R)- 2-hydroxylglutaryl -CoA 
and  4-hydroxylbutyrate-CoA pathways (figure 14) as well as the glutamate fermentation via 5-
aminovelarate which has form the 5
th
 route for this amino acid fermentation. However, the 
coenzyme B12 cofactor participates only in the two methylaspartate routes.   
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Figure 14; Isotopically traced intermediates of the three clostridia fermentation pathways leading from 
(S)-glutamate to butyrate. The coenzyme B12 dependent methylaspartate pathway (left), (R)- 2-
hydroxylglutaryl -CoA pathway (middle) and the inter-organismic route via the 4-hydroxylbutyrate-CoA 
(right).  
 
Besides the methylaspartate routes for glutamate fermentation; the participation of B12 in amino 
acids fermentation has also been described in a fermentation pathway which leads from L-lysine 
to acetate and butyrate in several clostridia, fusobacteria and Porphyromonas. The first reaction 
for this pathway is catalyzed by L-lysine-2,3-aminomutase which converts L-lysine to (3S)-3,6-
diaminohexanoate or -lysine, that rearranges to (3S, 5S)-3,5-diaminohexanoate during the 
coenzyme-B12 dependent reaction of L-β-lysine-5,6-aminomutase. Pyridoxal-5'-phosphate is also 
a cofactor for the L-β-lysine-5,6-aminomutase catalyzed rearrangement. Removal of the two 
amine groups present in L-lysine is accomplished during the reactions of L-erythro-3,5-
diaminohexaoate dehydrogenase and L-3-aminobutyryl coenzyme A deaminase in the 
pathway.
91,92
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1.5.2.2 Nicotinate fermentation 
Being a constituent of nicotinamide adenine dinucleotide (NAD) cofactor; nicotinate is abundant 
in environments where it offers energy for supporting anaerobic life by a fermentation pathway 
which B12 participate. The enzymatic transformations leading from nicotinate to NH3, CO2, 
acetate and propionate have been described in Eubacteria barkerei 
93 
with which the organism 
has been able to grow anaerobically on nicotine as the only carbon source. The formed 2-
methyleneglutarate intermediate of the pathway is converted to (R)-3-methylitaconate in the 
coenzyme B12 dependent rearrangement reaction by 2-methyleneglutarate mutase. 
93
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure15:  Fermentation pathway leading from nicotinate to NH3, CO2, acetate and propionate in 
Eubacteria barkerei 
 
Genes encoding nine enzymes for this fermentation have been spotted in recent released 
genomes of environmental isolates Natranaerobius thermophilus, Bacteroides capillosus, and 
Anaerotruncus colihominis.
94
 Medical relevant has been B. capillosus is a known resident of 
human intestines where it can cause neonatal sepsis as well as both cysts and wounds. Also a 
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medical implication is the recent isolation of A. colihominis in human stool specimens although 
the clinical significance in relation to this organism is yet to be established. 
95, 96
   
 
1.5.2.3 Anaerobic n-hexane oxidation 
 
Potentials of n-alkanes to be used as substrates for growth of organisms was first recognized with 
aerobic bacteria in the beginning of the last century. The terminal electron acceptor role by the 
dioxygen in the respiration during the aerobic growth of bacterial on n-alkanes is as important as 
other known aerobic respirations. However, the metabolic challenge to n-alkanes degradation for 
which growth on these hydrocarbons has been considered unique are the inert C-H bonds which 
make them resistant to enzymatic transformations. During the aerobic growth on n-alkanes the 
dioxygen has been established with an extra role of being co-substrate of the oxidation that is 
necessary for the activation of n-alkane by transformations into oxygen containing metabolites 
which are suitable for enzymatic degradation. 
97
 The anaerobic growth on such inert 
hydrocarbons was therefore considered impossible over years. However, the n-alkanes dependent 
anaerobic growths were later described in various denitrifying, iron (III) and sulfate reducing 
bacteria. 
72
 The activation of apolar C-H bonds of n-alkanes for oxidation during the growth in 
such strict anoxic environment is achieved through novel chemical steps which exclusively rely 
on metallocofactors as well as radical mechanisms.
98
 Among several examples is a recent report 
from the studies on the oxidation of n-hexane by the anaerobic denitrifying betaproteobacterium 
“Aromatoleum” strain HxN1 that describes the hydrocarbon tentative degradation pathway which 
coenzyme B12 participates in rearrangement of metabolites. 
72
 EPR spectroscopy identified 
glycyl radical enzyme; (1- methylalkyl)succinate synthase which has been convicted with the 
condensation of n-hexane with fumarate.
 
The carboxylate of the metabolic active condensation 
product (1-methylpentyl)succinate is believed to be transformed to CoA ester by (1- 
methylalkyl)succinate -CoA ligase before the epimerization which is followed by the postulated 
rearrangement reaction by a tentative coenzyme B12 dependent mutase.
72
 Further work for 
comprehending this mutase is current carried jointly in the laboratories of Wolfgang Buckel in 
the University of Marburg and Bernard Golding in Newcastle University. The mutase rearranged 
product is believed to be decarboxylated and subsequently oxidized before enters the oxidation 
β-pathway.        
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1.5.3 Metabolic pathways for carbon assimilation and 
biosynthesis 
Growth of organisms on two and three carbon compounds like acetate and ethanol which have to 
enter the central carbon metabolism in acetyl -CoA level has become possible because of 
evolutions to pathways which can assimilate acetyl -CoA. The isocitrate lyase metabolic 
switches to gyloxylate shunt in some bacteria have been the only known route for assimilating 
acetyl -CoA over the last 50 years.
99-101 
This metabolic switches to glyoxylate shunt has enables 
bacteria with isocitrate lyase to grow on two and three carbon sugars. The medical relevance to 
the glyoxylate cycle has been the Mycobacterium tuberculosis periods of latency survival with 
three carbon sugars diet in leucocytes which lead to their unique penetrance to human population 
via chronic tuberculosis. 
102
 Bacteria of the genus Pseudomonous and several strains of E. coli as 
well as many moulds were among early known organisms to demonstrate the growth on two 
carbon compounds with which they meet all their carbon requirements through conversions to 
any cell constituents via the glyoxylate shunt. 
101
   
Recently, a pathway for acetyl -CoA assimilation with intermediate coenzyme B12 dependent 
rearrangements reactions by a new described ethylmalonyl-CoA mutase as well as 
methylmalonyl-CoA mutase has been discovered in Rhodobacter sphaeroides.
99, 100
 The new 
pathway achieves the formation of the malate and succinyl -CoA from metabolic condesation of 
three molecules of acetyl -CoA, one molecule of CO2, and one molecule of HCO3
-
 (figure 16). 
Early steps of the pathway are reactions common to the synthesis of polyhydroxybutyrate which 
achieve the condensation of two molecules of acetyl-CoA and subsequent transformations to 
crotonyl -CoA that is carboxylated to (2S)-ethylmalonyl -CoA. Epimerization by methylmalonyl-
CoA/ethylmalonyl -CoA epimerases forms (2R)-ethylmalonyl -CoA which is rearranged to (2S)-
methylsuccinyl-CoA during the coenzyme B12 dependent reaction of ethylmalonyl -CoA mutase 
before further enzymatic conversions to glyoxylate and propionyl -CoA.
100 
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Figure 16: Proposed ethylmalonyl -CoA pathway for acetyl-CoA assimilation in phototrophic bacterium 
R. sphaeroides. Adapted from reference 100  
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While glyoxylate is converted to malate via L-malyl CoA, propionyl CoA is carboxylated to 
(2S)-methylmalonyl -CoA and subsequent epimerized by methylmalonyl -CoA epimerase to 
(2R)-methylmalonyl -CoA before rearranged to succinyl -CoA by the coenzyme B12 dependent 
methylmalonyl -CoA mutase. Hydrolysis of CoA ester achieves succinate which enters citric 
acid cycle like malate or succinyl -CoA. This novel acetyl -CoA assimilation pathway is believed 
to be in other bacteria like Methylobacterium extorquens and Streptomyces coelicolor as they 
have been known to lack isocitrate lyase which is in contrary to their demonstrated growth on 
two and three carbon substrates. 
99, 100, 103, 104
    
Cofactor roles by B12 are also revealed in lipids and glycerolipids metabolisms with which 
coenzyme B12 dependent propanediol dehydratase and ethanol amine ammonia lyase participate 
in intermediate steps by catalyzing rearrangements with irreversible elimination of water and 
NH3.  These coenzyme B12 dependent conversions lead to metabolites which are fed into various 
pathways including those for propionate and pyruvate metabolisms. Also significant cofactor 
role by coenzyme B12 is that for DNA synthesis by class II ribonucleotide reductases (RNRs) in 
some bacteria.  
 
1.6 Mechanisms for rearrangements by coenzyme B12 
dependent enzymes  
Various experimental authentications of the minimal mechanistic scheme for coenzyme B12 
dependent reactions have describe successful characterizations of substrate derived and product 
related radicals. For example the 4-glutamyl radical derived from glutamate during the reaction 
of glutamate mutase was identified by successions of EPR measurements in experiments 
involved the incubations of holoenzyme with glutamate and series of 
13
C labeled glutamates. 
105
 
During these experiments, freeze quenching of the reactions after few seconds of holoenzyme 
incubations with glutamates gave EPR signals which were interpreted to the substrate derived 
radical. Studies on the reaction of 2-methyleneglutarate mutase by mechanism based inactivation 
approach demonstrated the formation of radical adducts of 5'-deoxyadenosyl and enzyme 
inhibitors mimic of substrate derived and product related radicals. 
106
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The used analogues of 2-methyleneglutarate derived and itaconate related radicals; cis-
glutaconate and but-1,3-diene-2,3-dicarboxylate inactivate the enzyme by the mechanism which 
involve the addition of 5'-deoxyadenosyl radical to SP
2
 carbon centers on inhibitors resulting into 
adduct radicals. The EPR characterization of these adduct radicals verified the proposed minimal 
mechanistic scheme for coenzyme B12 dependent rearrangements. A similar approach was used 
to investigate propane-1,2-diol dehydratase by but-3-ene-1,2-diol which established the enzyme 
mechanism for regioselectivity towards the formation of the substrate derived radical. 
107
 
Present time endeavors to comprehend coenzyme B12 dependent reactions by many laboratories 
focus on the mechanisms by which substrates derived radicals rearrange reversibly to products 
related radicals. Theoretical chemistry based predictions on the reactivity of intermediate 
substrate derived and product related radicals in most of these reactions have put forward several 
mechanistic proposals for their inter-conversions rearrangements.  Most on-going studies on this 
theme are aiming at experimental verifications on those proposed rearrangement mechanisms. 
For the purpose of introducing the work reported in this thesis; various published findings on the 
experimental verifications of different mechanistic proposals for rearrangement reactions by 
selected carbon skeleton mutases; 2-methyleneglutarate mutase, methylmalonyl-CoA mutase, 
glutamate mutase as well as eliminases; ethanolamineammonia lyase and ribonucleotide 
reductases are highlighted in briefly. The successful productions of recombinant apo-proteins for 
these enzymes have allowed extensive invitro studies for the mechanisms of the reaction they 
catalyse. 
108, 109, 110, 111
 
    
1.6.1 Coenzyme B12 dependent carbon skeleton mutases 
 
1.6.1.1 2-Methyleneglutarate mutase 
2-Methyleneglutarate mutase was discovered from Clostridium barkeri in early 1970s.
112 
This 
species which was later re-classified as Eubacterium barkeri ferments nicotinate to NH3, CO2, 
acetate and propionate. Recent, the mgm gene which encodes for the 2-methyleneglutarate 
mutase together with other genes encoding for enzymes of the established pathway for nicotinate 
fermentation have also been found in the environmental isolates; Natranaerobius thermophilus, 
Bacteroides capillosus, and Anaerotruncus colihominis.
94
 2-Methyleneglutarate mutase catalyzes 
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the coenzyme B12 dependent reversible conversion of 2-methyleneglutarate (15) to (R)-3-
methylitaconate (16) which forms an intermediate step of the pathway for nicotinate 
fermentation by these bacteria (figure 15).  
  
O2C
H
O2C
H
CO2H
O2C
K= 0.07
2-Methyleneglutarate (15) (R)-3-Methylitaconate (16) 
 
Figure 17: The coenzyme B12 dependent 2-methyleneglutarate mutase catalyzed reversible rearrangement 
between 2-methyleneglutarate (15) and (R)-3-methylitaconate (16)   
Hirthro, the crystal structure of 2-methyleneglutarate mutase has not been solved, hence the 
mechanistic insights from the 3D structure of the holoenzyme complex is unavailable. The 
current understandings on the mechanism of 2-methyleneglutarate mutase catalysis have been 
provided from its mutation, kinetic and spectroscopic studies. Successful cloning of mgm gene 
from Eubacterium barkeri has allowed the over-production of the recombinant single α protein 
(70 kDa) of 2-methyleneglutarate mutase in E.coli and the invitro reconstitution of the active 
holoenzyme by assembling of the α-protein with the coenzyme B12.
108
 The holoenzyme complex 
of 2-methyleneglutarate mutase is postulated to be heterotetramer of the α-protein (α4, 4 x 70 
kDa) with the two bound coenzyme B12. The mii gene which encode for the 3-methylitaconate-Δ 
isomerase has also been cloned from Eubacterium barkeri and over-produced in E.coli. This 
isomerase catalyzes the elimination of the methine hydrogen from the product of the 2-
methyleneglutarate mutase reaction, the (R)-3-methylitaconate, which is converted to 2, 3-
dimethylmaleate during the nicotinate fermentation. The recombinant production of 3-
methylitaconate-Δ isomerase has allowed its application as an auxiliary enzyme for assaying 2-
methyleneglutarate mutase by converting the (R)-3-methylitaconate which is produced by 2-
methyleneglutarate mutase to 2,3-dimethylmaleate. The activity of 2-methyleneglutarate mutase 
has therefore been measured spectrophotometrically as the rate of 2, 3-dimethylmaleate 
formation at 256 nm in the coupled assay with 3-methylitaconate-Δ isomerase.113 In the studies 
approach by mutation of the mgm gene, the demonstrated decrease of the substrate turnover due 
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to the site directed mutation of the conserved cobalamin binding motif of the 2-
methyleneglutarate mutase α protein has implied the coenzyme B12 is bound to the apoenzyme 
by “base off, his on”.114 Additional support for the “base off, his on” binding of cofactor to the 2-
methyleneglutarate mutase protein comes from the study which the (Coβ-5'-deoxyadenosin-5'-
yl)-(p-cresyl)cobamide base off analogue of the coenzyme B12 was demonstrated to be an 
excellent cofactor of 2-methyleneglutarate mutase reaction with 5 times increased affinity to the 
apoenzyme in comparison to coenzyme B12.
115
  
The interpretation of cob(II)alamin and an organic radical from the results of an EPR study of 2-
methyleneglutarate mutase has implied the radical mechanism by this enzyme is initiated by the 
homolytic cleavage of coenzyme B12 Co-C bond. The cob(II)alamin formed from the homolysis 
of the cofactor Co-C bond has been identified by its anaerobic UV/Vis absorption peak at 470 
nm in several studies of 2-methyleneglutarate mutase. An organic radical, the 5'-deoxyadenosyl 
which is formed along with cob(II)alamin from the bond cleavage, stereoselective abstracts the 
pro-R hydrogen on the C-4 of 2-methyleneglutarate to form the substrate derived radical and a 
molecule of adenosine.
116
 The 2-methyleneglutarate radical rearranges reversibly to (R)-3-
methylitaconate radical which abstracts hydrogen from the methyl group of the adenosine to 
form (R)-3-methylitaconate with the regeneration of the coenzyme B12. The formation of the 
intermediate substrate derived and product related radicals have been demonstrated by EPR 
spectroscopy from the reactions of their structural analogues compounds, cis-glutaconate and 
buta-1,3-diene-2,3-dicarboxylate with 2-methyleneglutarate mutase.
106
 Two mechanistic 
possibilities for reversible inter-conversions between 2-methyleneglutarate and (R) -3-
methylitaconate radicals have been; 1) either via the fragmentation of the 2-methyleneglutarate 
radical into acrylate and acrylate radical which recombine to form (R)-3-methylitaconate radical 
(fragmentation-recombination) or, 2) because of the π electrons β to C4 radical on 2-
methyleneglutarate radical, the C4 radical is intra-molecularly added to the β π-electrons. The 
addition resulting into the formation of the cyclopropylcarbinyl radical intermediate which opens 
at C2-C3 bond to give the product related radical (addition –elimination) (figure 18). 114, 117 
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Figure 18: Proposed mechanisms for the coenzyme B12 dependent 2-methyleneglutarate mutase catalyzed 
reversible rearrangement between 2-methyleneglutarate derived and (R)-3-methylitaconate related 
radicals. Path a; is rearrangement by the addition elimination mechanism via the intermediate 
cyclopropylcarbinyl radical and path b; is the rearrangement via fragmentation into acrylate radical and 
acrylate which recombine to give the product related radical  
Performed experiments for identifying the mechanism of rearrangement by 2-methyleneglutarate 
mutase from the two propasals demonstrated the enzyme inhibition by the square concentration 
of acrylate. The inhibition was characterized by an EPR signal of an organic radical in 
interaction with cob(II)alamin similar to the reaction of the enzyme with 2-
methyleneglutarate.
114, 117, 
 This observation suggests the presence of two acrylate molecules 
provides structure which is analogue to the intermediate of the rearrangement mechanism which 
is catalyzed by this enzyme. However, these results were not sufficient to define which of the 
three steps intermediates; 2-methyleneglutarate radical, acrylate and acrylate radical fragments or 
(R) 3-methylitaconate radical has been mimicked by the two molecules of acrylate in case of the 
rearrangement by fragmentation- recombination. Since it is not possible to establish that the 
square concentration of acrylate mimics only the acrylate and acrylate radical fragments, these 
results could not be adequate to conclude the rearrangement is by fragmentation-recombination. 
The possibility for the formation of the cyclopropylcarbinyl radical as an intermediate of the 
rearrangement by intra-molecular addition of radical carbon to π-electrons on the molecule of the 
substrate derived radical was investigated by evaluating the interaction of 2-methyleneglutarate 
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mutase with cyclopropane stereoisomers 17-20. These stereoisomers were designated to mimic 
the cyclopropylcarbinyl radical in the enzyme active site. Study which explored the potentials for 
inhibiting 2-methyleneglutarate mutase by these compounds, could not establish an enzyme 
inhibition by any of the stereoisomer. 
117 
The results obtained from this study had therefore 
implied the cyclopropylcarbinyl radical does not exist as an intermediate in the reaction of 2-
methyleneglutarate mutase, hence the mechanism for rearrangement by this enzyme is not by 
addition-elimination. However, since the competition of the reaction intermediate with an 
enzyme inhibitor requires the formation of the intermediate to be a reaction rate determining 
step, the possibility for the addition-elimination mechanism cannot be excluded because the rate 
determined step during the rearrangement by this mechanism is the abstraction of hydrogen atom 
from the substrate.    
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Figure 19: Compounds used to investigate the reaction of 2-methyleneglutarate mutase. The compounds 
17-20 are stereoisomers of 1-methylcyclopropane-1,2-dicarboxylic acids which are analogue to the 
intermediate cyclopropylcarbinyl radical in the proposed rearrangement by the addition-elimination 
mechanism. The acrylate (24) was used to mimic the intermediate steps of the proposed rearrangement by 
fragmentation -recombination.  
The computational study by ab initio calculations reported ca 100 kJ mol
-1
 more energy 
requirement for the rearrangement by fragmentation-recombination as compared to that by 
addition-elimination.
118
 These computational studies also investigated the impact of protonating 
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the 2-exo methylene group on the substrate i.e, 2-methyleneglutarate or (R)-3-methylaitaconate 
which was reported to be important in facilitating the migration of acrylate moiety by lowering 
the activation energy of the reaction. In the enzyme system, the protonation can be accomplished 
by amino acid residues within the proximity of the enzyme active site. However, the effect of 
protonating 2-exo methylene group on the activation energy of the reaction stands relative to 
both proposed mechanistic routes and therefore left them undistinguished.    
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Figure 20: Schematic presentation on the proposed facilitation of 2-methyleneglutarate mutase catalyzed 
rearrangment by protonation of substrate 2-exo methylene group.  
 
1.6.1.2 Methylmalonyl -CoA mutase 
The coenzyme B12 dependent methylmalonyl -CoA mutase is metabolic important for the 
catalyses of the reversible stereospecific rearrangment between succinyl -CoA (21) and (R)-
methylmalonyl -CoA (22) (figure 21). This catalysis achieves the exchange between the 
substrate carbonyl-CoA group and its vinyl hydrogen atom which result into the formation of the 
rearranged product. The verification on the migration of carbonyl –CoA group during the 
catalysis by the methylmalonyl-CoA mutase was established from the experiments which 2-
[
14
C]-methylmalonyl-CoA was used as the substrate.
119
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Figure 21: The coenzyme B12 dependent interconversions between succinyl-CoA (21) and (R)–
methylmalonyl-CoA (22) which is catalyzed by methylmalonyl-CoA mutase    
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The methymalonyl -CoA mutase system is one of the well studied among the discovered 
coenzyme B12 dependent enzymes. This enzyme has been isolated from both bacteria and 
mitochondria of eucaryotes. The mammalian methylmalonyl -CoA mutase is homodimeric of α 
units (α2: 160 kDa), whereas the bacterial enzyme is an αβ heterodimer (150 kDa; α-subunit 80 
kDa and β-subunit 70 kDa).120, 121 The sequence as well as the structure of the bacteria α subunit 
show high similarity with that of the mammalian enzyme. Since the cobalamin binding His-asp-
ser trid is in the α subunit, hence the bacterial αβ holoenzyme is reconstituted with one cofactor 
whereas the mammalian homodimeric assembly is ideal for two active sites.  
 
In mammals the rearrangement by the coenzyme B12 dependent methylmalonyl -CoA mutase is 
an intermediate step in the oxidation of several branched chain amino acids e.g isoleucine as well 
as odd chain fatty acids and cholesterols. This mammalian oxidation pathway leads to pyruvate 
via propionate (figure 13).
122
 The medical relevance of this pathway is the progression to nerve 
damage which is caused by the methylmalonic aciduria resulted from the failure of the catalysis 
by the methylmalonyl-CoA mutase.
123
 Two types of aciduria; mut
- 
and mut
0 
which arise from the 
accumulation of methylmalonyl-CoA have been discribed. In the mut
-
 aciduria the gene 
encoding the methylmalonyl -CoA mutase is present but the accumulation of methylmalonic acid 
is caused by the deficiency of cobalamin due to the defect in the genes encoding for the 
cobalamin carrier proteins. The mut
0
 type of aciduria arises due to the defect of the gene 
encoding the methylmalony -CoA mutase and has been reported with even severe neurological 
complication.
124 
Also the physiological relevant in due to this oxidation has been the 
detoxification of propionate which accumulates from the oxidation of branched chain amino 
acids and cholesterols. In bacteria like Propionibacterium shermanii, Streptomyces 
cinnamonensis the rearrangement by this enzyme is an intermediate of the pathway leading from 
pyruvate to propionate.
125,126
 This bacteria metabolism forms a pathway which is reverse of the 
mammalian oxidation of propionate to pyruvate. In additional to succinyl –CoA which enters the 
central carbon metabolism at the level of the citric acid cycle in both mammalian and bacterial 
pathways, other intermediates provide precursors for the biosynthesis of polyketide anti-biotics 
in bacteria.
127
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The methylmalonyl -CoA mutase catalyzed rearrangement has been extensively studied by both 
kinetic and spectroscopic methods. Several developed continuous spectrophotometric as well as 
radiolabelled assays for methylmalonyl -CoA mutase
128
 have allowed the determinations of the 
kinetic constants of both methylmalonyl -CoA and succinyl -CoA in their respective reactions 
with this enzyme. The reaction Keq has been established to range between 20 and 30 in favor of 
the less branched succinyl -CoA.
125,129,130
 In addition to methylmalonyl -CoA and succinyl –
CoA, the substrate spectrum of methylmalonyl -CoA mutase has been extended to 
succinyl(carba)dethia-CoA, succinyl(dicarba)dethia -CoA and 4-carboxy-2-oxy-butyl-CoA. The 
kinetic constants for all these substrates in their reactions with methylmaonyl -CoA mutase have 
also been reported.
128
  
 
Significant mechanistic insights on the methylmalonyl -CoA mutase catalyzed reaction have 
been obtained from the enzyme 3D structures. The crystal structures of methylmalonyl -CoA 
mutase have been solved without substrate as well as with substrate and varieties of the enzyme 
inhibitors.
131, 132
 The substrate free holo-enzyme has been revealed to be in an open conformation 
with an accessible active site where the coenzyme B12 can be seen bound by “base off, his on” 
mode. Binding of the substrate causes holoenzyme to adopt a closed conformation with which 
the active site becomes inaccessible. The substrate as well as the bound cob(II)alamin stay 
enclosed whereas the adenosine moeity derived from the cofactor during the Co-C bond 
homolysis locates outside the active site. This conformational change in due to substrate binding 
is speculated to provide energy for assisting the homolysis of coenzyme Co-C bond.  
 
Similar to other coenzyme B12 dependent reactions, the 5'-deoxyadenosyl radical generated from 
Co-C bond homolysis is postulated to abstracts hydrogen from (R)-methylmalonyl–CoA to form 
(R)-methylmalonyl-CoA radical which rearranges reversibly to succinyl-CoA radical. The 
homolytic cleavage of the Co-C bond and reversible hydrogen abstraction during the catalysis by 
methylmalonyl –CoA mutase were demonstrated by EPR spectroscopy and tritium transfer 
experiments which the tritium laballed 3-carboxypropy –CoA was used to inhibit the enzyme.125 
Furthermore, evidence on the existence of the intermediate radicals in the methylmalonyl -CoA 
mutase catalysis has been provided by EPR signal which was mesured from the freeze quenching 
of the enzyme reaction under the steady state conditions.
125, 133
 The steric course of catalysis by 
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this enzyme has been well established. In the conversion of (R)-methylmalonyl-CoA to succinyl-
CoA, the migrating groups (hydrogen and carbonyl-CoA) retain the original configuration of the 
group they displace.
128
 The displaced group is either the hydrogen when the migrating group is 
carbonyl-CoA or the carbonyl-CoA group which is displaced by the migrating hydrogen to 
accomplish the enzyme catalyzed vicinal groups exchange. In contrast to other mutases like 
glutamate mutase as well as the 2-methyleneglutarate mutase, the methylmalonyl-CoA mutase 
either poorly distinguishes the 3-pro-R and 3-pro-S hydrogen atoms on the succinyl-CoA, or the 
migrating groups fail to retain the original configuration of the displaced group due to inversion 
during the mechanism for the conversion to (R)-methylmalonyl-CoA.
134
 This stereospecificity 
incapability is probably caused by the conformational flexibility at C2 or C3 (or both positions) 
of succinyl-CoA which have accounts for the poor selectivity in the movement of hydrogen 
during the catalysis by methylmalonyl-CoA mutase. The enzyme stereospecificity towards the 
(R)-methylmalonyl-CoA is predicted to be controlled by the interaction of the substrate with the 
active site residues His244, Arg207, and Tyr89.
128
  
 
Earlier mechanistic proposals for methylmalonyl-CoA mutase catalyzed reversible inter-
conversions between the postulated (R)-methylmalonyl -CoA and succinyl-CoA radicals 
included the rearrangements either via substrate carbocation or carboanion. Rearrangments via 
organocorbalt intermediates was also considered (figure 22). Since the cob(I)alamin has never 
been detected in the methylmalonyl –CoA mutase catalytic cycle,65 the possibility for the 
rearrangement via substrate carbocation which has to be formed along with the reduction of 
Co(II) to Co(I) was dropped. The rearrangement via substrate anion was investigated in the 
studies which the application of the model compounds [EtSC(=O)C(CH3)(CH2
•
)COOEt] and 
[EtSC(=O)C(CH3)(CH2
-
)COOEt] demonstrated its mechanism to be less rapid and 
selective.
128,135
 Furthermore, the reduction to the substrate anion has to be accomplished along 
with the oxidation of Co(II) to Co(III) which is against the potential gradient. This unfavourable 
redox gradient has also implied the rearrangement via the  carboanion will be hard to precede.
128
 
The possibility for rearrangement via organocobalt intermediates was investigated by model 
compounds which contain cobalt-bonded adducts. Although the used organocobalt compounds 
revealed the 1, 2 –migration of the groups by the enzyme, the results of these experiments were 
likely to have errors from the used organo-cobalt compounds because of their ability to form free 
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organic radicals. Furthermore, the methylmalonyl-CoA mutase crystal structures opposed the 
rearrangement via the organocobalt on the basis of the distance between the substrate and 
cob(II)alamin which seem not to allow the organocobalt intermediate to participate in the 
rearrangement.
128, 136
  
    
O2C
CoASOC
H
Co(II)
Co(I)
a
O2C
CoASOC
H
H
H
COSCoA
H
O2C
COSCoA
H
O2C
Co(I)
Co(II)
b CH2
O2C
CoASOC
H
Co(II) Co(III)
COSCoA
O2C
H
Co(III)Co(II)
c
Co
O2C
CoASOC
H
H
H
Co
COSCoS
O2C
H
 
Figure 22: Proposed mechanisms for the rearrangement of (R)-methylmalonyl -CoA (22) to succinyl -
CoA (21) via carbocation (route a), carboanion (route b) and organocobalt (route c) intermediates.  
 
Also proposed were rearrangement mechanisms via fragmentation of succinyl -CoA radical (23) 
into acrylate (24) and formyl-CoA radical (25) which recombine to (R)-methylmalonyl -CoA 
radical (26), as well as the possibility for rearrangement by addition–elimination via a 
cyclopropoxy radical (27) due to the π-electron system β to radical carbon like in the 2-
methyleglutarate mutase. 
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Figure 23: The proposed fragmentation-recombination (path a) and addition-elimination (path b) 
mechanisms for reversible rearrangement of (R)-methylmalonyl -CoA radical to succinyl -CoA radical in 
the reaction catalyzed by methylmalonyl -CoA mutase 
 
Although the methylmalonyl-CoA mutase was inhibited by the mixure of the acrylate and formyl 
–CoA, the conclution on wether the mechanism of this enzyme is by the fragmentation-
recombination was still far from reach since the inhibition was EPR silent. Furthermore, from the 
inhibition results it could not be established which among the three steps intermediates; the 
methylmalonyl -CoA related radical (26), the acrylate (24) and formyl -CoA radical (25) 
fragments or succinyl -CoA radical (23) were mimicked by the mixture of acrylate and formyl-
CoA. Also considered for distinguishing these two possibilities has been the result obtained from 
theoretical studies by the Ab initio molecular orbital calculations which
 
reported less energy 
requirement in due to the rearrangement by the addition -elimination in comparison to that by 
fragmentation -recombination. 
118
  
 
Recent reports from the studies of the methylmalonyl -CoA mutase by the group of Banerjee in 
the University of Michigan have described the role of the cobalamin binding his610 in 
facilitating the coenzyme B12 high affinity to apoenzyme.
137 
 The same group has also described 
the mechanisms for preventing the apomethylmalonyl –CoA mutase partnership with the 
cob(II)alamin as well as  reviving of the cob(II)alamin inactivated enzyme after several catalytic 
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turnovers.
138
 These preventions of the enzyme from being inactivated by cob(II)alamin were 
demonstrated to be accomplished by the methylmalonyl-CoA mutase associated MeaB molecular 
chaperon in the mechanisms which derive energy from GTP and ATP. Similar phenomenal has 
also been described in diol and glycerol dehydratases where the reactivase protein has been 
demonstrated to accomplish the revive of the cob(II)alamin bound enzyme by removing the 
cob(II)alamin from the inactivated enzyme.
139
  
    
1.6.1.3 Glutamate mutase 
The coenzyme B12 dependent glutamate mutase catalyses the reversible inter-conversion between 
(S)-glutamate (28) and (2S, 3S)-3-methylaspartate (29). This reaction forms the first step of the 
methylaspartate route for glutamate fermentation in Clostridia (figure 14).
5, 140
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Figure 24: Rearrangement reaction catalyzed by the coenzyme B12 dependent glutamate mutase 
The apo-glutamate mutase is composed of protein subunits; S, a monomer (σ, 14.8 kDa) and E, a 
homodimer (ϵ2, 2 × 53.5 kDa). An open reading frame encoding a molecular chaperon L (, 50.2 
kDa) has also been detected between the genes encoding components S and E in C. 
tetanomorphum and C. cochlearium. However, functioning holo-glutamate mutase has been 
reconstituted in vitro from the incubation of components S and E with coenzyme B12. Because 
the component L is not composury for functional reconstitution of the enzyme, glutamate mutase 
has been studied extensively by only recombinant components S and E overproduced in 
E.coli.
117, 141-145
 An active heterotetramer hologlutamate mutase (ϵ2σ2) possible bound by two 
molecules of coenzyme B12 is formed by assembling of protein components S and E with 
coenzyme B12. In other studies the holoenzyme has been prepared from assembling of the fused 
components S and E with coenzyme B12. The crystal structures of holo-glutamate mutase have 
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been solved with both an enzyme inhibitor (2S, 3S)-tartate and the substrate (2S, 3S)-3-
methylaspartate which revealed the “base off, his on” binding of coenzyme B12 to apoenzyme. 
The substrate is bound to the enzyme active site by hydrogen bonding of its carboxylate groups 
with arginines 149, 66 and 100 residues of the active site.
145, 146
 Glutamate mutase catalytic cycle 
start with the binding of substrate to holo-enzyme which triggers the homolysis of the coenzyme 
Co-C bond resulting into the formation of primary organic radical; 5'-deoxyadenosyl and 
cob(II)alamin. The former radical is directed by the holoenzyme system to C4 position of (S)-
glutamate where it stereo-specific abstracts pro S- Hsi to form the substrate derived 4-glutamyl 
radical. In contrast to mechanisms of 2-methyleneglutarate mutase as well as methylmalonyl -
CoA mutase and other carbon skeleton mutases with π-electrons β to the radical carbons of their 
substrate derived radicals, the 4-glutamyl radical does not possess π-system β to radical carbon. 
The rearrangement of 4-glutamyl radical to (2S, 3S)-3-methylaspartate related radical is therefore 
possible only by fragmentation –recombination mechanism. In this proposed mechanism; the 4-
glutamyl radical fragments into glycine radical (30) and acrylate (24b) which recombine to form 
(2S, 3S)-3- methylenespartate radical (figure 25).  
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Figure 25: Proposed mechanism for the rearrangement reaction catalyzed by glutamate mutase. The 4-
glutamyl radical derived from (S)-glutamate fragments into glycine radical (30) and acrylate (24b) which 
recombines to form (2S, 3S)-3-methyleneaspartate radical.  
Experimental verifications on the rearrangement of 4-glutamyl radical to (2S, 3S)-3-
methyleneaspartate radical by fragmentation-recombination has been provided from the work of 
Neil Marsh and his co-workers in the University of Michigan which reported the characterization 
of acrylate by HPLC during the enzyme reaction with (S)-glutamate. 
147
 The same group also 
reported the EPR characterization of thioglycolyl radical from the reaction of glutamate mutase 
with 2-thioglutarate.
 148 
During the reaction of glutamate mutase with 2-thioglutarate, the 
intermediate formed thioglycolyl radical mimics the glycine radical intermediate of the proposed 
fragmentation-recombination mechanism of glutamate mutase. Current studies on glutamate 
mutase by many laboratories are concentrating on gaining insights into the mechanism of 
homolytic cleavage of the cofactor Co-C bond and stabilizations of intermediate methylene 
radicals during the catalysis by this enzyme. The contribution of this thesis towards 
understanding the mechanism of Co-C bond cleavage and stabilization of intermediate radicals in 
glutamate mutase catalysis is given in the result and discussion chapters. The experimental 
designs with well defined aims of studies reported in this thesis are provided in the section for 
the objective of the studies (section 1.7) as well as in the result chapter.           
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1.6.2 Coenzyme B12 dependent eliminases 
The eliminase class of the coenzyme B12 dependent enzymes comprises glycerol dehydratase, 
propanediol dehydratase, ethyleneglycol dehydratase, ethanolamine ammonia lyase (EAL) as 
well as the ribonucleotide reductases (RNRs). Enzymes of this class are distinguished from 
mutases by their extended irreversible catalytic elimination of the migrating group x as water or 
NH3 after the vicinal exchange rearrangement they catalyze (figure 26).   
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Figure 26. Schematic presentation on the reactions of the coenzyme B12 dependent eliminases. The vicinal 
exchange between hydrogen and group X is followed by the elimination of X (X= NH2 or OH and R = H 
or CH3-)  
 
The minimal mechanistic scheme for the eliminases catalyzed rearrangments has mostly been 
predicted to resemble that of mutases. However, the mechanistic differences between the 
mutases and eliminases catalysis were at largely being revealed from the 3D structures of the so 
far structure solved coenzyme B12 dependent enzymes. The “base off, his on” partnerships 
between coenzyme B12 and mutases proteins so as the “base on, his off” for eliminases have been 
cleary confirmed by crystal structures of these enzymes. Since the axil ligands in the coenzyme 
B12 dependent holoenzymes have been postulated to labilise the cofactor β coordinate which 
promotes its homolytic cleavage following binding of the substrate to holoenzymes, 
137
 the 
difference in the cofactor binding suggests the mechanistic difference in the β coordinate 
labilisations between mutases and eliminases. Solution of structures of these enzymes by x-ray 
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crystallography have also revealed difference on the location of the cob(II)alamin between 
mutases and eliminases catalyzed reactions after the homolysis of the Co-C bond. While in the 
eliminases the cob(II)alamin has been revealed to locate at a distance from the intermediates of 
the rearrangements from which it has been considered  not involved with the rearrangement 
mechanisms (spectator), in mutases the cob(II)alamin locates reasonable close to the 
intermediates of the rearrangments. This observations have lead to the suggestion on the 
stabilizations of the rearrangement intermediates by cob(II)alamin in mutases (conductor).
149
 
However, although the cob(II)alamin which is formed along with the 5'deoxyadenosylradical 
from the Co-C bond homolysis has been postulated to be insensitive to the intermediates of the 
rearrangments in the eliminases catalyzed reactions, the course of the 5'-deoxyadenosylradical 
reactivity has largely resemble that of mutases. In the glycerol, propanediol and ethyleneglycol 
dehydratases as well as the ethanolamine ammonia lyase (EAL), the substrates derived radicals 
are usually direct formed by the 5'deoxyadenosylradical and rearrange to products related 
radicals before the products are formed along with the regeneration of the coenzyme B12 and 
proceed to the elimination of the migrating group x. The intermediate radical species useful 
stabilization feature in the catalysis by eliminases which also distinguishes them from mutases is 
the presence of the hydroxyl group bonded to the same carbon which bonds the abstracted 
hydrogen when the substrate derived radical is formed. This structure feature suggests the 
stabilization of the substrate derived radical by negative inductive effect from the hydroxyl group 
as well as promotion of the immigrant group elimination via deprotonation of the hydroxyl group 
by enzyme base. The migrating group in eliminases reactions is either hydroxyl or amine vinyl to 
the radical stabilizing hydroxyl group on the substrate.  
 
It is therefore important to highlight on the stabilizations of the intermediates of the coenzyme 
B12 dependent reactions as being postulated to be provided by the cob(II)alamin in the mutases 
and the negative inductive effect by the substrates hydroxyl group in the eliminases. These 
stabilization mechanisms have been among notable mechanistic differences between the 
rearrangements by mutases and eliminases which in recent years have become an active theme of 
investigations.  
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1.6.2.1 Ethanolamine ammonia lyase (EAL) 
The coenzyme B12 dependent ethanolamine ammonia lyase (EAL) is a substrate promiscuous 
enzyme which catalyses the irreversible conversion of protonated 2-aminoethanol to ethanal as 
well as both protonated R and S 2-aminopropanol to propanaldehyde. Ammonia is also formed as 
a product in all EAL catalyzed reactions. This enzyme was first described in Clostridium sp. with 
relation to choline fermentation before it was also found in several other organisms including 
Salmonella typhimurium and E. coli.
150, 151
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Figure 27: Conversions of the substrates with vicinal amine and -OH groups to their corresponding 
aldehydes with elimination of NH3 by the coenzyme B12 dependent ethanolamine ammonia lyase (EAL) 
The EAL has been considered as a key enzyme during the growth of bacteria like Salmonella 
enterica when the phospholipids derived ethanolamine forms the only source of carbon and 
nitrogen.
152,153
 The purification of EAL to homogeneity from Clostridium sp. and E. coli has 
allowed several extensive studies on this coenzyme B12 enzyme which has been revealed to be 
composed of two subunits, α (51 kDa) and β (36 kDa). These subunits are alleged to oligomerise 
with coenzyme B12 to form functioning holoenzyme which is composed of heterohexamer α6β6 
apo-protein complex.
111
 The number of coenzyme B12 per oligomeric assembling of holo-EAL 
has been uncertain. Results from the different experiments for the determination of the number 
of active sites per the EAL oligomer were not consistence.
151
 While the kinetic studies on the 
EAL suggested the existence of six active sites per oligomer, the titration of EAL with analogues 
of coenzyme B12 compounds indicated the existence of two active sites per oligomeric 
assembly.
111, 154
 Extensive kinetics and spectroscopic studies on the EAL catalyzed reaction with 
different substrates and enzyme inactivators which are analogues to the substrates have been 
reported to support the formation of the substrate derived 2-amino-1-hydroxylethyl radical. 
Among theoretical and experimental investigated prediction on the reactivity of the protonated 2-
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amino-1-hydroxylethyl radical has been its proposed rearrangement to 1-amino-1-hydroxylethyl 
radical by the intramolecular 1,2 –shift of the NH3
+
 group. The latter radical proceed to 1-amino-
1-hydroxylethane by claiming hydrogen from the adenosine before being converted to ethanal by 
the heterolytic elimination of NH4.
+ 
The proposed direct elimination of NH4
+
 from the 2-amino-
1-hydroxylethyl radical to form an allyloxy radical which proceed to ethanal by abstracting 
hydrogen from the adenosine was similarly investigated 
155 
(figure 28).   
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Figure 28: Proposed mechanisms for the respective EAL catalyzed rearrangements of the ethanolamine 
and enantiomers of the aminopropanol to ethanal and propanealdehydes. Path a is the rearrangement by 
1,2-shift of the amine group to form 1-amino-1-hydroxylalkyl radicals which proceed to the 
aldehydes products and path b is the rearrangement to the aldehydes via an allyloxy radicals by the 
direct elimination of NH4
+ .
155
  
Although the application of EPR spectroscopy in the studies for the EAL catalyzed reaction 
identified the radical which was related to the product of the rearrangment, clear 
characterizations on wether this radical was 1-amino-1-hydroxylethyl (path a) or an allyloxy 
(path b) could not be achieved. However, the rearrangement by 1,2- shift of the NH3
+
 group has 
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been predicted to be assisted by the groups in the EAL active site which are speculated to 
promote the recombination of NH3
+
 with the two carbon residue intermediate resulted from the 
fragmentation to form 1-amino-1-hydroxylethyl radical.
156 
Substantial theoretical support for the 
rearrangement by the migration of the NH3
+
 group to form 1-amino-1-hydroxylethyl radical 
comes from the evaluation on the realative reactivity of 1-amino-1-hydroxylethyl and allyloxy 
radicals. Ab initial calculations by Wetmore, S.D., et al revealed 1-amino-1-hydroxylethyl 
radical is much more reactive than the allyloxy radical of path b.
155
 This results suggest the 
migration of NH3
+
 group (path a) is the likely mechanisms for rearrangement by EAL because 
the formed 1-amino-1-hydroxylethyl radical is more capable of abstracting hydrogen from an 
adenosine than the allyloxy radical which seem to be stabilized by conjugation.   
Numerous putative mechanisms for the rearrangement of the protonated 2-amino-1-
hydroxylethyl radical to 1-amino-1-hydroxylethyl radical by the 1,2 migration of NH3
+
 group 
have been proposed from the theoretical predictions on the reactivity of these radicals. Their 
reversible interconversions via a ketyl radical which is predicted to allow the migration of the 
NH2 group to the carbon which bonds OH- where it finally eliminated as NH3 as well as the 
intra-molecular migration of -NH2 to the rearranged product before it is eliminated have been 
among considered mechanisms. Also proposed has been the possibility of the deamination of the 
protonated 2-amino-1-hydroxylethyl radical to form the resonance stabilized radical cation that 
allows re-addition of ammonia at the hydroxyl bearing carbon.
151
 
 
1.6.2.2 Ribonucleotide reductases (RNRs) 
Ribonucleotide reductases (RNRs) catalyze the conversions of ribonucleoside diphosphate or 
triphosphate to 2'-deoxyribonucleoside diphosphate or triphosphate (figure 29) during the 
reactions which the hydride is supplied from the oxidation of NADPH or formate. These unique 
transformations are accomplished by the radical mechanism that achieves the reductions of 
ribonucleotides to deoxyribonucleotides for incorporation in DNA in all organisms.  
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Figure 29: The ribonucleotide reductases (RNRs) catalyzed reduction of ribonucleoside diphosphate or 
triphosphate to 2'-deoxyribonucleoside diphosphate or triphosphate 
Hitherto, all known RNRs have been described to depend on three types of metallocofactors in 
generating their primary radicals. A chain of reaction is initiated by those primary radicals which 
create a transient thiyl radical that induces the nucleotide reduction by the radical mechanism in 
the enzyme active site. 
157
 This cysteine radical formed by the primary radical is a common 
species in the mechanism of all RNRs. The radical mechanism of nucleotide reduction induced 
by the thiyl radical which efficiently achieves the transformations to deoxyribonucleotide is also 
similar to all RNRs. However, despite all RNRs shares the common role for providing 
deoxynucleotide monomeric precursors for DNA synthesis with similarities in radical 
mechanism, their only difference in metallocofactor generators of primary radicals has provided 
the basis for their classification. The three classes of RNRs have therefore been formed on the 
basis of their metallocofactors and mechanisms for the formation of primary radicals.
 
 While in 
the E. coli and mammalian class-I RNRs chain radical is initiated by the diiron(III)-tyrosine 
radical, Lactobacillus leichmannii class-II RNRs uses coenzyme B12 to generate the 5'-
deoxyadenosyl radical which initiates the chain radical for nucleotide reduction. The chain 
radical in the class III RNRs which are found in anaerobic E. coli is also initiated by 5'-
deoxyadenosyl radical. However, in contrast to class II RNRs, the 5' deoxyadenosyl radical in 
class III RNRs is derived from S-adenosylmethionine (SAM) when it is coordinated with Fe 
from [4Fe-4S] cluster in the enzyme active site.
 
RNRs which use dimanganese-tyrosine cofactor 
to generate primary radical have recently been described by the groups of JoAnne Stubbe 
(Massachusetts Institute of Technology) and Wolfgang Lubitz (Max Planck Institute for 
Bioorganic Chemistry, Hannover), hence form the subclass Ib of RNRs.
158, 159
 
Although the class II RNRs initiate the radical mechanism by the homolytic cleavage of the 
coenzyme B12 Co-C bond which forms the 5'-deoxyadenosyl radical, the mechanism of these 
RNRs have slightly deviated from the established minimal mechanistic scheme for the coenzyme 
55 
 
B12 dependent enzymes. The formation of substrate derived radical in class II RNRs is achieved 
via the thiyl radical while in other coenzyme B12 dependent enzymes, the substrate derived 
radicals are formed direct by 5'-deoxyadenosyl radical. Established mechanism for class II RNRs 
revealed the regioselective abstraction of hydrogen from the 3'-position of the ribonucleotide by 
the thiyl radical to form the substrate derived radical. Deprotonation of the hydroxyl bonded to 
the 3'-radical carbon by Glu 441 achieves the formation of a carbonyl group with radical 
migration to 2'-position which eliminates the 2'-hydroxyl group that forms water with a proton 
from a cysteine residue.
160  
The intermediate carbonyl conjugated radical abstracts a hydrogen 
atom from a cysteine which gives disulfide radical anion.  One electron reduction by disulfide 
radical anion forms an intermediate anion radical that abstracts hydrogen from thiol group with 
protonation by Glu 441 residue to form the deoxyribonucleotide product. The protein disulfide is 
reduced by NADPH dependant thioredoxin reductase which recycles them for another turnover.
 
161, 162
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Figure 30:  Mechanism of RNRs catalyzed reduction of ribonucleoside diphosphate or triphosphate to 
deoxyribonucleoside diphosphate or triphosphate    
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 1.7 Objectives of the studies 
Studies reported in this thesis were aimed toward deriving mechanistic insights into the 
coenzyme B12 dependent glutamate mutase catalyzed reversible rearrangement between (S)-
glutamate and (2S,3S)-3-methylaspartate from the mechanism based inactivation of the 
holoenzyme as well as kinetic investigations on the reaction by using coenzyme B12 structural 
derivatives.  
The mechanism-based inactivation studies were specifically designed to demonstrate the 
formation of the postulated substrate-derived 4-glutamyl as well as the product-related (2S, 3S)-
3-methyleneaspartate radicals as the intermediates during the reaction of glutamate mutase. Used 
inhibitors, which are analogues to the 4-glutamyl radical, were trans- and cis-glutaconates, while 
structural analogues to (2S,3S)-3-methyleneaspartate radical included buta-1,3-diene-2,3-
dicarboxylate, itaconate, fumarate, maleate, and mesaconate. The mechanism for the 
hypothetical glutamate mutase inactivations by these inhibitors were theoretically predicted to 
end up with the formation of an adduct of the 5'-deoxyadenosyl radical at the inhibitor. 
Experiments in this thesis were focusing on the kinetic characterization of the enzyme 
inactivation by these inhibitors as well as spectroscopic identification of the postulated radical 
adducts. The halogenated glutaric acids, 2-fluoroglutaric acid and 2-chloroglutaric acid have 
been deliberately used to explore as substrates for glutamate mutase as well as deriving 
mechanistic insights from spectroscopic characterizations of their reactions with holo-glutamate 
mutase.  
Investigations with the structural derivatives of coenzyme B12, 2',5'-dideoxyadenosylcobalamin 
(32), 3',5'-dideoxyadenosylcobalamin (33), and peptidoadenylcobalamin (34) were intended to 
uncover the mechanisms for assisting the homolytic cleavage of Co-C bond and guiding the 5'-
deoxyadenosyl radical towards the substrate by hydrogen bonding interactions. The calculated 
stabilization of the 5'-deoxyadenosyl radical by hydrogen-bonding of its 3'-O with C19-H of 
cob(II)alamin and its 2'-OH with a conserved glutamate residue of the protein were evaluated 
kinetically by applying 32, 33 and 34.  
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Furthermore, the structural role for the reaction rate enhancement at the level of homolytic 
cleavage of the Co-C bond by the 5,6-dimethylbenzimidazole ribonucleotide tail of coenzyme 
B12 was also investigated kinetically by using the adenosylpeptide B12 (31) as cofactor for the 
glutamate mutase reaction during these studies.  
An open reading frame encoding a putative chaperon (GlmL, 50.2 kDa) was detected between 
the genes coding for glutamate mutase components E and S. While GlmL is not necessary for 
functional expression of glmE and glmS in E. coli, recently it has been speculated that this 
protein helps to revive the cob(II)alamin containing glutamate mutase by exchange of the 
inactive cofactor with coenzyme B12. Also aimed during the period of this thesis was over 
expression of the homologous mutL gene from C. tetanomorphum in E. coli to investigate the 
postulated function of MutL, which is closely related to GlmL.  
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2. Experimental 
 
2.1 Materials 
2.1.1 Chemicals, biochemicals and reagents 
Chemicals and biochemicals were purchased for direct use without any further purification from 
Sigma Aldrich (Steinheim), Fluka (Neu-Ulm), Merck (Darmstadt), Roth (Karlsruhe) and Bio-
Rad-Laboratories (München), except where sources have been mentioned separate in texts. 
When necessary, organic solvents were distilled from calcium hydride before used. Petrol refers 
to the petrol fraction with boiling point range 40-60 °C. Protein molecular mass markers, DNA 
size markers, enzymes for DNA manipulations, oligonucleotides and vector plasmids were from 
Fermentas GmbH (St. Leon-Rot, Germany). Primers were prepared by MWG-Biotech AG 
(Ebersberg, Germany) and oligonucleotides sequencing were by Seqlab (Göttingen, Germany). 
 
2.1.2 Equipments 
Large cultures of 10 L and100 L were grown in a fermenter (Braun, Melsungen, Germany) and 
anaerobic experiments were performed in a glove box supplied by Coy Laboratories (Ann Arbor, 
MI, USA). Bacterial cells were opened by a French press (American Instruments, Maryland, 
USA) or a sonifier (Branson 250, Heinemann, Germany) and the used ultra-centrifuge was 
supplied by Beckman (München, Germany). DEAE-Sephacel, Superdex 200 and phenyl-
Sepharose columns from Merck (Darmstadt) were used for protein purifications with FPLC 
systems supplied by Pharmacia (Sweden). The Ultimate 300 nano LC/MS system (Dionex, 
Idstein, Germany) was used for analysis of peptides. UV/visible spectrophotometric 
measurements of activities and absorption characteristics of enzymes were performed with 
Ultrospec 1100 pro (Amersham Biosciences) and Uvikon 943 (Kontron Instruments, 
Switzerland) photometers.  T Gradient thermal cycler (Biometra GmbH, Göttingen, Germany) 
was used for PCR and the purifications of DNA were performed by following appropriate 
procedures as described in standard protocols supplied with the purification kits (Fermentas 
GmbH, St. Leon-Rot, Germany and Qiagen Düsseldorf, Germany).  
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Electrophoresis power supplier (Knürr-Heinzinger, Rosenheim, Germany) was used for 
providing voltage during DNA gel electrophoreses and visualizations were under high intensity 
UV light after staining in ethidium bromide. PAC 200 Bio-rad power supplier (Ontario, Canada) 
was used to provide voltage for proteins SDS-PAGEs. 
TLCs were carried out on silica gel (Kieselgel 60 F254, 0.2 mm, Merck, Darmstadt) pre-coated 
aluminium plates. Separated compounds were visualized by both UV light and spraying with 
0.1% aqueous KMnO4. Silica gel (‘flash’, Kiesegel 40-63 U 60A) was used in medium pressure 
chromatography. Deuterated solvents with internal standard proton residual where used in NMR 
spectroscopy measured at stated frequencies in Bruker Advance spectrometers. Data were 
reported as follows: chemical shifts δ scale in ppm, multiplicity (s = singlet, d = doublet, t = 
triplet, m = multiplet) and coupling constant (Hz). 
 
2.2 Experiments and methods 
2.2.1 Cultivations of bacteria 
  2.2.1.1 Cultivation of Clostridium tetanomorphum 
Clostridium tetanomorphum (DSM 576) was anaerobically cultivated at 37°C in overnight 
cultures from 70 ml followed by 1.5 L which was inoculated to 10 L pre-culture used in the 
preparation of 100 L main fermenter culture.
163, 164
 Wet cells of C. tetanomorphum were 
harvested from the 100 L main culture and stored at -80° C. 
Medium composition 
 Per liter 
 Sodium glutamate      18.0 g 
 Yeast extract         5.0 g 
 Sodium thioglycolate        1.0 g 
 1 M Phosphate buffer (pH 7.4)    20.0 ml 
 Trace elements (SL10)     10.0 ml                                                                                           
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Trace elements solution (SL10) composition 
Per liter 
 Hydrochloric acid (25%, 7.7 M)    10.0 ml 
  FeCl2•4H2O         1.5 g 
 ZnCl2        70.0 mg 
 MnCl2•4H2O                100.0 mg 
 H3BO3          6.0 mg 
 CoCl2•6H2O                190.0 mg 
 CuCl2•2H2O         2.0 mg 
 NiCl2•6H2O       24.0 mg 
 Na2MoO4•2H2O      36.0 mg    
                                        
The media (70 ml and 1.5 L) in tight closed bottles were boiled, degassed and filled with 
nitrogen gas which replaced the removed air. During degassing, the anoxic were indicated by 
resazurin color change to reddish blue. Finally the media were autoclaved (121°C, 30 min) and 
stored at room temperature in the dark. Preparations of 10 L and 100 L media in fermenters were 
by the same procedure.
163, 164
  
                                                                                
 2.2.1.2 Cultivation of E.coli DH5α with pOZ3 and pOZ5 construct plasmids  
Construct plasmids pOZ3 and pOZ5 with respective glmS and glmE inserts for production of 
glutamate mutase protein components S and E were prepared and transformed separately in 
E.coli DH5α.109,110 Cells of E.coli DH5α carrying the construct plasmids were aerobically 
cultivated overnight at 37° C on standard I medium in 5 ml cultures before 250 ml pre-cultures. 
The 2 L main cultures were prepared by inoculations to 0.1 OD578 from pre-cultures and 
incubations at 37 °C for 3 hours to 0.5 OD578 before inductions by 1 mM IPTG. The induced 
main cultures producing components S and E were further incubated at 37 ° C for 3 hours and 
overnight respectively before cells were harvested (6000 × g, 20 min) and kept at -80 °C.    
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Composition of standard I broth – KOH pH 7.4 
Per Liter 
 Standard I        25.0 g 
 Mops         14.0 g 
 Carbenicillin        50.0 mg 
 Water           1.0 L   
                                                               
The solution of KOH (aq) was titrated to the mixture of Standard I, Mops and water to pH 7.4 
before the mixture was sterilized (121° C, 30 min). Carbenicillin was added aseptically after 
sterilization.  
    
 2.2.1.3 Cultivation of MutL expressing E.coli ROSETTA 
Constructed pASG-IBA3 vectors with component L of glutamate mutase encoding mutL insert 
were chemically transformed into E. coli ROSETTA cells which were overnight aerobic 
cultivated on LB medium at 37 °C from agar to 5 ml cultures. The 500 ml cultures of mutL 
expressing cells were finally prepared from the 5 ml cultures by inoculation to 0.1 OD578 and 
incubation for 4 hours at 37 °C to 0.5 OD578 before the cultures were induced by AHT (200µg/L) 
and further incubated for overnight. After overnight growth, cells were harvested (6000 × g, 20 
min) and kept at -80 °C. 
A similar cultivation procedure was used to prepare E.coli ROSETTA cells during the 
production of component L protein of glutamate mutase by 1 mM IPTG induction of cells 
transformed with pASG-IBA5 clone of mutL.   
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Composition of the LB medium -HCl pH 7.4  
                   Per Liter 
 Tryptone         10.0 g 
 Yeast extracts           5.0 g 
 NaCl          10.0 g 
 Water            1.0 L 
 Carbenicillin         50.0 mg  
 
HCl (aq.) was titrated to the mixture of tryptone, yeast extracts, NaCl, and water to pH 7.4 before 
the mixture was sterilized (121 °C, 30 min). During the preparation of LB agar plates, the 
bacteriological agar (15 g/L) was also added to the above medium composition before 
sterilization. Carbenicillin was added aseptically after sterilization. 
  
 2.2.1.4 Cultivation of E.coli MG 1655 
E. coli MG1655 (CGSC 6300) was aerobically cultivated at 37 °C on minimum basic media with 
various carbon sources and vitamin B12 supplement.
165
 The bacterial growth on the carbon 
sources and vitamin B12 media were measured at regular intervals for 7 days. 
 
Media composition 
Minimum basic medium: -  60 mM K2HPO4, 33 mM KH2PO4, 76 mM (NH4)2SO4,  
2 mM tri-sodiumcitrate, 0.1 % (v/v) SL 10
R
, 1 mM MgSO4  
Carbon sources and B12 supplement: -   
 20 mM Glucose  
 20 mM Methylmalonate  
 20 mM Methylmalonate and 10 µM 
cyanocobalamin 
 20 mM Propionate 
 20 mM Propionate and 10 µM cyanocobalamin 
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Media were sterilized by autoclaving (121° C, 30 min) before glucose, propionic acid, 
methylmalonic acid and cyanocobalamin were aseptically added.  Media with cyanocobalamin 
supplement were covered by aluminium foils in order to protect the vitamin from light.  
  
2.2.1.5. Cultivation of 2-hydroxylglutarate dehydrogenase expressing E.coli BL21   
The pACYCDuet
TM
-1 vector with 2-hydroxylglutarate dehydrogenase encoding hgdH insert was 
obtained from Ivana Djurdjevic and transformed into E. coli BL21.
166
 The transformed cells 
were cultivated overnight at 37 °C on LB medium from an agar via 5 ml and 500 ml pre-cultures 
to 2 L main cultures which grew from 0.1 OD578 to 0.5 OD578 before they were induced by AHT 
(200µg/L) and further overnight incubated. After the overnight growth, the 2-hydroxylglutarate 
dehydrogenase expressing cells were finally harvested (6000 × g, 20 min) and kept at -80 °C.   
Composition of the LB medium pH 7.4  
                 Per Liter 
 Tryptone         10.0 g 
 Yeast extracts           5.0 g 
 NaCl          10.0 g 
 Water            1.0 L 
 Carbenicillin         50.0 mg  
 
HCl (1 M) was titrated to the mixture of tryptone, yeast extracts, NaCl, and water to pH 7.4 
before the mixture was sterilized by autoclaving (121 °C, 30 min). During the preparation of LB 
agar plates, the bacteriological agar (15 g/L) was also added in the above medium composition 
before sterilization. Carbenicillin was added aseptically after sterilization.  
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2.2.2 General methods for protein biochemistry 
 2.2.2.1 Methods for cells disruptions 
Cells were suspended in appropriate buffers and disrupted by pressure (up to 1.4 MPa) applied 
by pre-cooled French press or ultrasonication under ice- cooling. Cells lyses were monitored by 
centrifugations (6000 × g, 1 min) or microscope and cells free extracts were separated from cells 
debris and unbroken cells by ultra-centrifugations (100,000 × g , 4°C, 30 min). 
 
 2.2.2.2 Identification of proteins  
SDS-PAGE was used for qualitative identifications of proteins by comparing their masses with 
those from the standard protein molecular mass markers. Protein samples for analysis were 
mixed with 1-2 parts of SDS-buffer (125 mM Tris/HCl, pH 6.8, 10% glycerol, 10% 
mercaptoethanol, 4% SDS and 0.2% bromophenol blue) and boiled (98 °C, 5- 10 min) to 
denature proteins. Standard proteins markers were loaded on the gel parallel to the prepared 
samples and run across stacking and separating gels in electrolyte buffer (25 mM Tris, pH 8.8, 
190 mM glycine, 0.1% SDS) by a constant applied voltage (up to 200 mV). The protein 
migration speed from cathode (-) to anode (+) increases with decreasing size, hence small 
proteins move faster across the gel than large proteins. The mass dependent migration speed 
achieves the separation of denatured proteins when running across the gel and therefore allowed 
their identification by comparing with the standard masses from the marker. Protein bands were 
visualized by staining (Coomassie brilliant blue R-250 in methanol: water: glacial acetic acid 
ratio 4:5:1) and destaining (ethanol: water: glacial acetic acid ration 4:5:1). 
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Components           Separating gel           Stacking gel 
1 M Tris/HCl pH 8.8     3000 µl       -  
1 M Tris/HCl pH 6.8         -    470 µl 
H2O       1370 µl            2900 µl 
10% SDS          85 µl     40 µl 
Acrylamide/Bisacrylamide (40%/1.6%)  2750 µl   585 µl 
5% TEMED          85 µl     40 µl 
10% Ammonium peroxodisulfate     115 µl     80 µl     
  
Table 3: Composition of SDS-PAGE. The migration speed of polypeptides from cathode(-) to anode (+) 
across stacking and separating gels due to the applied voltage increases with decreasing protein mass . 
 
When necessary, protein gel bands were accurately identified by peptide sequencing and LC-MS 
characterisations. Methylaspartase, 2-hydroxylglutarate dehydrogenase and components S and E 
of glutamate mutase were throughout confirmed by activity assays.  
 
 2.2.2.3 Protein dialysis and determination of concentration  
Protein dialysis for removal of salt after saturation with (NH4)2SO4 or NaCl separation gradients 
during purification was achieved by salts diffusion across membranes of protein dialyzing tubes 
to KPP buffers. Concentrating protein solutions were accomplished by spinning in appropriate 
Centricons among the available cutting sizes of 3, 10, 30 and 50 kDa. Proteins concentrations 
were determined by the Bradford method which uses the principle of the Coomassie brilliant 
blue maximum absorption shift from 465 to 595 nm after its reaction with the protein.
167
 In this 
method the protein concentration is obtained by fitting the sample absorption at 595 nm to a 
standard curve obtained with serum albumin. 
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2.2.3 Purification of proteins 
 2.2.3.1 Purification of methylaspartase 
Purification buffers 
Buffer A: 50 mM KPP, pH 7.4, 1 mM MgCl2, 1 mg DNase   
Buffer B: 5 mM KPP, pH 7.4   
Buffer C: 20 mM KPP, pH 7.4, 1 mM EDTA 
Buffer D: 20 mM KPP, pH 7.4, 1 mM EDTA, 3 mM DTT  
Buffer E: 20 mM KPP, pH 7.4, 1 mM EDTA, 3 mM DTT, 1 M NaCl 
Buffer F: 5 mM KPP, pH 7.4, 1 mM EDTA, 3 mM DTT 
Buffer G: 50 mM KPP, pH 7.4, 1 mM EDTA, 3 mM DTT, 100 mM KCl 
 
Frozen cells of Clostridium tetanomorphum (30 g) were suspended in buffer A (70 ml) before 
opened by sonication at 50% duty time under ice cooling for 4 × 5 minutes, with 5 minutes of 
cooling in between, which achieved approximately 70% of broken cells. The sonicated 
suspension was ultra-centrifuged (100,000 × g, 4 °C, 45 min) and (NH4)2SO4 (17 g) was added to 
the supernatant (74 ml) to attain 40% saturation. The protein solution was then ultra-centrifuged 
(25,000 × g, 4 °C, 30 min) and the obtained supernatant (72 ml) was further saturated to 70% 
(NH4)2SO4 (14g) with subsequently ultra-centrifugation (25,000 × g, 4 °C, 30 min). Pellets 
obtained at this step were dissolved in buffer B (25ml) and the formed protein solution was 
dialyzed for 6 hours (buffer C). DTT (18 mg, 5 mM) was added to the dialyzed protein solution 
(23 ml) before the solution was loaded to DEAE-Sephacel column pre-equilibrated with buffer D 
on the FPLC system. Proteins were eluted from the column by an increasing NaCl gradient from 
0 to 1 M (buffer E) through which methylaspartase was collected from 20% to 33% and 
identified by both SDS-PAGE and activity assays. Combined fractions of methylaspartase (68 
ml) was saturated to 80% (NH4)2SO4 (36 g), ultra-centrifuged (25,000 × g, 4 °C, 30 min) and 
pellets were dissolved in buffer F (25 ml). The formed protein solution was dialyzed for 4 hours 
(buffer F) before loaded on gel filtration column (Superdex 200) which was pre-equilibrated by 
buffer G and eluted by the same buffer.  
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Fractions containing methylaspartase were again identified by activity assays and SDS-PAGE, 
combined and concentrated to 2.8 ml (18 mg/ml) by Centricon (30 K). The partial purified 
enzyme was stored at -80 °C.
168, 169
   
       
 2.2.3.2 Purification of component S of glutamate mutase 
Purification buffers 
Buffer A: 20 mM KPP, pH 7.4, 1 mM EDTA, 2 mM DTT 
Buffer B: 20 mM KPP, pH 7.4, 1 mM EDTA, 2 mM DTT, 1 M (NH4)2SO4 
 
The GlmS expressing E. coli DH5α cells (10 g) were suspended in buffer A (25 ml) and opened 
by sonication at 5% duty time under ice cooling for 3 × 5 min, with 5 min cooling intervals in 
between. The sonicated suspension was ultra-centrifuged (100,000 × g, 4 °C, 1 hour) and 
(NH4)2SO4 (4 g) was added to the obtained supernatant (30 ml) which brought it to 1M 
(NH4)2SO4. DTT (20 mg) was also added to the supernatant (30 ml) to bring to 5 mM DTT, 
before it was loaded on phenyl-Sepharose column on FPLC system which was pre-equilibriated 
with buffer B. Column bound proteins were eluted by a decreasing (NH4)2SO4 gradient from 1 M 
to 0 during which component S of glutamate mutase was eluted approximately after 20% of 
buffer B and identified by activity assays. Column fractions containing the component S of 
glutamate mutase were combined, dialyzed for 6 hours (buffer A), concentrated (20 ml) and 
loaded on gel filtration column (Superdex 200) pre-equilibriated with buffer A. Proteins were 
eluted on Superdex 200 column by buffer A and fractions containing GlmS were identified by 
activity assays, combined and finally concentrated to 3 ml (10 mg/ml) by centricom (3 kDa). The 
partial purified component S protein was kept at – 80 °C.168, 169     
   
 2.2.3.3 Purification of component E of glutamate mutase 
Purification buffers 
Buffer A: 20 mM KPP, pH 7.4, 1 mM EDTA 
Buffer B: 20 mM KPP, pH 7.4, 1 mM EDTA, 1 M (NH4)2SO4 
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E. coli DH5α cells (6 g) producing component E of glutamate mutase were suspended in buffer 
A (17 ml) before cells were opened by sonication at 5% duty time under ice coiling for 3 × 5 
min, with 5 min cooling intervals in between. The sonicated suspension was ultra-centrifuged 
(100,000 × g, 4 °C, 1 hour) in order to separate cell debris and unbroken cells (pellets) from the 
cell free extracts (29 ml supernatant) which was brought to 1 M (NH4)2SO4 (4 g) before loaded 
on a phenyl-Sepharose column pre-equilibriated with buffer B attached to a FPLC system. 
Column bound proteins were eluted by decreasing (NH4)2SO4 gradient from 1 M to 0 through 
which component E of glutamate mutase was eluted after about 60% of buffer B before being 
identified by activity assays. Column fractions with mutase component E were combined, 
dialysed for 6 hours (buffer A) and concentrated to 20 ml before loaded on a gel filtration 
column (Superdex 200) which was pre-equilibriated with buffer A. Proteins were eluted on the 
gel filtration column by buffer A before column fractions containing glutamate mutase 
component E were identified by activity assays, combined and finally concentrated to 2.4 ml (5.2 
mg/ml) by centricom (30 kDa). The partial purified component E of glutamate mutase was stored 
at -80 °C.
168, 169
  
 
 2.2.3.4 Purification of 2-hydroxyglutarate dehydrogenase  
Purification buffers 
Buffer A: 100 mM Tris, pH 8, 150 mM NaCl 
Buffer B: 100 mM Tris, pH 8, 150 mM NaCl, 2.5 mM Desthiobiotine    
 
The 2-hydroxyglutarate dehydrogenase producing E. coli BL21 cells (5 g) where suspended in 
buffer A (15 ml) and opened by a pre- cooled French press with an applied pressure of 1.4 MPa. 
The suspension of opened cells was ultra-centrifuged (100,000 × g, 4 °C, 1 hour) and the 
obtained supernatant of cell free extract (17 ml) was loaded on the Strep-Tactin affinity column 
(5 ml) pre-equillibriated with buffer A at 4 °C. The recombinant 2-hydroxylglutarate 
dehydrogenase protein was washed on the column by buffer A (20ml) before being eluted by 
buffer B (15 ml), concentrated (10 kDa Centricon) and finally kept at ˗ 20 °C. 
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2.2.4 General methods for molecular biology 
 2.2.4.1 Identification of DNAs 
DNAs were identified on the basis of their sizes by agarose gel electrophoresis. Depending on 
the gel concentration, agarose was mixed with TAE buffer (50× diluted, 2 M Tris, 1ml acetic 
acid, 50 mM EDTA) in appropriate concentrations followed by microwave heating that dissolved 
the agarose in buffer. The hot agarose solution was cooled to 60 °C before poured into the 
casting tray fixed with wells shaping comb where it was allowed to solidify by cooling to room 
temperature. DNA samples were mixed with the loading buffer (0.21% bromophenol blue, 
0.21% xylene cyanol FF, 0.2 M EDTA, 50% glycerol, pH 8.0) and loaded on the gel parallel to 
the DNA ladder. Voltage potential which leads to the migration of double stranded DNA 
fragments (300 to 4000 base pairs) from cathode (-) to anode (+) was then applied across the gel 
in TAE buffer. As the DNA migration speed in due to the applied voltage increases with 
decreasing fragment size, DNAs were separated and identified by comparing their sizes with 
those of standard DNA fragments from the ladder. The visualization of DNA fragments was by 
UV light after staining in ethidium bromide. Purified DNA and plasmid clones were further 
precisely characterized by sequencing.   
     
2.2.4.2 DNA purification 
After extracted from C. tetanomorphum, the total genomic DNA was further purified by ethanol 
precipitation during the following procedure:- 
The mixture of DNA sample (2 ml), sodium acetate (3 M, pH 4.5, 200 µl) and 96% cold ethanol 
(4 ml, ˗20°C) was kept at ˗80 °C for 30 minutes during which DNAs precipitated. The solution 
with DNA precipitates was thereafter transferred to Eppendorf cups (1 ml each), centrifuged 
(15,000 × g, 30 min). Obtained pellets (DNAs) were further washed by suspending in 70% cold 
ethanol (200 µl, ˗20 °C), centrifuged (15,000 × g, 30 min) and dried (37 °C, 20 min). Finally the 
DNAs pellets were dissolved in sterile water (500 µl) and kept at 4 °C.     
PCR products and cloned plasmids were purified by established procedures from standard 
protocols which were provided with Gene JET
TM
 purification kits.  
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2.2.4.3 Determination of DNA purity and concentration 
The index of DNA sample absorptions ratio at 260 nm to 280 nm (A260/A280) was useful in 
determining the purity of extracted total genome. The index 1.8 A260/A280 indicated more than 
90% DNA purity. Concentrations of purified DNAs and vector plasmids were measured by 
UV/Visible spectrophotometer.  
 
2.2.5 Preparations of pASG-IBA3 and pASG-IBA5 clones of mutL 
 2.2.5.1 Extraction of Clostridium tetanomorphum total genome 
Extraction buffers 
Buffer A: - 50 mM Tris-HCl pH 8, 25% Saccharose 
Buffer B: - 50 mM Tris-HCl, pH 8, 25 mM EDTA 
Buffer C: - 50 mM Tris-HCl, Ph 8, 50 mM EDTA, 1% SDS 
Buffer D: - 10 mM Tris, pH 7.4, 1 mM EDTA 
 
Cells of C. tetanomorphum (2 g) were suspended in buffer A (4 ml) before lysozyme (50 mg) 
was added to the cells suspension and gently shaked at 37 °C for 90 minutes. After the shaking 
incubation, buffer B (4 ml) was added to the solution of suspended cells and further incubated in 
ice for 15 minutes. The suspended cells were thereafter lysed by the addition of buffer C, RNase 
(100 µg), proteinase K (10 mg) and shaking at 37 °C for 3 hours. Proteins were extracted from 
the solution of lysed cells (10 ml) by phenol (3 x 10 ml) and phenol-chloroform (2 x 10 ml) 
before the DNA solution was dialyzed for 24 hours (buffer D) and further purified to 1.8 
A260/A280 by ethanol precipitation. The extracted genome was finally stored at 4 °C. 
    
 2.2.5.2 PCR amplification of mutL from the genome of C. tetanomorphum  
The mutL gene from the genome of C. tetanomorphum was multiplied in a 50 µl PCR with the 
below sequence of primers and composition:-  
Forward primer: - aagctcttcagtggatgcttatttacttttag 
Reverse primer: - aagctcttcacccaactttaaccaaatactttttc  
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PCR composition: -  dNTP 200 µM  
    Forward primer 500 nM 
    Reverse primer 500 nM 
    Template DNA 2 to 50 ng/µL 
    Polymerase 1 U       
 
Temperature cycling: - 98 ° C 30 sec 
    98 ° C 10 sec 
    72 ° C 45 sec 
    72 ° C 10 sec 
     4 ° C 4 sec 
 
 2.2.5.3 Cloning of mutL into pASG-IBA3 and pASG-IBA5 vector plasmids  
The PCR amplified mutL gene was inserted on IBA-20 pre-entry vectors by Lgul and T4 ligase 
respective restriction and ligation reactions before the vectors were chemically transformed into 
E. coli DH5α cells which grew overnight at 37 °C on X-gal supplemented LB ager. White 
colonies from the ager culture were inoculated on LB medium (3 ml) and grew overnight at 37 ° 
C. IBA-20 vector plasmids with the mutL insert were purified (min-prep) from the 3 ml broth 
cultures and the mutL genes from these pre-entry vectors were thereafter inserted on pASG-
IBA3 and pASG-IBA5 expression vectors during the separate restriction and ligation reactions 
by ϵsp3I and T4 ligase respectively. Constructed expression pASG-IBA3 and pASG-IBA5 
vectors with mutL inserts were chemically transformed into E. coli DH5α cells which grew at 37 
°C on LB medium in overnights ager and broth cultures (3 ml) before were purified (min-prep) 
and finally kept at  -20 °C.    
The standard LB medium pH 7.4 composition was supplemented with x-gal (25 µgml
-1
), 
kanamycin (50 µgml
-1
) and carbenicillin (100 µgml
-1
) which were added aseptically after 
sterilization of the medium by autoclaving (121 °C, 30 min). 
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2.2.6 Synthesis of chemicals 
 2.2.6.1 Synthesis of cis-glutaconic acid  
  2.2.6.1.1  Dibromolaevulinic acid 
CO2H
O
Br Br
 
Figure 31: Dibromolaevulinic acid 
 
Bromine (8.28 g, 51.8 mmol, 2.66 mL) was added drop wise to laevulinic acid (3.06 g, 25.86 
mmol) in 48 % HBr (2.81 mL, 51.7 mmol) at 0 ºC over 30 min. The reaction mixture was stirred 
at 0 ºC for 4 h. Excess of bromine was removed by a nitrogen flow. The resulting solution was 
kept overnight at 0 ºC to give a solid which was taken up in ethyl acetate (70 mL), washed with 
saturated aqueous sodium metabisulfate (3 x 15 mL). After drying (MgSO4) the solvent was 
removed to afford a pale yellow crude solid (6.02 g).  
Recrystallisation from ethyl acetate/petrol afforded the title compound as a white solid (4.30 g, 
61 % yield). m.p. 109-112 °C.
106, 170 
1
H NMR (300 MHz, CDCl3): δ= 2.97 (dd, J = 5.6 and 17.6 Hz, 1 H, CHHCO2H), 3.29 (dd, J = 
8.1 and 17.4 Hz, 1 H, CHHCO2H), 4.07 (d, J = 13.2 Hz, 1H, CHHBr), 4.28 (d, J = 12.9 Hz, 1 H, 
CHHBr), 4.94 (br. t, J = 6 Hz, 1 H, CHBr) ppm. 
13
C NMR (75 MHz, CDCl3): δ = 30.9 (C-2), 38.4 (C-5), 41.1 (C-3), 174.5 (C-1), 194.4 (C-4) 
ppm.  
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2.2.6.1.2  Tert-butyltrichloroacetinidate 
Cl3C O
NH
 
Figure 32: t-Butyltrichloroacetinidate 
 
A solution of trichloroacetonitrile (5.0 g, 34.6 mmol) in dry diethyl ether (12 mL) was added 
dropwise to a solution of potassium t-butoxide (0.38 g, 3.46 mmol) in t-butanol (7 mL) and dry 
diethyl ether (8 mL) at 0 ºC under nitrogen. The reaction mixture was allowed to warm up at 
room temperature for 1 h before being heated at reflux under nitrogen for 1 h. After cooling to 
room temperature, the solvent was removed to give a residual oil, which was taken in n-pentane, 
filtered and evaporated to give a crude oil (6.26 g). Distillation at water pump pressure gave the 
title compound (4.58g, 61%).
170
   
1
H NMR (300 MHz, CDCl3):  δ = 1.5 (9H, s, O-C (CH3)3), 8.15 (1H, s, =NH)  
 
  2.2.6.1.3  3, 5-Dibromolaevulinic t-butylester 
COOtBu
O
Br Br
 
Figure 33: 3, 5-Dibromolaevulinic t-butylester 
 
A solution of t-butyltrichloroacetinidate (0.81 g, 3.71 mmol, 2 equivalents) in dichloromethane 
(5 mL) was added dropwise to a solution of dibromolaevulinic acid (0.52 g, 1.90 mmol) in 
dichloromethane (5 mL). After the overnight room temperature stirring, the reaction mixture was 
quickly treated with ice cold 5% NaHCO3 (2 x 10 mL), washed with water (2 x 10 mL) and dried 
(Na2SO4).  
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Solvent removal gave the crude solid (0.93 g) which was purified by flash chromatography 
(ether: petrol 10%) to give oil of the title compound (0.52 g, 83%). 
1
H NMR (300 MHz, CDCl3): δ = 1.37 (9H, s, -C (CH3)3), 2.80 (dd, J = 5.6 and 17.6 Hz, 1 H, 
CHHCO2H), 3.15 (dd, J = 8.1 and 17.4 Hz, 1 H, CHHCO2H), 4.14 (d, J = 13.2 Hz, 1H, CHHBr), 
4.31 (d, J = 12.9 Hz, 1 H, CHHBr), 4.90 (br. t, J = 6.0 Hz, 1 H, CHBr) ppm. 
 
2.2.6.1.4  Cis-glutaconic acid 
 
HOOC COOH
 
 
     Figure 34: Cis-glutaconic acid 
 
KHCO3 (17.0 g, 169 mmol) in water (210 mL) was added to 3, 5-dibromolaevulinic acid (5.5 g, 
21 mmol). The mixture was vigorously stirred for 19 h before the reaction was quenched by 
acidification (aq. HCl) to pH 2-3 and extracted by diethyl ether (10 × 30 mL). After drying the 
combined organic extracts (Na2SO4) the solvent was removed. The obtained yellow solid was 
decolourised by charcoal and recrystallised from acetonitrile to give the titled compound (0.22 g, 
8%).  m. p. 132- 133 ° C.
106, 170, 171
  
1
H NMR (300 MHz, CD3OD): δ = 3.71 (dd, J = 3.0 and 7.0 Hz, 2H, CH2CO2H), 5.93 (dt, J = 2.0 
and 11.5 Hz, 1 H, CH), 6.52 (dt, J = 7.0 and 11.6 Hz, 1 H, CH) ppm.   
13C NMR [δC (75 MHz, CD3OD)]: δ = 35.2 (C-4), 123.5 (C-3), 142.2 (C-2), 169.5 (C-1), 174.7 
(C-5) ppm.  
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  2.2.6.1.5  Cis-glutaconic t-butylester 
 
HOOC C O
O
 
 
Figure 35: Cis-glutaconic t-butylester 
 
During the different experiments performed in the below chemical equivalence with reaction 
time varied from 3 to 72 h and different workup attempts:- 
Solutions of dibromolaevulinic t-butylester (0.25 g, 0.76 mmol) in THF (1 mL) were added 
dropwise over 5 min to solutions of KHCO3 (0.40 g, 3.8 mmol) in water (3 mL) at room 
temperature. Reaction mixtures were kept stirred and monitored by TLC. In each experiment, the 
product (cis-glutaconic t-butylester) spot was formed after 2 h and the starting material spot was 
not decreasing even to those reaction mixtures which were left for 72 h. In the work up 
procedure which the reaction mixture was first diluted with water (10 mL), washed with ether (3 
x 10 mL) and acidified to pH 2 (aq. HCl) before extracted by diethyl ether (10 x 10 mL), dried 
(MgSO4) and evaporated, the mixture of cis and trans- glutaconic t-butylester  (0.01 g, 10%) was 
obtained. 56% of starting material (dibromolaevulinic t-butylester) was recovered from diethyl 
ether washings.  
In another work up procedure; the reaction mixture was washed with ether (2 x 10 mL), acidified 
to pH 2-3 (aq. HCl) and quickly saturated with brine before extracted by dichloromethane (10 x 
10 mL) afforded the same yield of the mixture of cis- and trans- glutaconic t-butylester.      
1
H NMR (300 MHz, CDCl3): δ = 1.40 (9H, s, -C (CH3)3), 3.60 (dd, J = 3.0 and 7.0 Hz, 2H, 
CH2CO2H), 5.90 (dt, J = 2.0 and 11.5 Hz, 1 H, CH), 6.57 and 6.85 (dt, J = 7.0 and 11.6 Hz, 1 H, 
CH) ppm.   
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  2.2.6.1.6 4-Bromodihydropyran-2, 5-dione 
O
O
O
Br
 
Figure 36: 4-Bromodihydropyran-2, 5-dione 
 
A solution of LiOH (0.153 g, 3.65 mmol) in water (35 mL) was added to dibromolaevulinic acid 
(0.90 g, 3.29 mmol) and stirred overnight at room temperature. The reaction mixture was then 
extracted by dichloromethane (5 x 10 mL), dried (MgSO4) and evaporated to give crude solid 
(0.24 g). TLC and NMR analysis showed the product 4-bromodihydropyran-2,5-dione was 
formed and the starting material dibromolaevulinic acid.  
1
H NMR (300 MHz, CDCl3 ): Dibromolaevulinic acid δ =  3.00 and 3.32 (2H, m, -CH -COOH), 
4.11 and 4.31 (2H, m, -CH -Br), 4.94 (1H, q, -CHBr-) and (4-bromodihydropyran-2,5-dione): δ 
= 2.99 (2H, m, -COCH CHBr-), 4.93 (1H, m, -CHBr-), 5.24 (2H, s, -OCH CO-).   
 
 2.2.6.2 Synthesis of 3-[
13
C-methyl]methylitaconic Acid 
  2.2.6.2.1  
13
C- triethylbut-1-ene-2, 3, 3-tricarboxylate 
 
H3
13C
EtO2C
EtO2C
CO2Et
 
 
Figure 37:
13
C-triethylbut-1-ene-2,3,3-tricarboxylate 
 
The reaction involved the Malachowski’s mixture (Triethylprop-1-ene-2, 3, 3-tricarboxylate and 
triethyl prop-2-ene-2, 3, 3-tricarboxylate).  
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Sodium hydride (60 %, 140 mg, 3.5 mmol) was washed with petrol three times, dried, suspended 
in anhydrous THF (7 mL) and cooled in an ice-bath. Malachowski’s mixture (0.645 g, 2.49 
mmol) was added dropwise and the reaction mixture was stirred at room temperature for 40 min. 
13 
C- methyl iodide (0.5 g, 0.22 mL, 3.5 mmol) was added and the reaction was heated (bath 
temperature 55 ºC) for 2.5 h. The solvent was removed and the resulting residue was dissolved in 
water (30 mL) before extracted with ether (3 x 20 mL). The ethereal solution was washed with 
water (1 x 10 mL) and standard brine (1 x 10 mL), dried (MgSO 4 ). Solvent was removed and 
the yellow oil residue was purified by a silica gel flash column chromatography (10 % 
ethylacetate: petrol) to afford light yellow oil (0.30 g, 1.1 mmol, 44 %).
172, 173
  
1
H NMR (300 MHz, CD3CN), δ = 1.23 (t, J = 7.1, 6H), 1.27 (t, J = 7.1, 3H), 1.60 (d, J = 130, 
3H), 4.18 (q, J =7.1, 6H), 5.79 (s, 1H), 6.30 (s, 1H) 
13
C NMR (300 MHz, CD3CN) δ = 15.35 (
13 CH 3 ) 
 
  2.2.6.2.2  3-[
13
C-methyl]methylitaconic acid 
 
HO2C
H3
13C CO2H
 
 
Figure 38: 3-[
13
C-methyl] methylitaconic acid 
 
The mixture of 13 C- triethylbut-1-ene-2, 3, 3-tricarboxylate (0.27 g, 1 mmol) and 20 % HCl (20 
mL) was heated (Oil bath temperature of 80 ºC) for 72 h. The solvent was removed and the 
resulting solid (0.12 g) was recrystallized from acetonitrile to give the title compound as a white 
crystalline solid (0.05 g, 0.34 mmol, 34 %).
172, 173 
1
HNMR (300 MHz, CD 3 CN), δ = 1.30 (dd, 3H 
13 CH 3 ), 3.53 ( q, 1H CH), 5.79 (s, 1H =CH 2 ), 
6.30 (, s, 1H =CH 2 )  
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13
C NMR (300 MHz, CD 3 CN), 15.35 (
13 CH 3 ) 
 
 2.2.6.3 Synthesis of coenzyme B12 structural derivatives cofactors and other probes 
Coenzyme B12 structural derivatives were synthesized in the laboratory of Dr. Felix H. Zelder, 
University of Zürich by slightly modified procedures from those described in the literature.
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Buta-1,3-diene-2,3-dicarboxylate and 2-fluoroglutaric acid were synthesized in the laboratory of 
Prof. B. T. Golding, Newcastle University. 
 
2.2.7 Assays for invitro enzymatic reactions 
Hologlutamate mutase was in vitro prepared from glutamate mutase components S and E as well 
as the coenzyme B12 or its structural derivatives cofactors. Light sensitive cofactors; coenzyme 
B12, active structural derivatives of coenzyme B12 and pyridoxal-5'-phosphate were throughout 
protected from light (aluminum foil shielding) and measurements involved these cofactors were 
under red light. Quartz cuvettes were used in all absorptions which were measured at any 
wavelength below 320 nm and 0.5 cm length cuvettes were important in decreasing absorptions 
to photometer measured range especially in those assays with multi-holoenzyme systems. 
Appropiate concentrations of all used free cobalamins in “base on” form as well as their 
reconstitutions to hologlutamate mutase with proteins S and E in Tris-HCl were scanned from 
300 nm to 700 nm by using quartz cuvette. Free cobalamins were scanned direct while in the 
reconstitutions of holoenzymes excess cobalamins were removed by sephadex G25 before 
scanning.       
 
2.2.7.1 Assays for methylaspartase 
Activity of the in vitro methylaspartase catalyzed irreversible conversion of (2S, 3S) 3- 
methylaspartate to mesaconate was generated by the addition of (2S, 3S) 3-methylaspartate to the 
enzyme in Tris/HCl buffer (pH 8.3) at 37°C. The enzyme activity were direct assayed by 
measuring the formation of mesaconate at 240 nm (Ɛ240 = 3.8 mM
-1
 cm
-1
).
179
 Assays for 
identification of column fractions containing the enzyme during purification were composed of 
Tris/HCl buffer (45 mM, pH
 
8.3), column fraction and (2S, 3S) 3-methylaspartate (70 mM) 
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which was added prior to the spectrophotometric measurement of mesaconate formation. 
Specific activities of methylaspartase in the form of the rate of mesaconate formation were 
measured by the same assay during each stage of its purification along with the protein 
concentrations (Bradford method) and therefore allowed the presentation of the purification 
report with the specific activities stated in Umg
-1
. During the series of assays for determination 
of the partial purified enzyme kinetic parameters by the Michaelis-Menten method, initial rates 
of mesaconate formation by the partial purified methyaspartase (0.018 mgml
-1
, 43.5 Umg
-1
)  
were measured in due to the variation of (2S, 3S) 3-methylaspartate concentrations  from 5 mM 
to 250 mM and plotted against the substrate concentrations (Michaelis-Menten curve). 
   
2.2.7.2 Assays for glutamate mutase catalyzed conversion of (S)-glutamate to (2S, 3S)-3-
methylaspartate 
Activity due to in vitro glutamate mutase catalysed conversion of (S)-glutamate to (2S, 3S)-3-
methylaspartate was measured by the methylaspartase coupled assay which was developed in 
1964 by Horace A. Barker.
180
 The assay employed an auxiliary enzyme; methylaspartase to 
convert the (2S, 3S)-3-methylaspartate generated from (S)-glutamate during the coenzyme B12 
dependent reaction of glutamate mutase to mesaconate which is measured at 240 nm (Ɛ240 = 3.8 
mM
-1
 cm
-1
). The activity of glutamate mutase was measured as the rate of mesaconate formation 
by addition of (S)-glutamate (40 mM) to the mixture of protein components S and E of glutamate 
mutase, coenzyme B12 (0.05 mM) and the partial purified methylaspartase (0.072 mgml
-1
, 43.5 
Umg
-1
) dissolved in Tris/HCl (30 mM, pH 8.3) with mercaptoethanol (1 mM) at 37 °C. The 
concentrations of coenzyme B12 and methylaspartase were throughout in excess of those of 
protein components S and E to assure the mutase activity being limiting. During purification of 
the glutamate mutase protein components S and E, the measurement of the specific activities in 
each stage of either component purification required excess of the other component. Proteins 
concentrations were also determined in each purification stage by Bradford method which 
allowed the presentation of the purification report with specific activities in Umg
-1
.  
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The kinetics for (S)-glutamate was determined with partial purified enzymes by the following 0.5 
ml assays:-  
 Tris-HCl pH 8.3                             30 mM 
 Mercaptoethanol      1 mM 
 GlmS        5.0 µg                      
 GlmE                   2.6 µg  
 Coenzyme B12       0.05 mM 
 Methylaspartase (43.5 U/mg)               36 µg  
 (S)-glutamate    Varied from 5 mM to 300 mM  
     
In each assay a particular concentration of (S)-glutamate was added prior to the measurement of 
initial rate for mesaconate formation in due to the added substrate concentration. Measured data 
were presented by Michaelis-Menten plotting of initial velocities against (S)-glutamate 
concentrations with stated kcat and Km values which were obtained from the plot. 
2.2.7.3 Assays for determining the effects of the proposed glutamate mutase inhibitors on 
methylaspartase 
In the different measurements by the modified methylaspartase assay; glutamate mutase 
inhibitors (1 mM and 2.5 mM) were incubated for 2 and 6 minutes with the partial purified 
methylaspartase (9 µgml
-1
, 43.5 Umg
-1
) in 45 mM Tris-HCl (pH 8.3) at 37 °C before 
methyaspartate (70 mM) were added prior to the measurement of enzyme activities. The 
activities of methylaspartase measured after the enzyme interactions with particular 
concentration of an inhibitor in specified duration in minutes were compared to the enzyme 
specific activity measured by the methylaspartase assay and reported as percent of 
methylaspartase specific activity.    
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2.2.7.4 Assays for determining effects of the proposed inactivators on glutamate mutase 
During the measurements by the modified assay for glutamate mutase catalyzed conversion of 
(S)-glutamate to (2S, 3S)-3-methylaspartate: the holoenzyme generated from the assembly of 
glutamate mutase components S (0.01 mgml
-1
) and E (0.0052 mgml
-1
) with coenzyme B12 (0.05 
mM) in Tris-HCl (30 mM, pH 8.3) and mercaptoethanol (1 mM) was incubated with glutamate 
mutase inhibitors (3 mM) at 37 °C for 5 minutes. Excess coenzyme B12 and inhibitors were 
filtered (Sephadex G25) before methylaspartase (0.072 mgml
-1
) was added and the mutase 
catalysis was assessed by measurement of the rate of mesaconate formation after the addition of 
(S)-glutamate (40 mM). The removal of excess inhibitors by filtration prevented the auxiliary 
enzyme from being inactivated by those inhibitors while allowed measurement of mutase 
inactivations following its incubation with inhibitors. The measured activities for glutamate 
mutase after being incubated with these inhibitors were reported as the percentage of mutase 
specific activity. The reconstituted hologlutamate mutase was also characterized by UV/visible 
wave scanning.    
 
2.2.7.5 Assay for conversion of (2S, 3S)-3-methylaspartate to (S)-glutamate catalyzed by 
glutamate mutase  
During the studies for this thesis an assay for measuring the activity of glutamate mutase in the 
reverse direction; the conversion of (2S, 3S)-3-methylaspartate to (S)-glutamate was developed. 
The new assay employed two auxiliary enzymes; the pyridoxal-5'-phosphate dependent 
glutamic- pyruvic transaminase for respective conversion of (S)-glutamate and pyruvate to 2-
oxoglutarate and alanine and the NADH dependent 2-hydroxyglutarate dehydrogenase for 
further conversion of 2-oxoglutarate to 2-hydroxyglutarate. Since the (S)-glutamate substrate for 
glutamic-pyruvic transaminase was generated from (2S, 3S)-3-methylaspartate by the coenzyme 
B12 dependent glutamate mutase rearrangement, hence the mutase reverse reaction was assayed 
by measuring the depletion of NADH at 340 nm (Ɛ340 = 6.3 mM
-1
 cm
-1
).   
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(2S,3S)-3-Methylaspartate = L-Glutamate 
L-Glutamate + Pyruvate = 2-Oxoglutarate + L-Alanine 
2-Oxoglutarate + NADH + H
+
  (R)-2-Hydroxyglutarate + NAD+ 
Sum: (2S,3S)-3-Methylaspartate + Pyruvate + NADH + H
+
  L-Alanine + (R)-2-
Hydroxyglutarate + NAD
+
 
The 1 ml assay mixture for the determination of kinetic constants of (2S, 3S)-3-methylaspartate 
in the reaction of glutamate mutase was with the following composition:-  
 Test buffer        30.00 mM             
 Mercaptoethanol         0.05 mM 
 GlmS         10.00 µg 
 GlmE           5.20 µg 
 Coenzyme B12        0.025 mM 
 Pyruvate        20.00 mM 
 Glutamic pyruvic transaminase (81 Umg-1)    40.00 µg 
 Pyridoxal 5- phosphate        0.02 mM 
 2-hydroxylglutarate dehydrogenase (1 KUmg-1)   20.00 µg 
 NADH                      0.20 mM 
 (2S, 3S)-3-Methylaspartate                  varied from 5 mM to 300 mM 
 
(2S, 3S)-3-Methylaspartate was added to the solution of glutamate mutase components S and E, 
coenzyme B12, pyruvate, glutamic pyruvic transaminase, pyridoxal 5-phosphate, 2-
hydroxyglutarate dehydrogenase and NADH  in Tris-HCl pH 8.3 with mercaptoethanol at 37 °C 
in the above concentrations prior to the measurement of NADH depletion at 340nm. The 
concentration of (2S, 3S)-3-methylaspartate was varied during the series of measurements for 
determination of kinetic constants of (2S, 3S)-3-methylaspartate by Michaelis-Menten method.  
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2.2.7.6 Assaying effect of inhibitors on auxiliary transaminase and dehydrogenase system 
Activities for the pyridoxal-5-phosphate dependent glutamic pyruvic transaminase and NADH 
dependent 2-hydroxglutarate dehydrogenase reactions were measured in both without and with 
proposed glutamate mutase inhibitors at 340 nm (Ɛ340 = 6.3 mM
-1
 cm
-1
) by below 1 ml assays 
and compared.    
 
‘Transaminase assay’ 
 Tris-HCl pH 8.3      30.00 mM  
    
 Mercaptoethanol        0.05 mM  
       
 Glutamic-pyruvic transaminase (81 Umg-1)   40.00 µg   
 
 Pyridoxal 5-phosphate       0.02 mM  
       
 2-Hydroxylglutarate dehydrogenase (1 KUmg-1)  20.00 µg  
   
 NADH           0.2 mM  
        
 INHIBITOR        without, 5 mM, 10 mM,15 mM and 20 mM           
  
 Pyruvate       20.00 mM  
        
 Glutamate       20.00 mM  
        
   
2.2.7.7 Characterizations on the interactions of glutamate mutase with its proposed 
inhibitors by the developed glutamic-pyruvic transaminase and 2-hydroxyglutarate 
dehydrogenase coupled assay 
In the below modified assay for conversion of (2S, 3S)-3-methylaspartate to (S)-glutamate by 
glutamate mutase; the assay mixture was incubated with proposed inhibitors of glutamate mutase 
for six minutes before (2S, 3S)-3-methylaspartate was added prior to the measurement of the rate 
of NADH depletion at 340 nm (Ɛ340 = 6.3 mM
-1
 cm
-1
). The measured activities of glutamate 
mutase after incubations with inhibitors were compared with activity measured without 
incubation with an inhibitor.  
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The 1 ml assay was with the following composition;-  
 Test buffer        30.00 mM             
 Mercaptoethanol         0.05 mM 
 GlmS         10.00 µg 
 GlmE           5.20 µg 
 Coenzyme B12        0.025 mM 
 Inhibitor         Without, 2.5 mM, 5 mM, 7.5 mM, 10 mM, 15 mM 
 Pyruvate        20.00 mM 
 Glutamic pyruvic transaminase (81 Umg-1)    40.00 µg 
 Pyridoxal 5- phosphate        0.02 mM 
 2-hydroxylglutarate dehydrogenase (1 KUmg-1)   20.00 µg 
 NADH                      0.20 mM 
 (2S, 3S)-3-Methylaspartate                        200 mM 
 
2.2.7.8 Assays for measurements of kinetic constants of cofactors in the reaction of 
glutamate mutase  
Kinetic constants of coenzyme B12 and its active structural derivative cofactors were measured at 
37 ᵒC by using standard methylaspartase coupled assay for glutamate mutase with Tris/HCl (50 
mM, pH 8.3), mercaptoethanol (0.05 mM) and partially purified enzymes: methylaspartase (43.5 
U/mg), GlmS (0.8 U/mg), and GlmE (1.6 U/mg). Hologlutamate mutase was generated from 
assembly of glutamate mutase components S, E and coenzyme B12 or its active structural 
derivative. Km and Vmax for the natural cofactor were determined in the presence of GlmS (5 µg), 
GlmE (2.6 µg), methylaspartase (36 µg), glutamic acid (20 mM) and coenzyme B12 (0.32  25 
µM) in 1 ml assays. Km and Vmax for the cobalamin derivatives were determined with 10-times 
increased amounts of components S and E and concentrations of active coenzyme B12 derivatives 
were varied from 0.35µM to 70 µM. Km and Vmax were obtained from the Michaelis-Menten 
presentation of activity data. The calculations of kcat for both coenzyme B12 and active 
derivatives were based on component E. 
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2.2.7.9 Spectroscopic characterizations on the interactions of hologlutamate mutase with its 
proposed inhibitors 
The anaerobic reconstitution of hologlutamate mutase from GlmS (68 µM), GlmE (19 µM)  and  
coenzyme B12 (250 µM) in  Tris-HCl pH 8.3 (30 mM) and mercaptoethanol (5 mM) was filtered 
by centricon to remove excess coenzyme B12 before incubated with fumarate (10 mM)  at 37 °C 
for 1 hour. The UV/visible spectra of the mixture were recorded before fumarate was added as 
well as after 5 minutes, 30 minutes and 1 hour of incubation with fumarate. In the control 
experiment, the auxiliary enzyme; methylaspartate (80 µM, 43.5 U mg
-1
) was added to the 
similar preparation of hologlutamate mutase without fumarate and the activity of the glutamate 
mutase was measured at 240 nm (Ɛ240 = 3.8 mM
-1
 cm
-1
) by addition of (S)-glutamate. 
In another experiment; 2-fluoroglutarate (10 mM) and 2-chloroglutarate (10 mM) were separate 
aerobic incubated with the hologlutamate mutase reconstituted from GlmS (6.8 µM), GlmE (0.5 
µM) and coenzyme B12 (250 µM) in dark at room temperature for overnight. The protein 
components of the mixture (GlmS, GlmE and reconstituted hologlutamate mutase) were removed 
by centricon and the obtained mixtures were analyzed by F
19 
NMR and LC-MS.   
 
2.2.8.0 Assays for the evaluations on the interactions of glutamate mutase with 2-
haloglutarates 
Since the incubation of 2-fluoroglutarate with methylaspartase (2.2.7.3) demonstrated the 
complete recovered of methylaspartase activity, the activity of glutamate mutase when 2-
fluoroglutarate was used as the substrate was measured by the standard methylaspartase coupled 
assay in the below composition of 0.5 ml assay mixture:-  
 Tris-HCl pH 8.3                             30 mM 
 Mercaptoethanol      1 mM 
 GlmS        5.0 µg                      
 GlmE                   2.6 µg  
 Coenzyme B12       0.05 mM 
 Methylaspartase (43.5 U/mg)               36 µg  
 2-fluoroglutarate      10 mM 
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Glutamate mutase activity was also measured by the standard methylaspartase coupled assay 
after the incubation of hologlutamate mutase with 2-fluoroglutarate at 37 °C for 5 minutes and 
compared with glutamate mutase specific activities by using the below 0.5 ml assays:- 
 
 Tris-HCl pH 8.3                             30 mM 
 Mercaptoethanol      1 mM 
 GlmS        5.0 µg                      
 GlmE                   2.6 µg  
 Coenzyme B12       0.05 mM 
 2-fluoroglutarate      0, 10 mM 
 5 minutes incubation at 37° C 
 Methylaspartase (43.5 U/mg)               36 µg  
 (S)-glutamate          10 mM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
87 
 
3. Results 
3.1  Growth of bacteria and proteins purifications  
 3.1.1 Purification of methylaspartase from Clostridium tetanomorphum 
Clostridium tetanomorphum (DSM 576) grew anaerobically on the medium with the 
composition specified in the experimental section 2.2.1.1 during the periods of overnight 
incubations at 37 °C to the cultivated 50 ml, 1.5 L and 10 L cultures as well as to the final 100 L 
main fermenter culture. The 340 g of C. tetanomorphum wet cells were harvested from the 100 L 
fermenter culture and used as the source of native methylaspartase as well as for the mutL gene 
during the three years period of these studies. Growth of C. tetanomorphum to > 1.8 OD578 in all 
culture volumes as well as to the 340 g which was harvested from the main fermenter culture 
required up to three days of incubation at 37 °C.  
The methylaspartase activity following the addition of (2S, 3S)-3-methylaspartate to the cell free 
extract of the harvested C. tetanomorphum was up to 13.7 U mg
-1 
with the measured Km = 2 mM 
for the (2S, 3S)-3-methylaspartate. The used method for assaying methylaspartase (section 
2.2.7.1) was developed in 1958 by Horace A. Barker.
179
 This method is based on the 
methylaspartase catalyzed conversion of (2S, 3S)-3-methylaspartate to mesaconate which 
absorbs UV at 240 nm, hence allows the activity assay by measuring the rate of mesaconate 
formation at 240 nm (Ɛ240 = 3.8 mM
-1
 cm
-1
). Glutamate mutase activity due to the conversion of 
(S)-glutamate to (2S, 3S)-3-methylaspartate was also detected upon addition of coenzyme B12 and 
(S)-glutamate to the cell free extract of C. tetanomorphum. The used method for assaying 
glutamate mutase exploits methylaspartase as the helping enzyme (section 2.2.7.2). Also 
developed by Barker in 1964,
180
 this method is based on coupling the glutamate mutase 
catalyzed conversion of (S)-glutamate to (2S, 3S)-3-methylaspartate with the methylaspartase 
which converts the (2S, 3S)-3-methylaspartate produced by glutamate mutase to mesaconate 
(Figure 39). The methylaspartase has therefore been used as the auxiliary enzyme for assaying 
glutamate mutase since early 1960’s when these enzymes were discovered by H. A. Barker. 
Most of the glutamate mutase kinetic results reported in literatures were determined by this 
assay.  
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Figure 39: Enzymatic transformations for assaying methylaspartase and glutamate mutase. The 
conversion of (2S, 3S)-3-methylaspartate to mesaconate is assayed directly by measuring the rate of 
mesaconate formation at 240 nm (Ɛ240 = 3.8 mM
-1
 cm
-1
). The conversion of (S)-glutamate to (2S, 3S)-3-
methylaspartate by glutamate mutase is assayed by coupling with methylaspartase.    
The saturation of C. tetanomorphum cell free extracts with (NH4)2SO4 up to 70% of the salt 
during the early steps of the methylaspartase purification was futile in improving the 
methylaspartase activity and removal of glutamate mutase, although a significant amount of 
protein was removed. Subsequent purification steps by increased NaCl gradient from 0 to 1 M on 
a DEAE Sephacel column which was followed by saturation with (NH4)2SO4 to 80% of the salt 
achieved almost twice enrichment of the methylaspartase activity which was elevated to 19.8 U 
mg
-1
. Further polishing by gel filtration elevated the activity of methylaspartase to 43.5 U mg
-1 
with complete separation of methylaspartase from glutamate mutase. Although after the gel 
filtration column the methylaspartase was still partial purified, the achieved three times 
enrichment of the activity as well as the separation of glutamate mutase after this step 
appropriated the methylaspartase for the application to the proposed kinetics and spectroscopic 
studies on glutamate mutase. 
 
 
 
 
 
 
OOC COO
NH3
OOC
COO
NH3
CH3
(S)-Glutamate (2S, 3S)-3-Methylaspartate
Coenzyme B12
Glm S + E
 Mesaconate
Methylaspartase
NH4
Absorb 240 nm
OOC
COO
CH3
89 
 
Purification Stage Activity (U) Protein (mg) Spec. Act. (U mg
-1
) Enr. Factor Yield (%) 
Cell free extract 386.7 2141.2 13.7 1 100 
(NH4)2SO4 40% 204.2 1492.1 10.1 0.7 53 
(NH4)2SO4 70% 262 689.7 9.5 0.7 68 
DEAE-Sephacel 138.7 353.9 26.6 2 36 
(NH4)2SO4 80% 239.4 302.1 19.8 1.4 62 
Superdex 200 96.7 50.3 43.5 3.2 25 
 
Table 4: Summarized results for the purification of the native methylaspartase from C. tetanomorphum 
 
During the course of its purification from C. tetanomorphum, methylaspartase demonstrated 
instability at 4 °C by rapidly decreasing its activity within 3 days of handling at 4 °C. The 
purification of methylaspartase is therefore strictly entailed to be completed at least within 48 
hours in order to allow storage of the enzyme at -80 °C where it significantly retains its activity 
up to the period of four years as observed during these studies. Portions of methylaspartase 
which were stored in 50% and 70% (NH4)2SO4 at -80 °C also persisted with similar stability as 
compared to their salt free counterpart which was stored at -80 °C.   
Measurement of activities with variations of (2S, 3S) 3-methylaspartate concentrations from 0 to 
250 mM (section 2.2.7.1) lead to the determination of the kinetic constants of (2S, 3S)-3-
methylaspartate; Vmax = 38 ± 0.4 U mg
-1
 and Km= 1.81 ± 0.05 mM (literature Km = 2.37 mM) in 
the reaction of the partial purified methylaspartase by the Michaelis–Menten method. The kinetic 
constants kcat = 29 s
-1
 and kcatKm
-1
 = 1.6 x 10
4
 s
-1
M
-1
 were also calculated from the parameters 
determined by the Michaelis-Menten method.  
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Figure 40: Michaelis-Menten plot for the determination of the kinetic constants of (2S, 3S)-3- 
methylaspartate in the reaction catalyzed by the partial purified methylaspartase      
 
3.1.2 Purifications of glutamate mutase protein components S and E from E. coli   
DH5α 
Cells of E.coli DH5α transformed with pOZ3 and pOZ5 vector plasmids for respective 
productions of components S and E of glutamate mutase grew aerobically at 37 °C on Standard I 
medium. The 5 ml culture as well as the 250 ml pre-culture grew from inoculated ≤ 0.1 to > 2 
OD578 during the overnight incubations. The 2 L main cultures grew from the inoculated 0.1 to 
0.5 OD578 for about 3 hours before they were induced by 1 mM IPTG to produce components S 
and E of glutamate mutase. Component S was produced within 3 hours of E. coli DH5α growth 
to ≥ 2 OD578 after induction while that of component E required an overnight growth to > 5 
OD578. The production of components S and E were enzymatically confirmed from the glutamate 
mutase activity which was detected after the addition of (S)-glutamate to the mixture of cell free 
extracts from both S and E preparations, coenzyme B12 and methylaspartase in Tris-HCl pH 8.3 
buffer as outlined in section 2.2.7.2. The measured glutamate mutase specific activity of 
expressed components S and E cell free extracts was up to 1.3 Umg
-1
. During the section 2.2.3.2 
outlined procedure for the purification of glutamate mutase components S, the decreased 
gradient of (NH4)2SO4 from 1 M to 0 on a phenyl Sepharose column achieved 11 times 
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enrichment of protein S activity by promoting its specific activity to 15 Umg
-1
. Further 
purification by gel filtration elevated the specific activity of component S to 66 Umg
-1
 which was 
an enrinchment of the activity by 51.   
 
Pur. stage  Protein (mg) Spec. activity 
(Umg
-1
) 
Enri. factor Yield (%) 
 
Cell free extract 
 
 516 1.3 1 100 
Phenyl 
Sepharose 
 
 33 15 11 72 
Superdex 200 
 
 7 66 51 65 
Table 5: Summarized results for the purification of the recombinant component S of glutamate mutase 
from E.coli DH5α 
By a procedure similar to that used in the purification of component S, component E was 
enriched 12 times from 0.5 U mg
-1
 in the cell free extract to 5.7 U mg
-1
 by the decreased gradient 
of (NH4)2SO4 on a phenyl Sepharose column. The gel filtration by Superdex 200 elevated the 
activity of component E to 18.1 Umg
-1 
which is 38-times enrichment. Measurement of the 
activities of the purification steps of component E were done with the partial purified component 
S (66 U mg
-1
). 
Although the recombinant glutamate mutase proteins S and E were only partial purified, the 
achieved specific activity was satisfactory for the proposed kinetic studies on the reaction of 
glutamate mutase as well as the spectroscopic experiments. Throughout during the studies for 
this thesis, hologlutamate mutase was successful generated from assembly of protein components 
S and E with the cobalamin cofactors (coenzyme B12 and its structure derivatives).   
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Pur. stage 
 
 
 
Protein (mg) 
 
Spec. activity 
(U mg
-1
) 
 
Enr. factor 
 
Yield (%) 
 
Cell free extract 
 
 516 0.5 1 100 
Phenyl sepharose 
 
 28 6 11 66 
Superdex 200  7 18 38 58 
 
Table 6: Summarized results for the purification of the recombinant component E of glutamate mutase 
from E. coli DH5α 
 
3.1.3 Characterization of the partial purified glutamate mutase 
The UV-vis spectrum of the hologlutamate mutase system generated from the assembling of the 
partial purified recombinant protein components S and E with coenzyme B12 closely follow that 
of coenzyme B12 in the base on state with characteristic absorption peaks at 490 nm and the 
maximum at 520 nm (Figure 41). This close resemblance as well as the detection of glutamate 
mutase activity indicates the presence of the protein bound cob(III)alamin. The spectrum also 
implies binding of coenzyme B12 to the apoenzyme in the “base off, his on” mode to form the 
holoenzyme system with cobalt in the Co (3+) d
6
 state. Activities generated due to the 
conversion of (S)-glutamate to (2S, 3S)-3-methylaspartate by the hologlutamate mutase 
reconstituted from the assembling of partial purified proteins S and E with coenzyme B12 were 
measured by the described standard methylaspartase coupled assay.
180
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Figure 41: UV-vis spectrum of 0.013 mM coenzyme B12 (red) and hologlutamate mutase (blue) 
reconstituted from the mixture of 0.68 µM component S, 0.05 µM component E and equimolar 
concentration of coenzyme B12 which was achieved by Sephadex G25 filtration after mixing with excess 
coenzyme B12. Note the spectrum of coenzyme B12 is reduced by 2.5    
The oligomeric nature of the holo-glutamate mutase system, which brings protein components S 
and E with the cofactor together for the reconstitution of the holoenzyme has allowed the 
determinations of the kinetic constants of (S)-glutamate as well as that of the coenzyme B12 in 
the glutamate mutase reaction from different compositions of apo-proteins S and E. 
Measurements of glutamate mutase activity for determinations of the kinetic constants were 
accomplished by the methylaspartase coupled assay (section 2.2.7.2 and 2.2.7.8). The kinetic 
constants of (S)-glutamate in the reaction of the partial purified glutamate mutase reconstituted 
with 14 excess folds of component S; Vmax= 3.2 ± 0.5 U (mg GlmE)
-1
 and Km = 2.25 ± 0.03 mM 
were obtained from the Michaelis-Menten method. These kinetic constants were used to 
characterize further the reaction of the partial purified glutamate mutase by calculating kcat = 2.85 
s
-1
 as well as the kcatKm
-1
 = 1.3 x 10
-3
 M s
-1
 for the conversion of (S)-glutamate to (2S, 3S)-3-
methylaspartate.       
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Figure 42: Michaelis- Menten plot for the determination of kinetic constants of (S)-glutamate in the 
reaction catalyzed by the partial purified glutamate mutase reconstituted with 14 excess folds of protein 
component S 
Kinetic constants of coenzyme B12 during the conversion of (S)-glutamate to (2S, 3S)-3- 
methylaspartate by the partial purified glutamate mutase reconstituted with 2 folds excess of 
component S; Vmax = 1.34 ± 0.40 U (mg GlmE)
-1
, Km = 1.12 ± 0.04 µM as well as kcat = 1.24 ± 
0.36 s
-1
 and kcatKm
-1
 = 1.10 × 10
6
 s
-1
M
-1
were also determined by Michaelis-Menten method.   
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Figure 43: Michaelis-Menten plot for the determination of kinetic constants of coenzyme B12 during the 
conversion of (S)-glutamate to (2S, 3S)-3-methylaspartate by the partial purified glutamate mutase 
reconstituted with a 2-fold excess of component S 
Kinetic constants of coenzyme B12 for the same catalytic conversion of (S)-glutamate to (2S, 3S)-
3-methylaspartate were also determined from the reconstitution of the enzyme with 7 as well as 
14-fold excess of component S. While the measured specific activities remained almost the 
same, the Km values of the coenzyme B12 when the enzyme was reconstituted with 7 and 14 folds 
excess of component S were 0.70 ± 0.05 µM and 0.52 ± 0.06 µM respectively. These kinetics 
lead to the respective calculated kcatKm
-1
 of 2.4 x 10
6
 s
-1
M
-1
 and 2.38 x 10
6
 s
-1
M
-1
from 
reconstitution of glutamate mutase with 7 and 14 folds excess of component S. It is important to 
mention on; the specific activity of glutamate mutase decreased from the reported 18.1 
U(mgGlmE)
-1
 when the enzyme was purified to between 3.2 U(mgGlmE)
-1
 and 1.34 
U(mgGlmE)
-1
 which were measured after 18 months and 2 years of – 80 ° C storage of 
components S and E.  
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Figure 44; Michaelis-Menten plot for the determination of the kinetic constants of coenzyme B12 during 
the conversion of (S)-glutamate to (2S, 3S)-3-methylaspartate by the partial purified glutamate mutase 
reconstituted with 7-fold excess of component S 
 
 
Figure 45; Michaelis-Menten plot for the determination of the kinetic constants of coenzyme B12 during 
the partial purified glutamate mutase catalyzed conversion of (S)-glutamate to (2S, 3S)-3-methylaspartate 
when the enzyme is reconstituted with 14 folds excess of component S 
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 3.1.4 Purification of 2-hydroxyglutarate dehydrogenase from E.coli BL21 
E. coli BL21 transformed with pACYCDuet
TM
-1 vector which carries the 2-hydroxylglutarate 
dehydrogenase encoding hgdH gene grew at 37 °C on LB medium from ager colonies to 5 ml 
and 250 ml broth cultures which grew from ≤ 0.1 OD578 to cultures of > 2 OD578 in the overnight 
incubations. The 2 L main culture was first grown for about three hours from 0.1 to 0.5 OD578 
before it was induced by 200 µg L
-1
 anhydrotetracyclin (AHT) to produce 2-hydroxylglutarate 
dehydrogenase and further incubated for overnight from which it grew to > 5 OD578. The activity 
of 2-hydroxylglutarate dehydrogenase (0.13 kU mg
-1
) was determined from the cell free extract 
of E.coli BL21 harvested from the 2 L main culture by addition of excess amount of 2-
oxoglutarate to the mixture of the cell free extract (105 µg ml
-1
) and NADH (0.2 mM) dissolved 
in Tris-HCl (100 mM, pH 8.0). The purification by Streptag (2.2.3.4) enriched the 2-
hydroxyglutarate dehydrogenase 8 times by promoting its specific activity to 1 kU mg
-1
.    
 
3.2 Synthesis of chemicals used in probing the reaction of glutamate mutase 
by the mechanism based inactivation approach  
 3.2.1 Synthesis of cis-glutaconic acid 
 
CO2H
O
(i)
CO2H
O
Br Br
(ii)
HO2C CO2H
61% 8%  
Figure 46: Synthesis of cis-glutaconic acid. Reagents (i) Br2, aq. 48% HBr; (ii) aq. KHCO3 
Cis-glutaconic acid was prepared in a two-step synthetic scheme
 
from laevulinic acid via 
dibromolaevulinic acid (figure 46).
106
 The first step, aqueous acidic bromination of laevulinic 
acid, yielded up to 61% of 3,5-dibromolaevulinic acid. This low temperature (0 °C) sensitive 
regio-specific brominations on the two carbons α to the carbonyl group of the laevulinic acid 
starts with a rate determining enolisation catalyzed by 48% HBr before progressing to rapid 
attack by bromine on the enol π-electrons. Since the ketone is able to form an enol with either of 
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the two carbons α to the carbonyl group, further bromination proceeds to form the 
dibromoketone.  
 
CO2H
O
H3O
Enolisation
CO2H
OHOH
CO2H
Br Br
CO2H
OH
Br
+ BrCO2H
O
Br
HBr +
Slow enolisation
CO2H
O
Br Br
up to 61%
Dibromolaevulinic acid
Laevulinic acid
 
 
Figure 47: The mechanism for the acidic bromination of laevulinic acid to 3,5-dibromolaevulinic acid  
The 2
nd
 step for the synthesis of cis-glutaconic acid is the rearrangement of the 
dibromolaevulinic acid by the Favorski mechanism induced by aqueous KHCO3 to yield cis-
glutaconic acid in 8% yield with traces of trans-glutaconic acid (less than 2% of the total 
product)  
A revised synthetic scheme aimed at improving the yield of cis-glutaconic acid during the 
Favorski reaction involved the protection of the carboxylic acid group on the dibromolaevulinic 
acid as a t-butyl ester. The dibromolaevulinic t-butyl ester was therefore synthesized in 83% 
yield during an overnight room temperature reaction between dibromolaevulinic acid and t-
butyltrichloroacetimidate in dichloromethane (DCM). The t-butyltrichloroacetimidate was 
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prepared in 61% from the reaction between trichloroacetonitrile and potassium tert-butoxide in t-
BuOH (Figure 48). However, the rearrangement of dibromolaevulinic t-butylester by Favorski 
mechanism when reacted with aq. potassium bicarbonate yielded cis-glutaconic mono-t-butyl 
ester in 8% yield with traces of trans-glutaconic mono-t-butyl ester. Attempted improvements by 
increasing the time for the rearrangement by Favorskii mechanism to 72 hours and a significant 
decrease in the amount of water used during work up after the reaction were futile toward 
increasing the yield of cis-glutaconic acid. The yield of cis-glutaconic acid was improved to 10% 
by saturation of the aqueous reaction mixture with brine after acidification to pH 2 followed by 
extensive extraction by dichloromethane. 
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HOOC COOH
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O
E-glutaconic t-butylester
-
less than 10%
 
 
Figure 48: Alternative scheme for the synthesis of cis-glutaconic acid.  
An also explored synthetic strategy to cis-glutaconic acid was via 4-bromodihydropyran-2, 5-
dione, which was obtained by a base-induced cyclisation of 3,5-dibromolaevulinic acid (Figure 
49). 4-Bromodihydropyran-2, 5-dione is also predicted to rearrange to cis-glutaconic acid by the 
Favorskii reaction with bicarbonate (figure 49).  
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Figure 49: A synthetic strategy to cis-glutaconic acid via 4-bromodihydropyran-2, 5-dione. 
 
Attempted cyclisation of 3,5-dibromolaevulinic acid by triethylamine in diethyl ether gave 
pyran-2, 5-dione, which resulted from base-induced elimination of Hbr from the initially formed 
4-bromodihydropyran-2, 5-dione (figure 50). An overnight reaction of 3,5-dibromolaevulinic 
acid with aqueous LiOH demonstrated slow formation of 4-bromodihydropyran-2, 5-dione in an 
estimated 20% yield from the analysis of TLC and 
1
H-NMR.  
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Figure 50: Base induced cyclisation of 3, 5-dibromolaevulinic acid to 4-bromodihydropyran-2, 5-dione. 
Route a (i) triethylamine, diethyl ether and route b (ii) aq. LiOH.  
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 3.2.2 Synthesis of 3-[
13
C-methyl]itaconic acid 
3-[
13
C-methyl]itaconic acid was prepared by a synthetic pathway already developed in the 
laboratory of Professor Bernard Golding (Newcastle University), which starts with NaH 
abstraction of protons on the methyl group of triethyl prop-2-ene-2,3,3-tricarboxylate and C-3 of 
triethyl prop-1-ene-2,3,3-tricarboxylate, which constitutes “Malachowski’s mixture”. The 
carbanion thus formed Malachowski’s mixture is methylated to 13 C-triethyl but-1-ene-2, 3, 3-
tricarboxylate by addition of 13 C-labelled methyl iodide. The methylation was complete in 40 
minutes and gave yields of up to 44 % tricarboxylate product. The last step, hydrolysis of two of 
the diethyl esters and removal of one carboxyethyl group bound to C- 3 of triethyl but-1-ene-
2,3,3-tricarboxylate was achieved by heating the tricarboxylate with 20% HCl at 80 °C for 72 
hours which afforded racemic 3-[ 13 C-methyl]itaconate in 34 % yield. 
H3
13C
EtO2C
EtO2C
CO2EtEtO2C CO2Et
EtO2C
13CH3I
EtO2C
EtO2C
CO2Et
EtO2C
EtO2C
CO2Et
NaH
44%
Triethylbut-1-ene-2,3,3-tricarboxylate
H+
H3
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HO2C
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34%
13C-methylitaconate
Malachowwski's mixture
 
 
Figure 51: Synthetic route to 3-[
13
C-methyl]itaconic acid 
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3.3 Mechanism based inactivation of glutamate mutase by inhibitors mimic 
of the 4-glutamyl and (2S, 3S) 3-methyleneaspartate radicals in the 
enzyme active site  
Studies approach by the mechanism based inactivation of glutamate mutase was performed 
during the period of this thesis in order to provide experimental verifications on the mechanism 
via the 4-glutamyl as well as the (2S, 3S)-3-methyleneaspartate radicals as proposed in the 
minimum mechanistic scheme for the coenzyme B12 dependent rearrangements. Inhibitors with 
structures analogue to the 4-glutamyl and (2S, 3S)-3-methyleneaspartate radicals intermediates in 
the proposed mechanism of the reaction catalyzed by glutamate mutase were designed. Inhibitors 
with structures analogue to the 4-glutamy radical used in experiments reported in this thesis were 
trans- and cis-glutaconates whereas those which were designed to mimic (2S, 3S)-3-
methyleneaspartate radicals in the enzyme active site were buta-1,3-diene-2,3-dicarboxylate, 
itaconate, fumarate, mesaconate and maleate. Fumarate, mesaconate and maleate have been also 
postulated to mimic the intermediate fragments; glycyl radical (30) and acrylate (24b) in the 
proposed rearrangement by fragmentation- recombination (figure 25). Also proposed inhibitors 
for use in this project included (Z, S)-aminoglutaconate and (E, S)-aminoglutaconate which are 
analogue to the 4-glutamyl radical.   
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Name 
 
Structure 
 
Mimicked intermediate of the enzyme reaction 
 
cis-glutaconate 
OOC COO
 
 
4-glutamyl radical 
 
trans-glutaconate 
 
 
4-glutamyl radical 
 
(Z,S)-aminoglutaconate 
OOC
OOC
NH3
H
 
 
 4-glutamyl radical 
 
(E,S)-aminoglutaconate 
OOC
COO
H3N H
 
 
4-glutamyl radical 
 
Fumarate 
COO
OOC
 
 
(2S, 3S)-3-methyleneaspartate radical as well as the 
intermediate fragments; glycyl radical and acrylate 
 
Maleate 
OOC COO
 
 
(2S, 3S)-3-methyleneaspartate radical as well as the 
intermediate fragments; glycyl radical and acrylate 
 
Itaconate 
OOC COO
 
 
(2S, 3S)-3-methyleneaspartate radical 
 
Buta-1,3-diene-2,3-
dicarboxylate 
 
 
(2S, 3S)-3-methyleneaspartate radical 
 
Mesaconate 
O
-O
O
O-
 
   
(2S, 3S)-3-methyleneaspartate radical and intermediate 
fragments; glycyl radical and acrylate                
 
Table 7: List of proposed inhibitors of glutamate mutase with structures analogue to 4-glutamyl and (2S, 3S)-3-
methyleneaspartate radicals. Results reported in this thesis were from the studies on the interactions of glutamate 
mutase, methylaspartase, glutamic-pyruvic transaminase and 2-hydroxylglutarate dehydrogenase with cis and trans-
glutaconates, fumarate, maleate, Itaconate and buta-1,3-diene-2,3-dicarboxylate  
OOC
COO
OOC COO
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The designing of these inhibitors considered both the size with respect to the number of carbon 
atoms as well as the skeletal resemblance to the 4-glutamyl and (2S, 3S)-3-methyleneaspartate 
radicals in order to arrive into structures which fit on the glutamate mutase active site. The SP
2 
carbons of the inhibitors were specifically designated to mimic the radical centers in the 4-
glutamyl as well as the (2S, 3S)-3-methyleneaspartate radicals while in the enzyme active site. 
The hypothetical potentials for these structures to bind enzyme active site by hydrogen bonding 
interactions of their terminal carboxylate with active site arginines 66, 100 and 149 like 
substrates and the intermediate radicals they are mimicking is postulated to be followed by their 
predicted reactivity on the enzyme active site. Binding of these inhibitors to the active site is 
expected to trigger the homolytic cleavage of the Co-C bond like the substrate. The 5'-
deoxyadenosyl radical resulted from the coenzyme β coordinate homolysis has been predicted to 
be added on the SP
2
 carbons of the inhibitors with hypothetical formation of radical adducts of 
inhibitors and the 5'-deoxyadenosyl radical.     
 
 
 
 
 
 
Figure 52: Postulated mechanism for the reaction of holo- glutamate mutase with (Z, S)- 
aminoglutaconate to form radical adduct 
The halogenated glutaric acids; 2-fluoroglutaric acid and 2-chloroglutaric acid have also been 
hypothesized to bind the glutamate mutase active site and react with the enzyme by rearrangment 
to the corresponding methylhaloglutarates in the mechanism similar to the rearrangement of (S)-
glutamate to (2S, 3S)-3-methylaspartate. This thesis reports on the findings from the kinetic 
studies as well as the spectroscopic characterizations of the hologlutamate mutase interactions 
with the aforementioned proposed compounds and discusses several suggestions on their further 
exploitations toward experimental verifications on the proposed mechanism for the reaction of 
glutamate mutase.  
O2C CO2
NH3H
O2C CO2
AdoH2C
NH3H
O2C CO2
CH2Ado
NH3H
AdoCH2
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COOHHOOC
F
2-fluoroglutaric acid
COOHHOOC
Cl
2-chloroglutaric acid  
Figure 53: Structures of haloglutaric acids for use in the investigations on the mechanism of glutamate 
mutase catalyzed reaction 
 
3.3.1 The interactions of the proposed inhibitors of glutamate mutase with 
methylaspartase 
Evaluations on the interactions of glutamate mutase with its proposed inhibitors by the standard 
methylaspartase coupled assay require non inactivation of the auxiliary methylaspartase by those 
inhibitors with structures analogue of the 4-glutamyl and (2S, 3S)-3-methyleneaspartate radicals. 
Determinations on the effects of these proposed inhibitors of glutamate mutase on 
methylaspartase by their direct incubations with methylaspartase (2.2.7.3) revealed the reduction 
of methylaspartase specific activity to less than 40% by at least 2 mM of trans-glutaconate, cis-
glutaconate and itaconate within 2 minutes of incubations which were performed separate for 
each inhibitor. The 2 mM concentrations of these inhibitors which were equivalent to Km values 
of (S)-glutamate and (2S, 3S)-3-methylaspartate in the respective reactions of glutamate mutase 
and methylaspartase further lowered the specific activity of methylaspartase when incubated 
longer with the enzyme. Fumarate and maleate exhibited the most effective inhibitions by 
complete inactivations of methylaspartase within 2 minutes of the enzyme incubation with 1 mM 
of either fumarate or maleate. The least inhibition effect on methylaspartase was found with the 
but-1,3-diene-2, 3-dicarboxylate which lowered the enzyme specific activity by 50% when 2 mM 
of this compound was incubated with methylaspartase for up to 6 minutes.  
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Figure 54: Methylaspartase specific activities in relative percentage of the activity of non-inhibited methylaspartase 
(blue bars) measured from the incubations of 1 mM of the proposed inhibitors of glutamate mutase with 
methylaspartase for 2 minutes (red bars) and 6 minutes (light green bars) 
  
 
Figure 55: Methylaspartase specific activities in relative percentage of the non-inhibited methylaspartase (blue bars) 
measured from the incubations of 2 mM of the proposed inhibitors of glutamate mutase with methylaspartase for 2 
minutes (red bars) and 6 minutes (light green bars) 
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3.3.2 Evaluations on the interactions of glutamate mutase with its proposed 
inhibitors by the modified methylaspartase coupled assay 
 
Since at least 2 mM of each of the proposed inhibitors of glutamate mutase has been 
demonstrated to inhibit methylaspartase significantly, the filtration of the hologlutamate mutase 
incubated with each inhibitor by Sephadex G 25 achieved the removal of both excess inhibitor 
and coenzyme before the auxiliary enzyme and (S)-glutamate were added in the assay (2.2.7.4). 
In the separate aerobic incubations of hologlutamate mutase with fumarate, maleate and 
mesaconate, each up to 3 mM, which were followed by filtrations to remove excess inhibitors 
and cofactor demonstrated the complete inactivation of the holoenzyme within five minutes. 
Glutamate mutase activity was almost fully recovered from those assays in which itaconate, 
buta-1,3-diene-2,3-dicarboxylate, cis or trans-glutaconates, 3 mM each, were aerobically 
incubated with the holoenzyme for 6 minutes before the excess inhibitors and cofactor were 
removed.  
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Assay description  
Additions to hologlutamate mutase 
Activity 
(U/ml) 
 
% activity 
none 33 100 
trans-glutaconic acid 23 70 
cis-glutaconic acid 27 82 
buta-1,3-diene-2,3-dicarboxylic acid 33 100 
itaconic acid 27 82 
fumaric acid 0 0 
maleic acid 0 0 
mesaconic acid 0 0 
 
Table 8: Activities of glutamate mutase after 6 minutes incubations of the holoenzyme with equimolar 
concentrations of the proposed inhibitors of glutamate mutase.  The incubated mixtures with inhibitor 
concentrations equivalent to that of the holoenzyme were prepared by Sephadex G25 filtration of excess 
inhibitor which were added to 3 mM.  
 
UV/visible scanning after up to 1 hour of the anaerobic incubation of 10 mM fumarate with 
hologlutamate mutase reconstituted from 68 µM GlmS, 19 µM GlmE with excess amount of 
coenzyme B12 gave the cob(III)alamin spectra (figure 56). The formation of mesaconate could 
not be detected upon the addition of an auxiliary enzyme; methylaspartase and (S)-glutamate to 
the holoenzyme incubated with fumarate. The reported Uv/visible scanning as well as the 
addition of methylaspartase and (S)-glutamate prior to measurement of mesaconate formation 
was done after centricom filtration of excess coenzyme B12 and fumarate from the incubation 
mixture. Notably was the formation of mesaconate upon the addition of the methylaspartase and 
(S)-glutamate in the control experiment in which the holoenzyme reconstituted in similar 
conditions was not incubated with fumarate.    
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Figure 56: Uv/visible spectra of hologlutamate mutase reconstituted from GlmS (0.68 µM), GlmE (0.05 
µM) and equimolar amount of coenzyme B12 (red) and the anaerobic incubation of hologlutamate 
reconstituted from GlmS (68 µM), GlmE (19 µM) and equimolar amount of coenzyme B12 with fumarate 
(10 mM) for 1 hour (dark blue).   
  
3.3.3 Development of a novel assay for glutamate mutase catalyzed conversion of 
(2S, 3S)-3-methylaspartate to (S)-glutamate  
During the mechanism based inactivation studies on glutamate mutase for this thesis, a novel 
assay for the glutamate mutase catalyzed conversion of (2S, 3S)-3-methylaspartate to (S) 
glutamate was developed in order to allow kinetic characterizations on the interactions of 
glutamate mutase with its inhibitors. The developed assay was also applied in measuring the 
kinetic constants of (2S, 3S)-3-methylaspartate in the reaction of glutamate mutase. Together 
with the kinetic constants of (S)-glutamate which were measured by the methylaspartase coupled 
assay, the equilibrium constant of the partial purified glutamate mutase was calculated by 
Briggs-Haldane equation. This new assay employs two auxiliary reactions which are coupled to 
the coenzyme B12 dependent conversion of (2S, 3S)-3-methylaspartate to (S) –glutamate. The 
pyridoxal-5'-phosphate dependent glutamic pyruvic transaminase catalysed respective 
conversions of pyruvate and (S)-glutamate produced by glutamate mutase to alanine and 2-
oxoglutarate. The 2-oxoglutarate produced from the transamination is further coupled to the 
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NADH dependent reduction by 2-hydroxyglutarate dehydrogenase to 2-hydroxglutarate. Since 
the two auxiliary enzymes have high specific activity and are added in excess, the NADH 
depletion during the 2-hydroxyglutarate dehydrogenase catalyzed reduction allow the 
determination of the rate for conversion of (2S, 3S)-3-methylaspartate to (S)-glutamate by 
glutamate mutase at 340 nm.  
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Figure 57: Enzymatic transformations for assaying the glutamate mutase catalyzed conversion of (2S, 3S)-
3-methylaspartate to (S) glutamate.  
The decreasing NADH absorption with time was demonstrated at 340 nm (Ɛ340 = 6.3 mM
-1
 cm
-1
) 
upon addition of 300 mM (2S, 3S)-3-methylaspartate to the mixture of hologlutamate mutase 
reconstituted from 10 µg ml
-1 
GlmS, 5.2 µg ml
-1
 GlmE and 0.025 mM coenzyme B12, 20 mM 
pyruvate, 40 µg ml
-1
 glutamic-pyruvic transaminase (81 U mg
-1
), 0.02 mM pyridoxal-5'-
111 
 
phoshate, 20 µg ml
-1
 2-hydroxyglutarate dehydrogenase (1 kU mg
-1
) and 0.2 mM NADH in 30 
mM Tris- HCl pH 8.3 and 0.05 mM mercaptoethanol.  
(2S, 3S)-3-Methylaspartate = (S)-Glutamate 
(S)-Glutamate + Pyruvate = 2-Oxoglutarate + L-Alanine 
2-Oxoglutarate + NADH + H
+
  (R)-2-Hydroxyglutarate + NAD+ 
Sum: (2S, 3S)-3-Methylaspartate + Pyruvate + NADH + H
+
  L-Alanine + (R)-2-
Hydroxyglutarate + NAD
+
 
 
 
 
 
Figure 58: Activity of glutamate mutase catalyzed conversion of (2S, 3S)-3-methylaspartate to (S) 
glutamate measured as the rate of NADH depletion by the new glutamic-pyruvic transaminase and 2-
hydroxyglutarate dehydrogenase coupled assay. The NADH absorption started to decrease with time from 
02:43 minutes when (2S, 3S)-3-methylaspartate was added to the mixture of hologlutamate mutase, 
pyruvate, hologlutamic-pyruvic transaminase and holo-2-hydroxylglutarate dehydrogenase as described 
in the main text with concentrations.  
112 
 
3.3.4. Determination of the kinetic constants of (2S, 3S)-3-methylaspartartate in the 
reaction of glutamate mutase 
The developed glutamic-pyruvic transaminase and 2-hydroxyglutarate dehydrogenase coupled 
assay was used to determine the kinetic constants of (2S, 3S)- 3-methylaspartate in the reaction 
of glutamate mutase. Measurement of activities in due to the glutamate mutase reverse reaction 
by the new assay with the variations of (2S, 3S) 3-methylaspartate concentration from 5 to 300 
mM (section 2.2.7.5) lead to the determination of the kinetic constants of (2S, 3S) 3-
methylaspartate; Vmax = 0.6 ± 0.6 U (mg GlmE)
-1
 and Km= 7.00 ± 0.07 mM in the reaction of the 
partial purified glutamate mutase by the Michaelis –Menten method. The partial purified 
glutamate mutase kcat = 0.54 s
-1
 and kcatKm
-1
 = 77 s
-1
M
-1
 were also calculated from the kinetic 
parameters determined by the Michaelis-Menten method. 
 
 
Figure 59; Michaelis-Menten plot for the determination of the kinetic constants of (2S, 3S)-3-
methylaspartate during its conversion to (S)-glutamate by the partial purified glutamate mutase 
reconstituted with 14 folds excess of component S 
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3.3.5 Summary of the kinetic constants for the reaction catalyzed by the partial 
purified glutamate mutase and determination of the reaction equilibrium 
constant by Briggs-Haldane equation 
 
 
 
GlmS: GlmE 
 
Apparent Km (µM) 
 
kcat (s
-1) 
 
kcatKm
-1 × 106 (s-1 M-1) 
 
14:1 
 
7:1 
 
2:1 
 
14:1 
 
7:1 
 
2:1 
 
14:1 
 
7:1 
 
2:1 
 
(S)-glutamate 
 
(2.25 × 103) ± 0.03 
 
       NM 
 
        NM 
 
2.85 ± 0.5 
 
        NM 
 
       NM 
 
1.3 × 10-9 
 
  NM 
 
    NM 
 
(2S, 3S)-3-
methylaspartate 
 
(7 × 103) ± 0.07 
 
       NM 
 
        NM   
 
0.54 ± 0.6 
 
        NM 
 
        NM 
 
77 × 10-6 
 
  NM 
 
    NM 
 
Coenzyme B12 
 
0.52 ± 0.06 
 
0.7 ± 0.05 
 
1.12 ± 0.04 
 
1.24 ± 0.36 
 
0.90 ± 0.4 
 
1.24 ± 0.36 
 
2.38 
 
1.29 
 
1.10 
 
Table 9: Kinetic constants for the reaction of glutamate mutase reconstituted from the partial purified 
enzyme components S and E. Constants of (S)-glutamate and coenzyme B12 were measured by the 
standard methylaspartase coupled assay while those of (2S, 3S)-3-methylaspartate were measured by the 
new developed glutamic pyruvic transaminase and 2-hydroxylglutarate dehydrogenase coupled assay for 
the reverse reaction of glutamate mutase. NM means not measured.   
The kinetic constants of (2S, 3S)-3-methylaspartate in the reverse reaction of glutamate mutase 
together with the available constants of (S)-glutamate in the enzyme forward reaction allowed 
the determination of the reaction equilibrium constant; Keq = 16 by Briggs-Haldane equation 
(Literature Keq = 12).
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Keq = [kcat/Km ((S)-glutamate)] / [kcat/Km ((2S, 3S)-3-methylaspartate)] = 16 
This calculated equilibrium constant Keq = 16 as well as that from literature implies the formation 
of (S)-glutamate is favored during the reversible rearrangement by glutamate mutase. 
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3.3.6 Evaluations on the interactions of glutamate mutase with its proposed 
inhibitors by the glutamic-pyruvic transaminase and 2-hydroxylglutarate 
dehydrogenase coupled assay 
Interactions of proposed inhibitors of glutamate mutase with the auxiliary enzymes; glutamic 
pyruvic transaminase and 2-hydroxylglutarate dehydrogenase were evaluated by measuring the 
activity of the glutamic-pyruvic transaminase after the incubations of auxiliary enzymes with 
inhibitors and compared to the specific activity of the transaminase which was measured without 
inhibitors (2.2.7.6). The activity of glutamic-pyruvic transaminase was fully recovered from the 
interactions of auxiliary enzymes (glutamic pyruvic transaminase and 2-hydroxylglutarate 
dehydrogenase) with up to 20 mM of cis-glutaconate, trans-glutaconate, itaconate, fumarate, 
maleate and mesaconate in separate incubations for 5 to 10 minutes.  
Activity in due to glutamate mutase conversion of (2S, 3S)-3-methylaspartate to (S)-glutamate 
was measured by coupling the reaction of glutamate mutase with the auxiliary glutamic pyruvic 
transaminase and 2-hydroxylglutarate dehydrogenase in the presence of trans-glutaconate and 
itaconate. These inhibitors were allowed to interact with glutamate mutase for at least 5 minutes 
in separate incubations and the measured activities were compared to glutamate mutase activity 
measured without inhibitor (2.2.7.7). Both trans-glutaconate and itaconate demonstrated the 
potential to inhibit glutamate mutase (figure 60).  
  
 
Figure 60: Inhibitions of glutamate mutase catalyzed conversion of (2S, 3S)-3-methylaspartate to (S)-
glutamate by itaconate (blue) and trans-glutaconate (red) 
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Itaconate exhibited more potent inhibition by reducing the activity of glutamate mutase to 50 % 
following the incubation of hologlutamate mutase with 2.5 mM of itaconate and complete 
inactivation from the incubation of holoenzyme with 15 mM of itaconate. Trans-glutaconate 
required about 8 mM to lower the glutamate mutase activity by 50%. Glutamate mutase was 
almost complete inactivated (activity reduced to less than 10%) in due to its incubation with 15 
mM of trans-glutaconate.       
      
3.3.7 The reaction of glutamate mutase with 2-fluoroglutaric acid 
Since the activity of methylaspartase was completely recovered from its incubation with up to 6 
mM of 2-fluoroglutarate (2.2.7.3), the standard methylaspartase coupled assay was used to 
evaluate the interaction of 2-fluoroglutarate with glutamate mutase. The formation of mesaconate 
was not detected when 2-fluoroglutarate (10 mM) was added to the mixture of methylaspartase 
(72 µg ml
-1
) and hologlutamate mutase reconstituted from GlmS (10 µg ml
-1
), GlmE (5.2 µg ml
-
1
) and coenzyme B12 (0.05 mM) in Tris-HCl pH 8.3 (30 mM) and mercaptoethanol (1 mM) 
(2.2.8.0). However, the activity of glutamate mutase measured by the standard methylaspartase 
assay was reduced to 45 % by incubation of hologlutamate mutase with 2-fluoroglutarate (10 
mM) for 5 minutes (2.2.8.0). Glutamate mutase was completely inactivated by incubation with 2-
fluoroglutarate (40 mM) for 5 minutes (2.2.8.0). The proton coupling 
19
 F NMR spectrum for the 
reaction mixture of holo-glutamate mutase and 2-fluoroglutarate showed further splinting of 
peaks in comparison to the proton coupling 
19 
F
 
NMR spectrum of 2-fluoroglutaric acid. This 
19
F 
NMR analysed mixture was taken from the experiment in which GlmS (6.8 µM), GlmE (0.5 µM) 
and coenzyme B12 (250 µM) were aerobically incubated in darkness with 2-fluoroglutarate (10 
mM) at room temperature for overnight (2.2.7.9). However, the proton decoupling 
19 
F NMR 
spectrum of the same reaction mixture gave a single peak. Further analysis of the reaction 
mixture by LC-MS revealed two peaks of compounds with masses 149 which appear after 1.67 
to 1.86 and 3.55 to 4.51 minutes retention times during the separation by C-18 column (figure 
61). Other organic compounds included in the analyzed mixture were Tris, coenzyme B12 and 2-
mercaptoethanol.   
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Figure 61: Separation of compounds in the reaction mixture of 2-fluoroglutarate and glutamate mutase by 
C-18 liquid chromatography. Two flourinated compounds with 149 masses and retention times between 
1.67 and 1.86 minutes as well as 3.55 and 4.51 minutes were separated. Other components of the mixture 
which was obtained after centricon removal of proteins GlmS and GlmE are coenzyme B12, Tris and 
mercaptoethanol.      
Mass spectrum of the compound with retention time 1.68 minutes matches with that of 2-
fluoroglutaric acid while the peak with retention time 4.51 minutes gave mass spectrum with 
fragments which correspond with 2-fluoro-3-methylaspartate. 
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(A) 
 
(B) 
Figure 62: Mass spectra of the compounds with retention times 1.68 minutes (A) and 4.51 minutes (B) in 
the liquid chromatography which was obtained from the C-18 separation 
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3.4 Kinetic probing of the glutamate mutase reaction by the structural 
derivatives of coenzyme B12 cofactors 
3.4.1 Investigations into the role of the 5, 6 -dimethylbenzimidazole D-
ribonucleotide tail of coenzyme B12 in the “base off, his on” catalysis by 
glutamate mutase 
Binding of coenzyme B12 to apo-glutamate mutase accomplishes the reconstitution of 
holoenzyme system for the reversible inter-conversions between (S)-glutamate and (2S, 3S)-3-
methylaspartate. The described “base off, his on” binding of the coenzyme B12 to protein is 
achieved by replacing the free cofactor α-ligand coordination to cobalt by imidazole base of the 
histidine residue from the protein cobalamin binding His-Asp-Ser triad. This cobalamin binding 
motif is conserved in mutases and therefore enables their assembling with coenzyme B12 by the 
“base off, his on” mode. The glutamate mutase cobalamin binding motif; the His16-Asp-Ser 
triad is located in the component S of the apo-enzyme. Crystal structures of glutamate mutase 
have disclosed the location of the cofactor displaced α-coordinate (the 5, 6 -
dimethylbenzimidazole D-ribonucleotide tail) which has been revealed to end up deposited in the 
hydrophobic patch of the enzyme component S after the “base off, his on” binding of coenzyme 
B12. Besides the binding of cofactor, the catalytic significance from the replacement of this 
ligand by protein histidine especially its contribution to enzymatic turnovers after being 
displaced is still uncovered in most mutases including the glutamate mutase. The conspicuous 
catalytic role by this ligand with which it has been linked with the mechanism by which the Co-
C bond is homolytically cleaved has been mainly due to the mechanochemical trans-ligand 
effect that apply only in ‘base on, his off’ eliminases in which the catalysis progress with 
cofactor intact 5, 6 -dimethylbenzimidazole. “A significant body of evidence suggests that the 
bulky lower 5, 6-dimethylbenzimidazole axial ligand, is important in catalysis either by sterically 
destabilizing the ground state, or by electronically stabilizing the transition state for Co-C bond 
homolysis” Kenneth L. Brown, Department of Chemistry and Biochemistry, Ohio State 
University. Although the similar trans-ligand role in Co-C bond homolysis has been ascribed to 
the axial histidine ligands in mutases “base off, his on” catalysis, a coenzyme B12 analog; 
AdoCbi-GDP has been demonstrated to bind methylmalonyl –CoA mutase in the “his off” mode 
and accomplished the rearrangement reaction with significant high kcat without the axial histidine 
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ligand.
182
 However, in contrast to the catalysis by the methylmalonyl –CoA mutase, AdoCbi-
GDP as well as the AdoCbi bind glutamate mutase by “his on” and reconstitute the holoenzyme 
which catalyze the rearrangement of (S)-glutamate to (2S, 3S)-3-methylaspartate in 10
4
- folds 
reduced kcatKm
-1
 in comparison to coenzyme B12.
183
 Besides the revealed usual enzyme catalysis 
in the presence of the axial trans-histidine coordinate by these results which support further 
endeavors for uncovering the role of the axial α-ligand towards trillion folds labilization of the β 
Co-C coordinate, also notably from these results has been the dependence of glutamate mutase 
catalytic turnover on the displaced 5, 6-dimethylbenzimidazole D-ribonucleotide tail.  
             
Studies approach by the structure activity relationship toward defining the role of the coenzyme 
B12 5, 6 -dimethylbenzimidazole D-ribonucleotide tail in the reaction of glutamate mutase were 
carried out during the period of this thesis by using an adenosylpeptide B12 (31) derivative of 
coenzyme B12 (4) as an artificial cofactor for glutamate mutase. The derivative cofactor (31) has 
a neutral peptidomimentic unit of two glycines which connect the dimethylbenzimidazole to 
ethanol propanamide side group of the corrin ring instead of ribose and the negatively charged 
phosphodiester linker in coenzyme B12 (4). This modification on the coenzyme B12 α-ligand was 
postulated to modulate the cobalamin base on/base off equilibrium and subsequently affect the 
enzymatic catalysis in both “base off, his on” mutases and “base on, his off” eliminases.184 This 
thesis presents the results obtained from the measurements of the kinetics of glutamate mutase 
reconstituted with the artificial cofactor (31) as well as provides mechanistic insights related to 
the catalytic role of the displaced bulk ribonucleotide tail in the reaction of glutamate mutase 
from comparison with the kinetics of the coenzyme B12 (4) dependent reaction. 
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                      (a)                                                     (b) 
 
Figure 63: Structures of (a) an artificial adenosylpeptide B12 cofactor (31) and (b) coenzyme B12 (4) with 
their α-ligand shown in blue. Note the coenzyme B12 (4) α-ligand ribose phosphodiester moiety is 
replaced by peptidomimentic unit of two glycines in the adenosylpeptide B12 (31).  
 
3.4.1.1 Reconstitution of hologlutamate mutase with an adenosylpeptide B12 
(31) as a cofactor 
 
The UV/visible spectrum of an artificial adenosylpeptide B12 (31) differs from that of ‘base on’ 
coenzyme B12 only between 400 and 450 nm by a continuous steep slope of increasing 
absorption with increasing wavelength as compared to coenzyme B12 absorptions in this region. 
The spectrum of coenzyme B12 has a characteristic absorption which forms a plateau peak 
between 410 and 445 nm. Since the maximum absorption of ribose is within this region, the 
absorption difference has been attributed to the ribose unit of coenzyme B12 α-ligand which is 
missing in the adenosylpeptide B12 (31).  
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Between 350 and 400 nm as well as from 450 to 600 nm the spectrum of an adenosylpeptide B12 
(31) closely resembles that of coenzyme B12 with an absorption at 490 nm and maximum 
absorption at 520 nm (figure 64). Similar to the reconstitution of hologlutamate mutase from its 
apoenzyme components and coenzyme B12, the UV/visible spectrum of the reconstituted 
holoenzyme from the assembling of components S and E with an adenosylpeptide B12 (31) 
closely follow that of an adenosylpeptide B12 (31) (figure 64). 
 
 
 
Figure 64: UV/visible spectra of 0.13 mM “base on” coenzyme B12 (blue), 0.1 mM adenosylpeptide B12 
(31) (red) and hologlutamate mutase reconstituted with 0.43 µM component S, 0.03 µM component E and 
equivalent molar concentration of an adenosylpeptide B12   (31) (grey). 
An activity due to the conversion of (S)-glutamate to (2S, 3S)-3-methylaspartate by glutamate 
mutase was demonstrated by the standard methylaspartase coupled assay when the enzyme was 
reconstituted with adenosylpeptide B12 (31). However, to attain the rate of mesaconate formation 
equivalent to that achieved by holoenzyme reconstituted with coenzyme B12, 10 times more 
amount of apoenzyme components have been required to reconstitute the holoenzyme with an 
adenosylpeptide B12 (31). 
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Figure 65: Activity of hologlutamate mutase reconstituted from 6.8 µM S, 0.5 µM E and excess 
adenosylpeptide B12 (31) measured as the rate of mesaconate formation by the standard methylaspartase 
coupled assay. The 0.14 U (mg GlmE)
-1
 specific activity of glutamate mutase was determined from this 
activity in due to the reconstitution of holoenzyme with an adenosylpeptide B12 (31) as a cofactor.  
   
3.4.1.2 Kinetic constants of an adenosylpeptide B12 (31) in the reaction of 
glutamate mutase  
Kinetic constants of an adenosylpeptide B12 (31) in the reaction of glutamate mutase were 
determined by the Michaelis-Menten method from the reconstitution of the holoenzyme in 14 
and 2-fold excess of component S with an adenosylpeptide B12 as the cofactor. The kinetic 
constants Vmax = 0.13 ± 0.01 U (mg GlmE)
-1
 (kcat = 0.12 ± 0.01 s
-1
 ) were obtained along with Km 
values for the adenosylpeptide B12: 0.35 ± 0.05 µM and 1.07 ± 0.04 µM to the apo-glutamate 
mutase from the respective reconstitutions in 14 and 2 fold excess of component S. Almost equal 
Km but 10-times higher Vmax values were found with the native coenzyme B12 (4) (see table 10).  
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Figure 66: Michaelis-Menten plot for the determination of the kinetic constants of an adenosylpeptide B12 
(31) in the conversion of (S)-glutamate to (2S, 3S)-3-methylaspartate by glutamate mutase reconstituted 
with 14 excess folds of component S 
 
 
Figure 67: Michaelis-Menten plot for the determination of the kinetic constants of an adenosylpeptide B12 
(31) in the conversion of (S)-glutamate to (2S, 3S)-3-methylaspartate by glutamate mutase reconstituted 
with 2-fold excess of component S 
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Km (µM) 
 
Vmax (U/mg GlmE) 
 
kcat (s
-1
) 
 
kcat/Km (s
-1
M
-1
) 
 
GlmS:GlmE 
 
14 
 
2 
 
14 
 
2 
 
14 
 
2 
 
14 
 
2 
 
Coenzyme B12 (4) 
 
0.52±0.06 
 
1.12±0.04 
 
1.39±0.40 
 
1.39±0.40 
 
1.24±0.36 
 
1.24±0.36 
 
2.38  10
6
 
 
1.10  10
6
 
 
Adenosylpeptide 
B12 (31) 
 
0.35±0.05 
 
1.07±0.04 
 
0.10±0.01 
 
0.13±0.01 
 
0.09±0.01 
 
0.12±0.01 
 
2.57  10
5
 
 
1.12  10
5
 
 
 
Table 10:  Kinetic constants of an adenosylpeptide B12 (31) and coenzyme B12 (4) in the forward reaction 
of glutamate mutase measured from reconstitutions of enzyme in 14 and 2 excess folds of component S. 
 
3.4.1.3 B12 dependent bacteria growth on three carbon substrates 
Demonstration on the in vivo bioactivity of an adenosylpeptide B12 (31) requires the B12 
dependent growth of bacteria. This type of growth is possible via the aerobic oxidation of 
propionate to pyruvate which exploits coenzyme B12 for the intermediate rearrangement of (R)- 
methylmalonyl -CoA to succinyl -CoA by methylmalonyl -CoA mutase. The assimilation of 
propionate or (R)-methylmalonyl-CoA by this pathway is accomplished by the B12 dependent 
reaction which allows these substrates to enter the central carbon metabolism at the succinyl -
CoA level. The annotation of methylmalonyl-CoA mutase and adenosyltransferase encoding 
genes in the genome of E .coli MG1655 lead to the design of an experiment which the strain was 
cultivated on minimum medium with propionate or (R) –methylmalonyl -CoA as the only carbon 
sources. The experimental set up (2.2.1.4) provided five sets of media which differ in carbon 
sources as well as the supplementation with B12 to accommodate the control experiments. In the 
first and second set the minimum media were supplemented with propionate and propionate + 
cynocobalamin, respectively, while third and fourth sets were designed similarly with (R)-
methylmalonate as a carbon source. The fifth set contained glucose was a control experiment. 
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Neither the propionate nor (R)-methylmalonate as well as their supplementation with 
cyanocobalamin supported the growth of E. coli MG1655. The control experiment demonstrated 
the growth on glucose.  
  
3.4.2 Probing the formation of the primary organic radical; 5'-deoxyladenosyl and 
the participation of cob(II)alamin in the stabilization of substrate activation 
during the glutamate mutase reaction 
The paramagnetic species cob(II)alamin formed along with the 5'-deoxyadenosyl radical from 
the homolytic cleavage of the coenzyme B12 Co-C bond was once thought of being marginal 
toward the rearrangement mechanisms of the coenzyme B12 dependent enzymes. The curiosity 
on the involvement of cob(II)alamin in rearrangements arise from its close proximity to the 
intermediate species in rearrangements during the catalysis by enzymes of the mutase class. In 
contrast to the catalysis by coenzyme B12 dependent enzymes of the eliminase class in which the 
cob(II)alamin locates at a distance of 10 Ǻ from intermediates of rearrangements for which it has 
been considered insensitive to rearrangements, in mutases cob(II)alamin remains within 7 Ǻ 
from the intermediates of rearrangements.
149
 Besides the location, another evidence to convict 
the cob(II)alamin from non-participation in the eliminases catalyzed rearrangements is the fact 
that other eliminases, which do not use coenzyme B12 to generate the primary organic radical are 
known. These enzymes e.g class I and III RNR’s use other radical generators like diiron(III)-
tyrosine metalocofactor and SAM to initiate the chain of radical reactions which accomplish 
similar rearrangements without cob(II)alamin.
157
 Since in mutase catalyses there is no other 
known radical generator than coenzyme B12, the cob(II)almin which locates close to the 
intermediates species of reactions has been postulated to contribute in the mechanisms of 
rearrangements by mutases. The terms “spectator” to implies just watching the rearrangement at 
a distance without being involved and “conductor” for explaining the cob(II)alamin participation 
by interacting with intermediates species formed during the rearrangements were introduced to 
describe the two cob(II)alamin scenarios in respective catalysis by eliminases and mutases. In the 
glutamate mutase catalyzed reaction cob(II)alamin remains about 3 Ǻ from the 5'-deoxyadenosyl 
radical and further 4 Ǻ from the intermediates of rearrangement which predicts the stabilizations 
of these intermediates by interactions with cob(II)alamin.
149
 The EPR studies for the 
identification of intermediate radical species during the reaction of glutamate mutase 
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demonstrated the interaction of the 4-glutamyl radical with cob(II)alamin which supports the 
proposed cob(II)alamin conductor role in the glutamate mutase reaction.
105 
 Crystal structures of 
hologlutamate mutase revealed the two different orientations of the coenzyme B12 β-ligand 
during the catalysis by this enzyme (Figure 68). While in the orientation (A) the 2' -OH and 3' -
OH groups of the ribose extends away from corrin ring, the orientation (B) which permits the 
abstraction of hydrogen from the substrate by the 5' deoxyadenosyl radical brings the 3'OH close 
to corrin. The crystal structure shows the hydrogen bonding distance between 3'OH and C19-H 
from the corrin ring in the orientation (B) which suggests the facilitation of the ribose re-
orientation that aid the homolysis of the Co-C bond and stabilization of substrate activation step 
by 3'OH hydrogen bonding interaction with the C19-H. 
 
 
 
 
 
 
 
 
 
(A)                                                       (B) 
Figure 68; Crystal structures of coenzyme B12 in action after the homolytic cleavage of Co-C bond. (a) 
Ribose O3' points away from the corrin ring and (b) an orientation that brings the ribose O3' at the 
hydrogen bonding distance to C19-H from corrin.
149
 (Note in these structures the protein is omitted)  
Gas phase calculations by the functional density theory (FDT) reported critical interactions 
between the C19H and ribose 3'OH which contribute to stabilization amounting to 30 kJmol
-1
.
185
 
These calculations further suggested the polarization of C19-H bond after the homolytic cleavage 
of the cofactor Co-C bond which facilitate the interaction.  The same computational studies also 
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reported sizable stabilization (5 kJmol
-1
) in due to 2'OH interactions. Studies on the glutamate 
mutase reaction conducted for this thesis used the three derivatives of coenzyme B12 (4): 2',5'-
dideoxyadenosylcobalamin (32), 3',5'-dideoxyadenosylcobalamin (33) and 
peptidoadenylcobalamin (34) as cofactors in order to demonstrate the influence of 2'OH and 
3'OH towards the formation of the 5'-deoxyadenosyl radical and the participation of 
cob(II)alamin in the formation and stabilization of 5'-deoxyadenosyl radical. The latter 
cobalamin consists of a peptide mimic unit that contains the same number of atoms between 
Co(III) and the adenosine base instead of ribose unit on the β-ligand. With these cofactor 
derivatives the interactions of the enzyme-coenzyme complex with either O2' or O3' of ribose or 
with both oxygen during the reaction were not possible. This thesis reports on the impairments of 
the enzyme kinetics resulted from the replacement of coenzyme B12 by 32, 33, and 34 as well as 
providing structure related mechanistic implications derived from the impairments. 
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Figure 69: Structures of the β-ligand modified coenzyme B12 derivatives used in probing the 
cob(II)alamin participartions in the formation of the 5'-deoxyadenosyl radical and its stabilization during 
the substrate activation by hydrogen abstraction in the reaction of glutamate mutase. 2',5'-
dideoxyadenosylcobalamin (32),  3',5'-dideoxyadenosylcobalamin (33) and peptidoadenylcobalamin (34) 
128 
 
3.4.2.1 Assembling of apoglutamate mutase with β-ligand modified coenzyme 
B12 derivatives 
The UV-visible spectra of used β-ligand modified derivatives of coenzyme B12 (4); 2',5'-
dideoxyadenosylcobalamin (32), 3',5'-dideoxyadenosylcobalamin (33) and 
peptidoadenylcobalamin (34) as well as that of coenzyme B12 (4) were similar from 350 to 700 
nm. All the derivatives exhibited absorption peak at 430 nm as well as the maximum absorption 
at 520 nm with a 490 nm shoulder like the coenzyme B12 (figure 70). The absorptions similarities 
between 300 and 700 nm shown by these cobalamins were expected since they differ only on β-
ligand that has been modified to structures which absorbs below 300 nm like an adenosine 
moiety in the coenzyme B12.  The UV-visible spectra of hologlutamate mutase reconstituted with 
these derivatives as cofactors also closely follow their corresponding “base on” spectra like in 
the reconstitution of the holoenzyme with coenzyme B12 (figure 70).  
 
Figure 70: UV-visible spectra of 0.063 mM 2',5'-dideoxyadenosylcobalamin (32) (dashed red), 0.07 mM 3',5'-
dideoxyadenosylcobalamin (33) (dashed blue), 0.063 mM peptidoadenylcobalamin (34) (dashed green) and 
hologlutamate mutase reconstituted from 0.68 µM S, 0.05 µM E and equivalent amounts of 2',5'-
dideoxyadenosylcobalamin (32) (red), 3',5'-dideoxyadenosylcobalamin (33) (blue) and peptidoadenylcobalamin (34) 
(green) as cofactors. Note the holoenzyme reconstituted with 3',5'-dideoxyadenosylcobalamin (33) is 3 times 
magnified while those from 2',5'-dideoxyadenosylcobalamin (32) and peptidoadenylderivatives were 3.5 and 4 times 
magnified respectively. 
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The glutamate mutase activity due to the conversion of (S)-glutamate to (2S, 3S)-3-
methylaspartate was detected from the reconstitution of holoenzyme with 3',5'-
dideoxyadenosylcobalamin (33) as a cofactor (figure 71). However, 10 times more holoenzyme 
reconstituted with 3', 5'-dideoxyadenosylcobalamin(33)  was needed to attain the conversion rate 
equivalent to that achieved by holoenzyme reconstituted with coenzyme B12 (4). 
 
Figure 71: Measurement of glutamate mutase activity as the rate of mesaconate formation by the 
methylaspartase coupled assay. The measured rate of mesaconate formation from the assay in which the 
holoenzyme was reconstituted by 6.8 µM S, 0.5 µM E and 35 µM 3',5'-dideoxyadenosylcobalamin (33) 
was used to determine the enzyme specific activity, 0.11 U (mg GlmE)
-1 
which is 15 times less compared 
to specific activity determined from the coenzyme B12 (4) dependent reaction 
The reconstitution of hologlutamate mutase with 2',5'-dideoxyadenosylcobalamin (32), and 
peptidoadenylcobalamin (34) as cofactors could not accomplish the enzymatic conversion of (S)-
glutamate to (2S,3S)-3-methylaspartate. Addition of coenzyme B12 to these complexes did not 
restore activity.  
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3.4.2.2 Determination of kinetic constants of 3', 5'-dideoxyadenosycobalamin 
(33) in the reaction of glutamate mutase 
Kinetic constants of 3', 5'-dideoxyadenosycobalamin (33) in the glutamate mutase catalyzed 
conversion of (S)-glutamate to (2S, 3S)-3-methylaspartate were determined by the Michaelis-
Menten method from the reconstitution of holoenzyme in 14 folds excess of component S. 
Measurements of initial rate of mesaconate formation were recorded from various concentrations 
of 3',5'-dideoxyadenosycobalamin (33) used to reconstitute the holoenzyme (section 2.2.7.8) and 
subsequently applied to plot the Michael-Menten curve. The enzyme Vmax = 0.10 U (mg GlmE)
-1
 
( Kcat = 0.089 ± 0.01s
-1
 ) were obtained from the plotted Michelis –Menten curve along with the 
Km = 0.56 ± 0.02 µM of 3',5'-dideoxyadenosycobalamin(33) for glutamate mutase. The kcatKm
-1
 = 
1.59 x 10
5
s
-1
M
-1
 of the 3',5'-dideoxyadenosycobalamin (33) dependent glutamate mutase reaction 
was also calculated from these kinetic constants. 
 
 
Figure 72: Michaelis-Menten plot for the determination of the kinetic constants of 3', 5'-
dideoxyadenosycobalamin (33) in the conversion of (S)-glutamate to (2S, 3S)-3-methylaspartate by 
glutamate mutase reconstituted with 14 folds excess of component S 
 
The measured Km values of 3', 5'-dideoxyadenosylcobalamin (33) and coenzyme B12 (4) in the 
reaction of glutamate mutase reconstituted by 14 folds excess of component S were equal. 
However, the kcat as well as kcat Km
-1
 in the coenzyme B12 (4) dependent reaction were about 15 
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fold higher than those measured from the reconstitution of the holoenzyme with 3', 5'-
dideoxyadenosylcobalamin (33) as cofactor.  
 
 Coenzyme B12 (4)   3',5'-Dideoxyadenosylcobalamin (33)  
Km  0.52 ± 0.06 μM 0.56 ± 0.02 μM 
kcat  1.24 ± 0.36 s
1 0.089 ± 0.01 s1 
kcat Km
1  2.38  106 s1 M1 1.59 × 105 s1 M1 
 
Table 11: Summary of the kinetic constants of coenzyme B12 (4) and 3', 5' –dideoxyadenosylcobalamin 
(33) in the reaction of glutamate mutase reconstituted with 14 folds excess of component S.   
 
The kcat for coenzyme B12 (4) dependent reaction and that obtained from the kinetics of 3', 5' 
dideoxyadenosylcobalamin (33) were used to determine the energy difference between the 
coenzyme B12 (4) and 3', 5' dideoxyadenosylcobalamin (33) co-catalyzed reactions of glutamate 
mutase at their assayed condition (37 °C). 
 
∆E = E(4)  - E(33) =  - RTln [kcat(4) ]/[kcat(33)] = 7 kJmol
-1
 
 
This calculated 7 kJmol
-1
 energy difference between the coenzyme B12 (4) dependent reaction 
and that which 3', 5' -dideoxyadenosylcobalamin (33) was used as cofactor is the extent of 
facilitation towards Co-C bond homolysis and stabilization of the hydrogen abstraction by 5'-
deoxyadenosyl radical contributed from the interaction of 3'OH with cob(II)alamin.
186
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3.5 Investigations into the role of MutL chaperone in glutamate mutase 
catalysis 
After about 100,000 turnovers glutamate mutase becomes inactive due to loss of the 5'-
deoxyadenosyl radical leaving cob(II)alamin tightly bound to the protein. This happens not only 
in vitro but also in vivo as shown by isolation of component E, component S and inactive 
cob(II)alamin containing holo-glutamate mutase from Clostridium cochlearium.
168
 The presence 
of cob(II)alamin in the cell, which is formed as an intermediate in the pathway for cobalamin 
biosynthesis, is also another possibility to form an inactive complex with component E and S. 
The mechanism for removal of cob(II)alamin bound to the enzyme has been studied in 
methylmalonyl-CoA mutase as well as diol dehydratase. The methylmalonyl -CoA mutase 
associated MeaB chaperone protein, which is not required for the functional production of the 
enzyme, has been demonstrated to play a central role in preventing the binding of cob(II)alamin 
to the mutase as well as the removal of cob(II)alamin by exchange with coenzyme B12 when 
bound to the mutase in an ATP dependent mechanisms.
138
 A similar role of the protein known as 
reactivase has been established in diol dehydratase.
139
 Between the genes encoding for glutamate 
mutase components E and S in C. cochlearium, an open reading frame coding for a putative 
chaperon GlmL (50.21 kDa) has been detected (figure 73). Similar to MeaB of methylmalonyl -
CoA mutase and reactivase of diol dehydratase, the deduced GlmL sequence has a conserved 
ATP binding motif and is not required for the functional production of glutamate mutase. The 
protein has therefore been speculated to help to reactivate inactive glutamate mutase by 
exchange of cob(II)alamin with coenzyme B12 as well as preventing the binding of cob(II)alamin 
to glutamate mutase. An investigation on the role of GlmL requires the recombinant production 
of this protein in E. coli. Thus in this thesis the cloning of mutL gene from C. tetanomorphum is 
reported, from which the MutL chaperone can be over-produced in E.coli and used in the 
proposed experiments toward establishing its in vivo role in provision of active enzyme.   
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Figure 73: Genes encoding glutamate mutase components S, L and E in C. cochlearium and C. 
tetanomorphum. bma encodes the subsequent enzyme; the methylaspartase in the (S)-glutamate 
fermantion pathway. 
 
3.5.1 Cloning of Clostridium tetanomorphum mutL gene in pASG-IBA3 and pASG-
IBA5 expression vectors 
The mutL gene consists of 1386 base pairs of which 484 (35%) are G-C and 902 (65%) are A-T. 
The gene is expressed as a sequence of 462 amino acids which forms the 50.21 kDa MutL 
protein. The PCR multiplied mutL gene with terminal Lgul restriction sites, which were included 
via the used primers, was successfully incorporated into the pre-entry IBA-20 vector by Lgul 
restriction and T4 ligation reactions. The constructed pre-entry vector with a mutL insert was 
transformed into E. coli DH5α which grew on agar and later in broth culture from where it was 
purified. Cloning of mutL into pre-entry IBA-20 vector was confirmed by both sequencing 
(figure 74) as well as analysis by a DNA agarose gel which gave respective 1.8 and 1.4 kbp 
bands for IBA-20 and mutL after being digested by Esp3I. Constructions of the expression 
vectors pASG-IBA 3 and pASG-IBA 5 with mutL inserts were accomplished in the respective in 
frame Esp3I restrictions and T4 ligation reactions. The vectors were transformed in E. coli DH5α 
and clones of mutL in pASG-IBA 3 and pASG-IBA 5 were purified and confirmed by DNA 
agarose gel which when digested by Hind III and Xbar gives the vector band (2.8 kbp) as well as 
other three bands with sizes between 400 and 800 kbp. These three bands arise from the 
digestion of mutL by HindIII. Analysis of the mutL sequence by a restriction map confirmed the 
restriction sites of HindIII at 148, 657 and 977 of the mutL sequence. Further confirmation of the 
successful cloning of mutL into pASG-IBA 3 and pASG-IBA 5 was obtained by the recombinant 
production of the MutL protein (3.5.2). 
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     1 GTGGATGCTT ATTTACTTTT AGATTTTGGT AGCACCTATA CAAAACTTAC 
   51 TGCAGTAGAT ATAGAAAATG AAGGGATATT AGCTACAGCA AAAGATATAA 
  101 CAACTATAGA AAGCGATATA ATGGTAGGGT TTAACAAAGC CTACGAAAAG 
  151 CTTACTGAAC AGTTAGAAGG AAAAGAAGTG AATTTTGTTA AAAAGTTAGC 
  201 ATGTTCATCT GCAGCAGGTG GACTAAAGAT GATAGCCATC GGTCTTGTAC 
  251 CAGAACTTAC AGCAGAAGCT GCAAAGAGAG CTGCTCTTGG AGCAGGAGCT 
  301 AGGGTACTAA ATGTATATAG TTACGATTTG ACTAATAAAG AAGTTGAAGA 
  351 AATAAAAAAT TCTAACTTGG ACATAATACT TTTAGCAGGT GGTACAGATG 
  401 GTGGAAATAA AGAATGTATG ATTCATAATG CAAAAATGCT AGCTGAGCAT 
  451 GGAGTTAAAC TTCCAATAGT TGTAGCAGGA AATAAAGTAG TTAGTGATGA 
  501 AGTATCAGAA ATATTTGATA AAGCAGGTAT ATTTTATAGA GTTACTGAAA 
  551 ATGTAATGCC CAAGTTAAAT ACATTAAATG TAGAACCTGC AAGAGAAGAA 
  601 ATAAGACAAA TATTTATGAA AAAAATTGTA GAAGCAAAAG GAATGTCAAA 
  651 TGCTGAAAGC TTTATTAATG GAATACTTAT GCCTACTCCA GCAGCAGTTT 
  701 TAAAGGCAGC TAGAGTATTA GCAGAAGGAA CCGATAAAGA AGATGGTATT 
  751 GGCGATTTAA TAGTAGTAGA TATTGGTGGT GCTACTACAG ATGTACACTC 
  801 ACTTGCAGAT GGCGAGCCAT CTAAGCCAGG AGTTACATTA AGAGGGCTTG 
  851 AAGAACCTTT TGCAAAAAGA ACTGTTGAAG GCGACCTAGG AATGAGATAT 
  901 TCTGCCATTT CCTTATGGGA GGCATCAGGA ACAAGAAAAC TTCAAAAATA 
  951 TCTATGTGAT AATACTGTAG ATGTAGAAGC TTGTTGTAAA TATAGAGCTG 
 1001 AACATATAAA AATGGTACCC GAGACAGAAG AAGAAATTAA GTTTGATGAA 
 1051 GCTATGGCTA AGGTTGCAAC TGATATGGCT ATGGAAAGAC ATGTAGGAGT 
 1101 TATAGAAAGT ATGTATACTC CTATGGGAGT CATATATAGT CAGATAGGTA 
 1151 AAGACTTGTT AAACGTAAAG TGTGTAATAG GAACTGGAGG AGTACTAGTT 
 1201 CATAGTAAGA ATCCAGGTGA AATACTAAAA GCAGGGTCAT TTGATATGGC 
 1251 CGATGCTACT CATTTGAAAC CACAGCATCC AGAATATTAT ATAGATAAAA 
 1301 CATATATATT ATCTGCAATG GGGCTTCTAG CAGAAGATCT TCCAGATAAA 
 1351 GCAGTTAGAA TAATGAAAAA GTATTTGGTT AAAGTTGGGT GA 
 
Figure 74; Sequence of the mutL insert in the pre-entry IBA-20 vector. The 1
st
 codon (GTG) which is 
translated to methionine and the last (GTT) which encodes valine are shown in red. The triplet GGG 
between GTT and stop codon (TGA) is derived from primers used in the PCR, where it formed the 
restriction site for Lgul.   
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3.5.2 Expression of mutL in E.coli  
The LC-MS analysis of the SDS-PAGE bands of the 50 kDa proteins from the cell free extracts 
of E. coli Rosetta, which were transformed with pASG-IBA3 and pASG-IBA5 vectors with mutL 
insert and respective induced by IPTG and AHT revealed the expression of mutL in both 
constructs. These expressions are in the meantime pending for Streptag or Histag purification of 
MutL. Experiments for this thesis have already demonstrated the formation of an inactive 
glutamate mutase complex by incubation of GlmS and E with hydroxycobalamin (2). Since no 
enzymatic activity could be obtained upon addition of coenzyme B12 (4) and (S)-glutamate to this 
complex, pending experiments are the inclusion of GlmL and ATP or GTP into the incubation 
mixture. 
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4. Discussion 
4.1 Reconstitution of hologlutamate mutase from protein components S and 
E with cofactors 
The kinetic investigations on the reaction of glutamate mutase reported in this thesis have 
described the two active coenzyme B12 (4) derived cofactors, 3', 5'-dideoxyadenosylcobalamin 
(33) and adenosylpeptide B12 (31). While the former differs from coenzyme B12 (4) only by the 
absence of the 3'OH- group of the β-ligand ribose, the latter consists of two glycine units in place 
of the phosphodiester bond and ribose in the coenzyme B12 α-ligand. Despite the described 
structure modifications, these coenzyme B12 derivatives were able to assemble with glutamate 
mutase components S and E to form a heterotetrameric holoenzyme that accomplishes the 
reversible conversion of (S)-glutamate to (2S, 3S)-3-methylaspartate, although their co-catalysis 
were with significant reductions in the reaction rates as compared to coenzyme B12 (4). The 
reported measurements of the kinetic constants for these cofactor derivatives as well as for 
coenzyme B12 (4) in the reaction of glutamate mutase reconstituted with 14, 7 and 2-fold excess 
of component S, have demonstrated similar Km values for these cofactors compared to the 
coenzyme B12 (4). Detailed discussions of these results in the context of structural roles for 
cofactor binding to the apoenzyme during the glutamate mutase catalysis are given later in this 
chapter. A significant mechanistic insight related to the reconstitution of hologlutamate mutase 
drawn from the trend of Km values of these derivatives and those of coenzyme B12 (4) is the 
dependence of the cofactor affinities to the apo-enzyme on the concentration of component S. 
The measured Km values for coenzyme B12 (4), 0.52 ± 0.06 µM, 0.7 ± 0.05 µM and 1.12 ± 0.04 
µM at 14, 7, and 2-folds excess of component S, respectively, as well as for the adenosylpeptide 
B12 (31), 0.35 ± 0.05 µM and 1.07 ± 0.04 µM at respective 14 and 2-fold excess of component S, 
have demonstrated an increase of the cofactor’s Km with decreasing concentration of protein S. 
These data suggest that the affinities of coenzyme B12 (4) as well as those of the two derived 
cofactors to apo-glutamate mutase decrease with decreasing amounts of component S during 
reconstitution of the holoenzyme. Since the cofactor is bound by component S of glutamate 
mutase and the reconstituted heterotetrameric hologlutamate mutase complex E2S2 is postulated 
to be composed of two cofactors, which form two active sites each at the interface of component 
S and E, these results have led to an insight into the order of assembling. It is logical to put 
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forward an argument that component S is able to bind coenzyme B12 (4) as well as the other two 
cofactor derivatives before it joins with component E resulting in an increase of the cofactor 
affinity to the enzyme with increasing concentration of component S. There is no doubt with the 
other order of assembling, which brings components S and E together before the cofactor is 
bound, since other laboratories use the fused component S and E apoenzyme system to 
reconstitute the holoenzyme with coenzyme B12 (4). This is likely to be the case in vivo, where a 
native chaperone, which is not necessary for functional expression of the enzyme, is also a part 
of the enzyme. The Km value of 5.5 ± 0.7 µM for coenzyme B12 (4) 
187
 obtained from the kinetic 
measurements with fused SE apoenzyme is almost five times larger than 1.12 ± 0.04 µM, which 
was obtained from reconstitution of the holoenzyme with a 2-fold excess of component S. These 
Km values show that the reconstitution of the holoenzyme from the protein components S and E 
with coenzyme B12 (4) increases the apparent affinity of the cofactor five times in comparison 
with reconstitution by assembling of fused SE with coenzyme B12 (4). Raising the amount of 
component S further by 7 and 14-fold excess has demonstrated that increasing cofactor affinity 
to glutamate mutase is due to reconstitutions from separated components S and E. These kinetic 
results suggest that component S is able to bind its cofactor before it joins with component E 
with higher affinity than it does after its partnership with E.      
 
4.2 Mechanism based inactivations of glutamate mutase  
4.2.1 Evaluations on the interactions of glutamate mutase with its proposed 
inhibitors by the coupled assay with methylaspartase  
Since at least 2 mM of each of the following inhibitors; cis-glutaconate, trans-glutaconate, 
itaconate, buta-1,3-diene-2,3-dicarboxylate, fumarate and maleate were demonstrated to 
inactivate methylaspartase to less than 50% of its activity, an application of the standard 
methylaspartase coupled method for assaying the interactions of these inhibitors with glutamate 
mutase was not appropriate. An assay for evaluating the interactions of glutamate mutase with 
these inhibitors requires an auxiliary enzyme which is not inactivated by an inhibitor in much 
higher concentrations than the Km value of its natural substrate in the reaction that it catalyzes. 
Therefore an alternate assay without auxiliary enzyme was established. Hologlutamate mutase 
was incubated with the potential inhibitor for a certain time followed by the removal of the 
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excess inhibitor by gel filtration. The residual activity was assayed with methylaspartase. This 
modified assay, however, only works with irreversible inhibitors, i.e. inactivators. The non 
inactivations of glutamate mutase by itaconate, buta-1, 3-diene-2, 3-dicarboxylate, cis-
glutaconate and trans-glutaconate reported in this work indicated that these compounds either 
did not affect glutamate mutase at all or were reversible competitive, noncompetitive or 
uncompetitive inhibitors. In contrast the related coenzyme B12-dependent 2-methyleneglutarate 
mutase exhibited inactivation by buta-1,3-diene-2,3-dicarboxylate and cis-glutaconate as 
indicated by the formation of cob(II)alamin.
106
 The observed potentials of fumarate, maleate and 
mesaconate to inactivate hologlutamate mutase was surprising. However, these results are 
contrast to the in vivo situation where mesaconate is present as intermediate in the pathway for 
glutamate fermentation, although several cases in which a substrate or cofactor of an 
intermediate metabolic step inhibits another enzyme of the same metabolic pathway are known. 
Rescuing enzyme inhibitions by intermediates of the same or other metabolic pathways are 
mostly achieved kinetically by those intermediates having high affinities to enzymes which they 
are taken as substrates through which their effect on other enzymes becomes minimal. Although 
the Km values for mesaconate in the respective reactions of mesaconase and mesaconate 
hydratase are known, the inquiry on how the inactivation of glutamate mutase by mesaconate is 
prevented in vivo cannot be addressed since its effect on glutamate mutase has not been well 
established. Also important to be considered has been the results obtained from further 
characterization on the interaction of fumarate with glutamate mutase, which could not establish 
the formation of cob(II)alamin by UV/visible spectroscopy as hypothesized in the mechanism 
based inactivations of glutamate mutase. This observation suggests the binding of fumarate on 
the enzyme active site does not trigger the homolysis of the cofactor Co-C bond.  
However, since the modified standard methylaspartase assay cannot characterize the interactions 
of these inhibitors with glutamate mutase kinetically, their effects on glutamate mutase has 
remained unclear pending the development of an appropriate assay with an auxiliary enzyme 
system which is not affected by these inhibitors.      
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4.2.2 Evaluations on the interactions of glutamate mutase with its inhibitors by a 
coupled assay with glutamic-pyruvic transaminase and 2-hydroxyglutarate 
dehydrogenase  
Coupling the glutamate mutase catalyzed reverse conversion of (2S, 3S)-3-methylaspartate to 
(S)-glutamate with glutamic-pyruvic transaminase and 2-hydroxyglutarate dehydrogenase 
catalyzed reactions achieves the conversion of (S)-glutamate to 2-hydroxyglutarate via 2-
oxoglutarate (figure 57). These transformations are accomplished in the new developed assay by 
the two auxiliary conversions; the pyridoxal-5-phosphate dependent glutamic-pyruvic 
transaminase conversion of (S)-glutamate produced from the glutamate mutase reaction to 2-
oxoglutarate and NADH dependent 2-hydroxyglutarate dehydrogenase catalyzed reduction of 2-
oxoglutarate to 2-hydroxyglutarate. Pyruvate, the co-substrate of transamination, is included in 
the assay mixture to be converted to alanine along with the formation of 2-oxoglutarate. 
Decreasing absorptions of the assay mixture at 340 nm with time due to depletion of NADH 
during the dehydrogenase catalyzed reduction permits the measurement of the rate of the 
glutamate mutase reaction. The high specific activities of glutamic-pyruvic transaminase (81 U 
mg
-1
) and 2-hydroxyglutarate dehydrogenase (1 kU mg
-1
) enabled the inclusion of relative small 
amounts of these auxiliary enzymes in the optimized assay with efficient conversions to 2-
hydroxyglutarate, and hence reliable determination of the kinetics of the glutamate mutase 
reverse reaction. Furthermore, the inability of cis-glutaconate, trans-glutaconate, itaconate, 
maleate, fumarate and mesaconate to inhibit glutamic-pyruvic transaminase and 2-
hydroxyglutarate dehydrogenase as demonstrated with up to 20 mM of each inhibitor has 
qualified this assay for application toward determinations of the kinetics for glutamate mutase 
interactions with these inhibitors. Evaluations on the interactions of hologlutamate mutase with 
itaconate and trans-glutaconate by this assay revealed the potentials of the two inhibitors to 
inactivate glutamate mutase (figure 60). These preliminary results demonstrated the reduction of 
glutamate mutase activity to 50% by 2.5 mM itaconate whereas 8 mM trans-glutaconate was 
required to reduce glutamate mutase activity to 50% and therefore suggesting that itaconate is 
more potent inhibitor than trans-glutaconate. Further experiments for this project will explore 
potentials for inactivating glutamate mutase by other designed inhibitors (table 7) as well as 
kinetic characterizations on their interactions with glutamate mutase. This study has therefore 
demonstrated the reliability of the optimized glutamic-pyruvic transaminase and 2-
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hydroxyglutarate dehydrogenase coupled assay for the reverse reaction of glutamate mutase in 
evaluating the interactions of glutamate mutase with these inhibitors including their kinetic 
characterizations.  
Also evaluated in this study was fitting of these inhibitors to mimic the 4-glutamyl and (2S, 3S)-
3-methyleneaspartate radicals at the active site of glutamate mutase. Preliminary fitting of cis-
glutaconate indicated an orientation that brings cis-glutaconate COO
-1
 (1) into interaction with 
arginines 66 and 149 whereas COO
-1
 (5) interacts with arginine 100, as being the only possibility 
for cis-glutaconate to bind to the enzyme active site. Because the rotation between C2-C3 of cis-
glutaconate is restricted by the double bond, the skeletal structure of cis-glutaconate cannot fit 
into the arginine claw in an alternative orientation. Critical in relation to the orientation, with 
which cis-glutaconate skeletal structure fits in the arginine claw, has been the C2-C3 π electrons 
which locates close to carboxylate of the active site glutamate 171 residue, and hence leads to 
C2-C3 π electrons repulsions with the carboxylate. A similar phenomenon is predicted in the 
binding of (Z, S)-aminoglutaconate. These model fittings predict reduced affinity of cis-
glutaconate and (Z, S)-aminoglutaconate to glutamate mutase and thus suggesting the use of 
glutamate 171 mutant enzyme in order to improve the binding of these inhibitors. However, 
since this project is focusing on spectroscopic characterizations of radical adducts of 5'-
deoxyadenosyl radical with these inhibitors (figure 52), the use of mutant enzyme will be useful 
only in case of poor inhibitions of wild type glutamate mutase by cis-glutaconate and (Z, S)-
aminoglutaconate or any other inhibitors with which significant π electrons repulsion with active 
site carboxylate will occur.   
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(a)       
 
 
 
 
 
 
 
 
 
 (b)    
 
 
 
Figure 75; Binding of molecules to the active site of glutamate mutase (a) binding of (S)-glutamate by 
interactions of its carboxylates with the active site arginines (arginine claw). The COO
-1
 (1) of (S)-
glutamate interacts by hydrogen bonding with arg-66 and arg-149 and COO
-1
 (5) with arg-100, (b) 
Preliminary model fitting of cis-glutaconate on the arginine claw by the orientation which brings COO
-1
 
(1) of cis-glutaconate in interactions with arg-66 and arg-149, whereas COO
-1
 (5) interacts with arg-100. 
The π electrons from cis-glutaconate C2-C3 locate close to COO- of glutamate 171.  
 
 
Arg-100 
Arg-149 
Arg-66 
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4.2.3 The reaction of glutamate mutase with 2-fluoroglutarate 
Since methylaspartase is not inactivated by 2-fluoroglutarate, the interaction of glutamate mutase 
with 2-fluoroglutarate was investigated by using the standard methylaspartase coupled assay. 
The demonstrated reduced activity in conversion of (S)-glutamate to (2S, 3S)-3-methylaspartate 
by glutamate mutase resulting from the incubation of glutamate mutase with 2-fluoroglutarate 
suggested the binding of 2-fluoroglutarate on the glutamate mutase active site which inhibit the 
binding of (S)-glutamate. On the other hand, 
19
F NMR analysis of the protein free mixture 
obtained from Centricon filtration after the overnight incubation of holo-glutamate mutase with 
2-fluoroglutarate reveals spectral changes in comparison to the 
19
F NMR of 2-fluoroglutarate 
which suggested another fluoro compound had been formed during the incubation. This result 
was further supported by LC-MS analysis of the same preparation which was analyzed by 
19
F 
NMR. The LC-MS chromatograph showed two separated fluorinated compounds, each with a 
mass of 150 and thus suggesting the rearrangement of 2-fluoroglutarate to 2-fluoro-3-
methylaspartate by hologlutamate mutase. However, when 2-fluoroglutarate was used as the 
substrate of glutamate mutase in the standard methylaspartase coupled assay, the formation of 
mesaconate could not be demonstrated. Together, these results suggest that 2-fluoroglutarate is 
both an inhibitor and substrate of glutamate mutase, by which is rearranged to 2-fluoro-3-
methylaspartate that cannot be deaminated to mesaconate by methylaspartase. (figure 76) 
 
OOC COO
F
OOC
COO
F
OOC
COOX
2- Fluoroglutarate
GlmS + E
Coenzyme B12
Fluoromethylaspartate Mesaconate
Methylaspartase
 
 
Figure 76: Respective reactions of glutamate mutase and methylaspartase with 2-fluoroglutarate and 2-
fluoro-3-methylaspartate as postulated from the results of experiments in which 2-fluoroglutarate was 
incubated with hologlutamate mutase and that which it was used as the substrate of glutamate mutase and 
assayed by the standard methylaspartase coupled assay.    
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Also proposed for further characterization of fluoromethylaspartate formed from the reaction of 
glutamate mutase with 2-fluoroglutarate is the extraction of the two fluorinated compounds by an 
organic solvent to allow their identification by 
1
H and 
13
C NMR. The extraction of fluorinated 
compounds by organic solvent is relevant for excluding coenzyme B12, which is in the mixture 
after protein was removed. In this experimental design the presence of fluoromethylaspartate will 
be demonstrated by the methyl peak in both 
1
H and 
13
C NMR which is not found in 2-
fluoroglutarate.  
This study has also suggested a rearrangement by fragmentation of the 2-fluoroglutaryl radical 
(35) which is derived from 2-fluoroglutarate, into fluoroacetate radical (36) and acrylate (24) 
which recombine to the product related radical, fluoromethylaspartate radical (38) (figure 77), 
like the proposed rearrangement of (S)-glutamate to (2S, 3S)-3-methylaspartate (figure 25). 
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Figure 77: Proposed mechanism for the reaction of 2-fluoroglutarate with holo-glutamate mutase. The 
substrate derived 2-fluoroglutaryl radical (35) fragments into fluoroacetate radical (36) and acrylate (24) 
which recombine to form the fluoromethylenaspartate radical (38). 
The above proposed mechanism for the reaction of hologlutamate mutase with 2-fluoroglutarate 
predicts the formation of a highly stable fluoroacetate radical (36) due to radical stabilization by 
fluorine. This phenomenon suggests an easy EPR characterization of this intermediate mimic of 
the glycine radical (30) in the reaction of glutamate mutase with (S)-glutamate. The ability of 2-
fluoroglutarate to bind at the glutamate mutase active site and react like (S)-glutamate together 
with the usefulness of the high electronegative property of fluorine in stabilizing radicals have 
lead to the suggestion of the application of the fluoro-compounds (39) and (40) in demonstrating 
the formation of the fluoromethyleneaspartate radical which mimics the (2S, 3S)-3-
methyleneaspartate radical in the reaction of glutamate mutase.  
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Similar chemistry is predicted in the reaction of hologlutamate mutase with 2-chloroglutarate. 
 
HOOC
COOH
NH2
CH2F
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Figure 78: Structures of proposed fluorinated methylaspartatic acids probes for demonstrating the 
formation of (2S, 3S) 3- methylaspartate related radical in the reaction of glutamate mutase. 
 
4.3 Kinetic probing of glutamate mutase reaction by coenzyme B12 derived 
cofactors  
4.3.1 Investigations on the role of the 5, 6-dimethylbenzimidazole ribonucleotide 
tail of coenzyme B12 in the reaction of glutamate mutase 
The ability of an adenosylpeptide B12 (31) to act as a cofactor indicates successful assembling of 
apo-glutamate mutase with the artificial cofactor (31) to reconstitute the functioning holoenzyme 
system. Strong evidence of the potential for this artificial cofactor to bind to glutamate mutase 
like coenzyme B12 (4) is from the comparison of its kinetic constants in the reaction of glutamate 
mutase with those of coenzyme B12 (4). The reported similarities in the Km values of coenzyme 
B12 (4) and the artificial cofactor (31) in the glutamate mutase reaction from the reconstitution of 
holoenzyme in 14 as well as 2-fold excess of component S during these studies have implied 
equal affinities of these cofactors for the apo-glutamate mutase. These kinetic results 
provisionally suggest that the coenzyme B12 α-ligand especially the ribose and phosphodiester 
units are not involved in the mechanism of cofactor binding to apo-glutamate mutase, since their 
modification has not affected the binding of the cofactor to the protein. However, the established 
adenosylpeptide B12 (31) equilibrium shifts towards the base-off state by the spectrophotometric 
pH titrations of the artificial cofactor predicted impairment on the binding of the modified 
cofactor to both mutases as well as the eliminases partner proteins. 
184
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The shift of the cobalamin base-on/base-off equilibrium towards the base-off state due to 
coenzyme B12 (4) structure modification to adenosylpeptide B12 (31) was further supported by 
the observed dissociation of 5,6-dimethylbenzimidazole from the Co
3+
 center in an UV/visible 
experiment.
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 In contrast to the equilibrium based prediction on the binding to enzyme, the 
results reported in this thesis demonstrated that the binding of an adenosylpeptide B12 (31) to 
glutamate mutase is insensitive to the cofactor base-on/base-off equilibrium.  
  
 
 
Figure 79: Schematic model for loading of an artificial adenosylpeptide B12 (31) in proteins of the 
coenzyme B12 dependent enzymes. A) ‘base-on, his-off’ and B) ‘base-off, his-on” binding of the artificial 
cofactor. 
However, the limitation of results reported in this thesis with relation to the context of the 
discussed affinity of an adenosylpeptide B12 (31) to glutamate mutase has been the absence of 
experimental evidence for the mode by which an adenosylpeptide B12 (31) binds apo-glutamate 
mutase. The UV/visible wavescan which demonstrated the cob(III)alamin spectrum of 
hologlutamate mutase reconstituted with an adenosylpeptide B12 (31) is not sufficient to 
conclude the artificial cofactor binds apo-enzyme by “base-off, his-on” since the possibility for 
‘his-off’ binding with retained cofactor α-ligand coordinate as in eliminases or α-coordination to 
-OH cannot be perceptibly excluded. The unexpected ‘his-off’ binding of the α-ligand modified 
base-off AdoCbi-GDP analogue of coenzyme B12 (4) has been demonstrated in methylmalonyl-
CoA mutase with which the analogue accomplished the co-enzymatic catalytic role with kcat 
comparable to coenzyme B12 (4).
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The demonstrated decrease of reaction rate from the reconstitution of hologlutamate mutase with 
an adenosylpeptide B12 (31) implies the 5, 6-dimethylbenzimidazole ribonucleotide tail is 
important in enhancing the rate of the reaction during the glutamate mutase catalytic cycle. This 
10 folds decrease of kcat as well as the kcatKm
-1
 is predicted to be caused by the alteration on the 
extent of conformational changes imposed by the peptidomimentic structure while deposited in 
protein pocket in comparison to coenzyme B12 (4) ribonucleotide structure (figure 80). These 
conformation changes are part of whole conformational changes by protein and cofactor which 
are initiated by substrate binding and being direct linked with the coenzyme Co-C bond 
homolysis. Assistance of the Co-C bond homolytic cleavage by protein as well as the cofactor 
conformational changes was estimated to about 10
11
 in the mechanism which has remained 
uncovered. 
65,66 
The demonstrated reduction of glutamate mutase kcatKm
-1
 resulted from the 
structure modification to an adenosylpeptide B12 (31) implies significant contribution by the 
histidine replaced tail towards glutamate mutase efficient catalytic turnover. 
   
 
Figure 80: The superposition of glutamate mutase components S (σ-subunits) solution structures. 
Magenta is in the absence of the cofactor, whereas in cyan the ‘base off, his on’ bound coenzyme B12 is 
shown with the histidine 16 displaced 5, 6-dimethylbenzimidazole ribonucleotide tail buried in protein 
pocket.
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4.3.2 Probing the stabilization of hydrogen abstraction from the substrate by 5'-
deoxyadenosyl radical in the reaction of glutamate mutase 
The mechanistic usefulness of the β-ligand modified derivatives of coenzyme B12, 2', 5'-
dideoxyadenosylcobalamin (32), 3',5'-dideoxyadenosylcobalamin (33) and 
peptidoadenylcobalamin (34), as cofactors for the glutamate mutase reaction is their ability to 
reconstitute the holoenzyme system without the enzyme-coenzyme complex interactions by 
either 2'-OH or 3'-OH of the ribose or both OH groups. Since the crystal structures of 
hologlutamate mutase led to proposals of the requirements of the ribose 2'-OH and 3'-OH 
interactions with the active site Glu 330 and cob(II)alamin for the sp
2
 radical carbon of the 5'-
deoxyadenosyl radical to reach its target hydrogen on the substrate by pseudorotation, the use of 
these derivatives have been important in revealing the mechanism by which the highly reactive 
5'-deoxyadenosyl radical is guided to the substrate including the cob(II)alamin participation in 
the stabilization of this radical during the substrate activation by hydrogen abstraction.   
In contrast to the gas-phase calculations by density functional theory (DFT) which reported 
strong interactions between C19-H of the corrin backbone and the ribose 3'-OH (∆G ≈ -30 kJmol
-
1
) from which without this interaction the reaction of glutamate mutase was considered 
impossible, 
185
 the reconstitution of holoenzyme with 3',5'-dideoxyadenosylcobalamin (33) as a 
cofactor accomplished the rearrangement of (S)-glutamate to (2S, 3S)-3-methylaspartate without 
3'-OH. The measured 15-fold reduced rate of the glutamate mutase reaction from the 
reconstitution of holoenzyme with 3',5'-dideoxyadenosylcobalamin (33) as compared with 
coenzyme B12 (4) indicated that the 3'-OH is a useful functional group for rate enhancement in 
the reaction of glutamate mutase. Besides the demonstrated reduction in reaction rate, the 
difference in kinetics; the kcat as well as the kcatKm
-1
 between the reaction catalyzed by enzyme 
reconstituted with 3', 5'-dideoxyadenosylcobalamin (33) and that depends on coenzyme B12 (4) 
has been converted to (∆G ≈ -7 kJmol-1). This energy difference is the contribution by the 
interactions of the 3'-OH of the ribose toward facilitating the abstraction of hydrogen on the 
substrate by 5'-deoxyadenosyl radical.
186
 This effect has been specifically attributed to the weak 
hydrogen bonding between the 3'-OH with either the C19-H from the corrin or the active site Glu 
330.  
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Further experimental contradiction to the gas-phase calculations by DFT which reported sizable 
stabilization of the substrate activation step by 2'-OH interactions (∆G ≈ -5 kJmol-1)185 is the 
deletion of 2'-OH demonstrated by 2',5'-dideoxyadenosylcobalamin (32) which resulted in 
complete loss of glutamate mutase activity. This loss has also been demonstrated with the 
reconstitution of the holoenzyme with peptidoadenosylcobalamin (34), which forms the 
holoenzyme without both 2'-OH and 3'-OH. These results have suggested the requirement of 
critical interactions by 2'-OH to accomplish the abstraction of hydrogen from the substrate by the 
5'-deoxyadenosyl radical. The crystal structures of the hologlutamate mutase show the 
conformational changes of the ribose moiety of the coenzyme B12 β-ligand after homolytic 
cleavage of the Co-C bond which brings the ribose 3'OH close to the corrin’s C19-H and thereby 
takes the sp
2
 radical carbon of the 5'-deoxyadenosyl radical to the substrate which is located at 
6.6 Ǻ from Co(II) (figure 68). These conformational changes correspond with the pseudorotation 
of the ribose moiety from the C2'-endo to the C3'-endo in a fixed C-N torsion angle which links 
the adenine.
188
 The strong hydrogen bonding interactions between the 2'-OH and Glu 330 before 
the homolytic cleavage of the Co-C bond as well as after the bond cleavage as revealed by the 
crystal structures has been suggested to act as a hinge during the pseudorotation. The complete 
loss of the glutamate mutase activity caused by the deletion of 2'-OH conforms to these crystal 
structure based explanations. Furthermore, the suggestion of the assistance on the homolytic 
cleavage of the Co-C bond by 3'-OH interactions with C19-H from the DFT calculations have 
been supported by the deletion of 3'-OH which demonstrated the 15-fold reduction in the 
reaction rate that was translated to a weak interaction (∆G ≈ -7 kJmol-1) with 3'-OH. The 
pseudorotation of the ribose is believed to be caused by conformational changes which are 
induced by binding of the substrate to the holoenzyme. Results obtained from the use of the β-
ligand modified derivatives of coenzyme B12 predict the inability to cleave the Co-C bond due to 
the deletion of the hinge (2'-OH). Since the pseudorotation stretch the Co-C bond, the less 
stretching on the bond resulted from the pseudorotation which is not assisted by the 3'-OH weak 
interaction with C19-H due to the deletion of 3'-OH caused the 15 fold reduction in the reaction 
rate. The inability to cleave the Co-C bond due to the deletion of 2'-OH can be further tested by 
anaerobic UV/visible scanning for detection of cob(II)alamin upon the addition of the substrate 
to holoenzyme reconstituted with 2',5'-dideoxyadenosylcobalamin (32).  
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These results from the use of β-ligand modified derivatives of coenzyme B12 (4) have thus 
suggested that the highly reactive 5'-deoxyadenosyl radical is anchored to the protein and the 
cob(II)alamin by hydrogen bonding interactions of its ribose OH groups and guided along to the 
substrate which is located 6.6 Ǻ away from Co(II). The hydrogen bonds are notable in 
preventing the primary radical from any side reactions on its way to the substrate. The 
association of the corrin interactions with ribose 3'-OH demonstrates the speculated 
cob(II)alamin conductor role in the reactions catalyzed by mutases as proposed by Buckel et 
al.
149 
The illustrated hydrogen bonding controlled mechanism for 5'-deoxyadenosyl radical 
conformational changes which accomplish the substrate activation by hydrogen abstraction in the 
reaction of glutamate mutase is an example of negative catalysis.
188
 This concept of negative 
catalysis elaborates on the enzymatic stabilisation of highly reactive radical species from their 
formation to the site where they react by which they are prevented from causing side reactions.
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(a)                                                                        (b) 
 
(c) 
Figure 81. Crystal structures of holo-glutamate mutase active site with bound tartrate (an analogue of (2S, 
3S)-3-methylaspartate) after the homolytic cleavage of the Co-C-bond. (a) Before and (b) after 
pseudorotation, which brings the sp
2
 radical carbon of the 5'-deoxyadenosyl radical close to tartrate fixed 
by arginines (red dotted lines). Note, the ribose pseudorotation from the C2'-endo to the C3'-endo brings 
the O3' into hydrogen bonding distance to both C19-H and E330. O2' locates within hydrogen bonding 
distance with E330 before and after pseudorotation. (c) two overlapping ribose conformations (before and 
after pseudorotation) in one plane showing intact 2.5 Ǻ hydrogen bonding interaction between 2'-OH and 
Glu 330 (hinge), as well as the non-interacting 3'-OH before pseudorotation which locates at respective 
2.7 Ǻ and 3.4 Ǻ distances from Glu 330 and C19-H after the pseudorotation. Adapted from reference 146. 
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The mutual importance of 2'-OH and 3'-OH respective interactions towards the formation of the 
5'-deoxyadenosyl radical as well as their role in guiding this primary radical to the substrate as 
concluded from the studies reported in this thesis is consistent with the results from the new 
computational studies.
190 
 Although the calculations for these new computational studies were 
with methylmalonyl-CoA mutase, their results lead to the conclusion that the formation of 5'-
deoxyadenosyl radical is due to the ribose pseudorotation which is aided by 2'-OH and 3'-OH 
respective interactions as well as the potential of 2'-OH and 3'-OH interactions in guiding the 
radical to the substrate. The established weak interactions by 3'-OH has also been supported by 
other studies which investigated the dependence of the pKa value of C19-H on the cobalt redox 
state in which the exchange of C19-H with deuterium from D2O was analyzed by NMR. Since the 
DFT calculations claimed the polarization of the C19-H bond after the homolytic cleavage of the 
Co-C bond, which was hypothesized to promote the C19-H critical interactions with the ribose 3'-
OH by hydrogen bonding, the acidity of the C19-H was consequently evaluated in cob(I)alamin, 
cob(II)alamin as well as cob(III)alamin. These studies demonstrated the inability of C19-H in 
cob(I)alamin, cob(II)alamin as well as in cob(III)alamin to exchange with deuterium from D2O 
in pH ranging from 3 to 10.8 and therefore implied weak hydrogen bonding in case of any C19-H 
interactions as established from the use of the 3',5'-dideoxyderivative (33).
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Other experimental explorations for determination of the extent of C19-H and 3'-OH interactions 
were provided by studies which used the diastereoisomers; (R)- and (S)-2,3- 
dihydroxypropylcobalamin as models for coenzyme B12. Both the NOE and HMBC based 1D as 
well as the results from the 2D NMR spectroscopic studies for these model compounds were not 
able to reveal spatial interactions of C19-H with β-ligands of R2 and S2. These results were 
compromised by description on the inability to demonstrate the interactions by NMR 
spectroscopy in due to the course of C19-H weak interactions as established by other studies 
designs. Furthermore, the crystal structures of the model compounds revealed C19-H  O distances 
of 3.214 and 3.281 for respective R and S-isomers which suggested weak hydrogen bonding 
interactions. The dissociation energies for these crystal structures predicted hydrogen bonds were 
estimated to ˂ 6 kJmol-1.186      
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Also mechanistically significant in relation to the studies which used modified β-ligand 
coenzyme B12 derivatives has been the same Km values of 3',5'-dideoxyadenosylcobalamin (33) 
and coenzyme B12 (4) for apo-glutamate mutase. These values have suggested coenzyme B12 (4) 
and 3', 5'-dideoxyadenosylcobalamin (33) equal affinities to glutamate mutase protein. The 
demonstrated inhibition of glutamate mutase by 2',5'-dideoxyadenosylcobalamin (32), 
peptidoadenylcobalamin (34) as well as the peptidoindolecobalamin further implies the strength 
of binding to glutamate mutase exhibited by these β-ligand modified cobalamin derivatives is 
comparable to coenzyme B12. Hydroxocobalamin has also inhibitory properties to glutamate 
mutase similar to these β-ligand modified derivatives. Mechanistic implication related to the 
cofactor structure derived from these results has been the suggestion that the ribose moiety of the 
5'-deoxyadenosyl ligand does not have a role in “base-off, his-on” binding of cofactor to apo-
glutamate mutase.  
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